	<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
	<channel rdf:about="https://biorxiv.org">
	<admin:errorReportsTo rdf:resource="mailto:biorxiv@cshlpress.edu"/>
	<title>bioRxiv Channel: Impact of Genomic Variation on Function (IGVF)</title>
	<link>https://biorxiv.org</link>
	<description>
	This feed contains articles for bioRxiv Channel "Impact of Genomic Variation on Function (IGVF)"
	</description>

		<items>
	<rdf:Seq>
		</rdf:Seq>
	</items>
	<prism:eIssn/>
	<prism:publicationName>bioRxiv</prism:publicationName>
	<prism:issn/>

	<image rdf:resource=""/>
	</channel>
	<image rdf:about="">
	<title>bioRxiv</title>
	<url/>
	<link>https://biorxiv.org</link>
	</image>
	<item rdf:about="https://biorxiv.org/content/10.64898/2026.04.02.716195?rss=1">
<title>
<![CDATA[
Hybrid crosses reveal a cell-type-specific landscape of mouse regulatory variation 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.04.02.716195?rss=1</link>
<description><![CDATA[
Understanding the genetic architecture of gene expression is fundamental to evolutionary biology and medicine. As part of the IGVF Consortium, we present a single-nucleus RNA-seq resource of 5.3 million nuclei across eight tissue groups, featuring seven F1 hybrids from C57BL/6J dams crossed with the other Collaborative Cross founder strains for comparison against parental strains. We identify 25,864 genes (91% of those detected) exhibiting non-conserved regulatory behavior in at least one of 92 cell types in one or more crosses. Our results show that while cis-acting variation primarily drives divergence, trans-acting effects are substantially more cell-type specific and sensitive to tissue environment. Notably, bulk tissue analyses frequently mask these signals, particularly in smaller populations such as astrocytes. Furthermore, increasing genetic divergence primarily expands the landscape of cis-acting variation, while trans-acting effects remain stable across genetic distances within species. This atlas establishes a foundational framework for decoding the complex interplay between genetic variation and cell-type-specific regulation across the mammalian body.
]]></description>
<dc:creator>Weber, R.</dc:creator>
<dc:creator>Carilli, M.</dc:creator>
<dc:creator>Rebboah, E.</dc:creator>
<dc:creator>Filimban, G.</dc:creator>
<dc:creator>Liang, H. Y.</dc:creator>
<dc:creator>Trout, D.</dc:creator>
<dc:creator>Duffield, M.</dc:creator>
<dc:creator>Mahdipoor, P.</dc:creator>
<dc:creator>Taghizadeh, E.</dc:creator>
<dc:creator>Fattahi, N.</dc:creator>
<dc:creator>Mojaverzargar, R.</dc:creator>
<dc:creator>Kawauchi, S.</dc:creator>
<dc:creator>Williams, B. A.</dc:creator>
<dc:creator>MacGregor, G.</dc:creator>
<dc:creator>Wold, B.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:creator>Hallgrimsdottir, I. B.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:date>2026-04-04</dc:date>
<dc:identifier>doi:10.64898/2026.04.02.716195</dc:identifier>
<dc:title><![CDATA[Hybrid crosses reveal a cell-type-specific landscape of mouse regulatory variation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.30.715055?rss=1">
<title>
<![CDATA[
High-throughput biochemical phenotyping of SHP2 variants reveals molecular basis of diseases and allosteric drug inhibition 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.30.715055?rss=1</link>
<description><![CDATA[
Interpreting clinical and functional consequences of genetic variants remains challenging due to limited quantitative biochemical data at scale. We applied high-throughput microfluidic enzyme kinetics to profile 190 clinical variants of SHP2, a protein tyrosine phosphatase linked to developmental disorders and cancers. Through >300,000 reaction progress curves, we derived kinetic and thermodynamic parameters quantifying variant effects on catalysis, autoinhibition, stability, phosphopeptide binding, and drug responses. This multidimensional dataset reveals that dysregulated autoinhibition, rather than altered stability or catalysis, predominantly determines SHP2-associated pathogenesis. Thermodynamic modeling reveals that clinical-stage allosteric inhibitors preferentially stabilize a previously underappreciated, partially active conformation over the fully inactive state, leading to variant-dependent drug responses. Our high-throughput biochemical framework establishes a general approach to decipher the biochemical logic connecting protein variants to clinical outcomes.
]]></description>
<dc:creator>Lee, A. A.</dc:creator>
<dc:creator>Mokhtari, D. A.</dc:creator>
<dc:creator>Egan, E. D.</dc:creator>
<dc:creator>Blacklow, S. C.</dc:creator>
<dc:creator>Herschlag, D.</dc:creator>
<dc:creator>Fordyce, P. M.</dc:creator>
<dc:date>2026-04-01</dc:date>
<dc:identifier>doi:10.64898/2026.03.30.715055</dc:identifier>
<dc:title><![CDATA[High-throughput biochemical phenotyping of SHP2 variants reveals molecular basis of diseases and allosteric drug inhibition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.27.714794?rss=1">
<title>
<![CDATA[
Structured Pooling Improves Detection of Rare Regulatory Mutations in Population-Scale Reporter Assays 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.27.714794?rss=1</link>
<description><![CDATA[
Identifying genetic variants in noncoding DNA that impact gene expression and thereby contribute to disease risk remains a difficult but important challenge in genomic medicine. Modern reporter assays such as STARR-seq and MPRA provide an efficient and effective means of testing, in very high throughput, millions of variants captured directly from patient genomes. While these assays have previously been scaled to whole genomes and, separately, to populations, we report findings from the first whole-genome population-scale STARR-seq experiment performed on 100 individuals. In order to achieve that scale we devised a novel experimental design that partitions samples into pools so as to increase allele frequencies within pools and thereby reduce expected dropout and increase signal-to-noise ratio in experimental readouts. We show that this design produces more accurate estimates of variant effect sizes, and we provide a Bayesian model for robust estimation of those effect sizes that also reports full posterior distributions for assessment of confidence in estimates. Together, these methodological innovations facilitate the detection of functional regulatory variants, particularly rare variants, with much higher accuracy and at greater scale than previously possible. We demonstrate the utility of this approach on the task of functional annotation of quantitative trait loci such as eQTLs and caQTLs, and show concordance with patterns of constraint in transcription factor binding profiles.
]]></description>
<dc:creator>Dura, K.</dc:creator>
<dc:creator>Siklenka, K.</dc:creator>
<dc:creator>Strouse, K. P.</dc:creator>
<dc:creator>Morrow, S.</dc:creator>
<dc:creator>Zhang, C.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Reddy, T. E.</dc:creator>
<dc:creator>Majoros, W. H.</dc:creator>
<dc:date>2026-03-31</dc:date>
<dc:identifier>doi:10.64898/2026.03.27.714794</dc:identifier>
<dc:title><![CDATA[Structured Pooling Improves Detection of Rare Regulatory Mutations in Population-Scale Reporter Assays]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.27.714770?rss=1">
<title>
<![CDATA[
Modeling gene regulatory perturbations via deep learning from high-throughput reporter assays 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.27.714770?rss=1</link>
<description><![CDATA[
Assessing likely variant effects on phenotypes is of critical importance in diagnostic settings, and while much progress has been made in interpreting genic mutations based on our understanding of coding sequence, noncoding variants can be much more challenging to reliably interpret based on DNA sequence alone. High-throughput reporter assays such as STARR-seq and MPRA have shown utility in experimentally measuring regulatory effects of noncoding variants present in samples but provide no readout for variants not present in the assay inputs. However, whole-genome reporter assays provide copious data that can be used to train predictive models for prioritizing variants not directly observed in the experiment. We describe a retrainable predictive modeling framework, BlueSTARR, for this task, and present results of training several models with this framework on whole-genome STARR-seq data from two cell lines and one drug treatment. Using these models, we uncover a global signature across the human genome consistent with purifying selection against both loss-of-function and gain-of-function regulatory variants, with the latter showing a significant bias consistent with selection against gains of cis regulatory function in closed chromatin proximal to genes. By testing the model on synthetic enhancers with binding motifs for transcription factors GR and AP-1, we find that when trained on drug perturbation data, the model is able to learn distance-dependent and treatment-dependent binding patterns and their resulting reporter gene activation. These results demonstrate that lightweight, easily retrainable models such as ours have utility in probing latent signals present in novel experimental data. Finally, we find only modest differences in performance between different deep-learning architectures when trained on this single data modality, and while somewhat greater predictive accuracy can be achieved with much larger models trained at great expense on many terabytes of data, there is still copious room for improvement even for industrial strength, state-of-the-art models.
]]></description>
<dc:creator>Venukuttan, R.</dc:creator>
<dc:creator>Doty, R.</dc:creator>
<dc:creator>Thomson, A.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Li, B.</dc:creator>
<dc:creator>Duan, Y.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>Dura, K.</dc:creator>
<dc:creator>Ko, K.-Y.</dc:creator>
<dc:creator>Lapp, H.</dc:creator>
<dc:creator>Reddy, T. E.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Majoros, W. H.</dc:creator>
<dc:date>2026-03-31</dc:date>
<dc:identifier>doi:10.64898/2026.03.27.714770</dc:identifier>
<dc:title><![CDATA[Modeling gene regulatory perturbations via deep learning from high-throughput reporter assays]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.20.712202?rss=1">
<title>
<![CDATA[
A graph-based learning approach to predict the effects of gene perturbations on molecular phenotypes 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.20.712202?rss=1</link>
<description><![CDATA[
MotivationLarge-scale gene knockdown/knockout screens have been used to gain insight into a wide array of phenotypes and biological processes. However, conducting such experiments is expensive and labor-intensive. In this work, we present a general graph-based machine-learning approach that can predict the effects of gene perturbations on molecular phenotypes of interest given some measured phenotypic effects of other gene perturbations. The motivation for learning models that can predict the effects of gene perturbations is fourfold. Such models can (1) predict effects for unmeasured genes in cases in which cost or technical barriers preclude perturbing every gene, (2) prioritize unmeasured genes or sets of genes for subsequent perturbation experiments, (3) hypothesize mechanisms that underlie the relationships between the perturbed genes and their effects, and (4) generalize to other unmeasured phenotypes of interest.

ResultsWe evaluate our approach by applying it, in conjunction with four different learning methods, to learn models for four varied phenotypes. Our empirical evaluation demonstrates that the learned models (1) show relatively high levels of predictive accuracy across the four phenotypes, (2) have better predictive accuracy than several standard baselines, (3) can often learn accurate models with small training sets, (4) benefit from having multiple sources of evidence in the input representation, (5) can, in many cases, transfer their predictive value to other phenotypes.

Data availabilityThe assembled data sets and source code for this work are available at: https://github.com/Craven-Biostat-Lab/graph-molecular-phenotype-prediction

Author summaryOne general approach for gaining insight into the genes involved in a specific biological process is to conduct an experiment in which individual genes are perturbed and the effect on the process is measured for each perturbation. Large-scale experiments of this type have provided important biological insights, but they are often expensive and labor-intensive to perform. As a result, it is not always feasible to measure the effects of perturbing every gene. In this article, we present a machine-learning approach to predicting the effects of gene perturbations using available experimental data and biological network information. Our method can estimate the effects of genes that have not yet been experimentally measured, helping researchers identify promising genes to study next. In addition, the models can suggest hypotheses about the molecular interactions that link genes to the biological process of interest. Approaches like this may help guide experimental studies and accelerate the discovery of gene-phenotype relationships.
]]></description>
<dc:creator>Jin, Y.</dc:creator>
<dc:creator>Sverchkov, Y.</dc:creator>
<dc:creator>Sushkova, A.</dc:creator>
<dc:creator>Ohtake, M.</dc:creator>
<dc:creator>Emfinger, C.</dc:creator>
<dc:creator>Craven, M.</dc:creator>
<dc:date>2026-03-23</dc:date>
<dc:identifier>doi:10.64898/2026.03.20.712202</dc:identifier>
<dc:title><![CDATA[A graph-based learning approach to predict the effects of gene perturbations on molecular phenotypes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.13.711357?rss=1">
<title>
<![CDATA[
Comparing bulk and single-cell methodologies and models to profile gene expression, chromatin accessibility and regulatory links in endothelial cells treated with TNFα 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.13.711357?rss=1</link>
<description><![CDATA[
Genome-wide association studies (GWAS) have identified thousands of non-coding variants associated with complex traits and diseases. However, it remains challenging to pinpoint the causal genes that are regulated by associated genetic variants. Connecting causal non-coding variants with genes can rely on methods that identify direct physical interactions (e.g. chromosome conformation capture) or on probabilistic models that predict regulatory links. These statistical models take advantage of gene expression and chromatin accessibility profiles generated in cells and tissues by bulk or single-cell (sc) methodologies. Here, we tested whether using bulk or sc RNAseq/ATACseq data and corresponding predictive enhancer-to-gene models impact the prioritization of causal GWAS genes. Using non-treated and TNF-treated human endothelial cells in vitro as a well-controlled experimental system, we show that bulk and sc RNAseq/ATACseq profiles are similar and highlight the same biology (e.g. biological pathways). Despite these similarities, we show using GWAS results for coronary artery disease (CAD) and diastolic blood pressure that applying enhancer-to-gene models designed for bulk or sc methodologies can yield differences in terms of captured heritability, fine-mapped variants and linked genes. For instance, at one CAD locus, the bulk-based ABC model predicts a regulatory link with BCAR1, whereas the sc-based model scE2G prioritizes a different gene (CFDP1). On the same experimental model, our results indicate that choosing between a bulk or sc approach will influence regulatory link model predictions; this should be considered when planning functional experiments to characterize GWAS discoveries.
]]></description>
<dc:creator>Zevounou, J.</dc:creator>
<dc:creator>Lo, K. S.</dc:creator>
<dc:creator>McGinnis, C. S.</dc:creator>
<dc:creator>Satpathy, A. T.</dc:creator>
<dc:creator>Lettre, G.</dc:creator>
<dc:date>2026-03-16</dc:date>
<dc:identifier>doi:10.64898/2026.03.13.711357</dc:identifier>
<dc:title><![CDATA[Comparing bulk and single-cell methodologies and models to profile gene expression, chromatin accessibility and regulatory links in endothelial cells treated with TNFα]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.09.710372?rss=1">
<title>
<![CDATA[
Genome-scale mapping of variant, enhancer and gene function in primary human CD4+ T cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.09.710372?rss=1</link>
<description><![CDATA[
CD4+ T cells harbor a disproportionate enrichment of immune disease risk loci and represent the primary cellular context for immune disease biology, yet the genes and regulatory programs these variants affect remain largely unknown. We combined targeted Perturb-seq of 1,032 cis-regulatory elements (CREs) overlapping 4,724 variants across 14 immune diseases with genome-wide Perturb-seq of all expressed genes in primary human CD4+ T cells, spanning 4.1 million cells. We identified 626 CRE-gene pairs, and connected CRE targets to downstream regulatory cascades. At the TYK2 and DEXI/CLEC16A loci, we resolved target genes and linked noncoding variants to inflammatory and metabolic programs. Across diseases, we revealed that dispersed variants converged on shared and disease-specific programs. Our work provides a framework for tracing variant-to-CRE-to-gene-to-network in disease-relevant primary cells.
]]></description>
<dc:creator>Moonen, D. P.</dc:creator>
<dc:creator>Claringbould, A.</dc:creator>
<dc:creator>Gschwind, A. R.</dc:creator>
<dc:creator>Schrod, S.</dc:creator>
<dc:creator>Braunger, J.</dc:creator>
<dc:creator>Feng, C.</dc:creator>
<dc:creator>Rauscher, B.</dc:creator>
<dc:creator>Yi, J.</dc:creator>
<dc:creator>Bi, S. Z.</dc:creator>
<dc:creator>Matthess, Y.</dc:creator>
<dc:creator>Kaulich, M.</dc:creator>
<dc:creator>Acob, R. A.</dc:creator>
<dc:creator>Ayer, A.</dc:creator>
<dc:creator>Engreitz, J. M.</dc:creator>
<dc:creator>Velten, B.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Trynka, G.</dc:creator>
<dc:creator>Zaugg, J. B.</dc:creator>
<dc:creator>Schraivogel, D.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:date>2026-03-11</dc:date>
<dc:identifier>doi:10.64898/2026.03.09.710372</dc:identifier>
<dc:title><![CDATA[Genome-scale mapping of variant, enhancer and gene function in primary human CD4+ T cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.07.710282?rss=1">
<title>
<![CDATA[
Reprogramming of neuronal genome function and phenotype by astrocytes 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.07.710282?rss=1</link>
<description><![CDATA[
Heterotypic cell-cell interactions are critical to governing cellular physiology, disease progression, and responses to the environment and pharmacologic interventions. For example, neurons and astrocytes engage in intricate interactions that are essential for brain development and function1-3. However, the transformation of these extracellular signals into epigenomic regulation that governs cell function is poorly understood. Here, we report that weeks of co-culture between human induced pluripotent stem cell (hiPSC)-derived neurons and mouse cortical astrocytes extensively reprograms gene expression and the chromatin accessibility landscape in neurons, affecting thousands of genes and putative gene regulatory elements (REs), including many transcription factors (TFs). These genes are enriched for functions implicated in neuronal differentiation and maturation, and tend to be impacted in schizophrenia, and autosomal dominant Alzheimers disease. Through complementary CRISPR interference and activation screens, we recapitulated hundreds of astrocyte-induced transcriptional and chromatin remodeling events in mono-cultured neurons at both promoters and distal regulatory elements (REs) of TF genes. We discovered functional REs for [~]50 astrocyte-responsive TF genes, providing a map of gene regulatory network control. Astrocyte-responsive TF genes fall into groups that exert independent or counter-balancing transcriptional effects, highlighting the complex coordination of the neuronal response to astrocytes. Functional effects of specific TFs, including POU3F2 and TFAP2E, on neurite morphology and neuronal electrophysiology are consistent with transcriptional effects, demonstrating the capacity of direct epigenetic control to mimic heterotypic cellular signals. This work illuminates the regulation of neurodevelopment-and disease-relevant gene modules by neuron-astrocyte interactions, and provides a blueprint for applying modern functional genomics to uncover the links between cell microenvironment and epigenomic programming.

HighlightsO_LINeuronal gene expression and chromatin accessibility landscape are profoundly remodeled by astrocytes over weeks of co-culture
C_LIO_LIAstrocyte-responsive neuronal gene modules and neuron-responsive astrocytic gene modules are enriched for genes associated with schizophrenia and familial Alzheimers Disease
C_LIO_LISingle-cell CRISPR interference and activation screens of astrocyte-responsive gene regulatory elements identified dozens of functional regulatory elements of TF genes in neurons
C_LIO_LISingle-cell CRISPR interference and activation screens of >200 astrocyte-responsive TF genes uncovered discrete functional clusters that promote neuronal maturity or stemness
C_LIO_LIAstrocyte-responsive TF genes reprogram neuronal electrophysiology and neurite morphology
C_LI
]]></description>
<dc:creator>Li, B.</dc:creator>
<dc:creator>Hagy, K.</dc:creator>
<dc:creator>Safi, A.</dc:creator>
<dc:creator>Beer, M. A.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>Geraghty, S.</dc:creator>
<dc:creator>Rai, R.</dc:creator>
<dc:creator>Pederson, A. N.</dc:creator>
<dc:creator>Reisman, S. J.</dc:creator>
<dc:creator>Love, M. I.</dc:creator>
<dc:creator>Sullivan, P. F.</dc:creator>
<dc:creator>Eroglu, C.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2026-03-07</dc:date>
<dc:identifier>doi:10.64898/2026.03.07.710282</dc:identifier>
<dc:title><![CDATA[Reprogramming of neuronal genome function and phenotype by astrocytes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.04.709349?rss=1">
<title>
<![CDATA[
Single-Cell Genomics Decontamination with CellSweep 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.04.709349?rss=1</link>
<description><![CDATA[
Single-cell genomics technologies enable high-throughput cell profiling, but technical contamination remains an obstacle to accurate downstream analysis. Free-floating ambient molecules released from lysed cells and global bulk contamination introduced during library preparation can distort molecular profiles. These artifacts can obscure cellular identities and reduce the reliability of differential analysis or clustering results. We present an efficient and effective approach to removing ambient and bulk contamination that can be applied to data generated from a wide variety of technologies. We show that our tool, CellSweep, outperforms other methods to remove artifacts using numerous benchmarks.
]]></description>
<dc:creator>Caskey, M.</dc:creator>
<dc:creator>Rich, J.</dc:creator>
<dc:creator>Weber, R.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:creator>Hallgrimsdottir, I. B.</dc:creator>
<dc:date>2026-03-06</dc:date>
<dc:identifier>doi:10.64898/2026.03.04.709349</dc:identifier>
<dc:title><![CDATA[Single-Cell Genomics Decontamination with CellSweep]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.05.709922?rss=1">
<title>
<![CDATA[
Massive-scale single-nucleus multi-omics identifies novel rare noncoding drivers of Parkinson's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.05.709922?rss=1</link>
<description><![CDATA[
Most genetic variants contributing to complex diseases reside in the noncoding genome. While common variants uncovered by genome-wide association studies often fail to explain much of the observed heritability of these diseases, rare variants often have higher effect sizes and cumulatively explain a larger portion of heritability. However, rare variants, particularly rare noncoding variants, have remained under-characterized largely due to the difficulties of accurately predicting variant functionality at scale, given that each individual carries an average of [~]10,000 rare variants. Here, we generated multi-omic data from >3.3 million nuclei sampled from five brain regions across a cohort of 80 individuals with Parkinsons disease (PD) and 21 neurologically normal control individuals with matched 30x whole-genome sequencing. We use this data to identify cell type-specific features of PD, map cell type-specific chromatin accessibility and expression quantitative trait loci, and train machine learning models to predict the effect of variants on gene regulation. We identify rare noncoding variants statistically associated with sporadic PD and extend our approaches to predict drivers of familial PD of unknown genetic origin. Our results underscore the significance of rare noncoding variants in complex diseases and provide a roadmap for applying similar approaches in other disease systems.
]]></description>
<dc:creator>Menon, S.</dc:creator>
<dc:creator>Turner, A. W.</dc:creator>
<dc:creator>Chang, S. H.</dc:creator>
<dc:creator>Johnson, A. W.</dc:creator>
<dc:creator>Chang, H. H.</dc:creator>
<dc:creator>Shah, A. J.</dc:creator>
<dc:creator>Zeng, Y.</dc:creator>
<dc:creator>Strohlein, C. E.</dc:creator>
<dc:creator>Kampman, L.</dc:creator>
<dc:creator>Colston, C.</dc:creator>
<dc:creator>Kozlenkov, A.</dc:creator>
<dc:creator>Dracheva, S.</dc:creator>
<dc:creator>Avenali, M.</dc:creator>
<dc:creator>Palermo, G.</dc:creator>
<dc:creator>Ceravolo, R.</dc:creator>
<dc:creator>Valente, E. M.</dc:creator>
<dc:creator>Gabbert, C.</dc:creator>
<dc:creator>Trinh, J.</dc:creator>
<dc:creator>Serrano, G. E.</dc:creator>
<dc:creator>Beach, T. G.</dc:creator>
<dc:creator>Global Parkinson's Genetic Program (GP2),</dc:creator>
<dc:creator>Shulman, J. M.</dc:creator>
<dc:creator>Blauwendraat, C.</dc:creator>
<dc:creator>Montine, T. J.</dc:creator>
<dc:creator>Fang, Z.-H.</dc:creator>
<dc:creator>Belloy, M. E.</dc:creator>
<dc:creator>Corces, M. R.</dc:creator>
<dc:date>2026-03-05</dc:date>
<dc:identifier>doi:10.64898/2026.03.05.709922</dc:identifier>
<dc:title><![CDATA[Massive-scale single-nucleus multi-omics identifies novel rare noncoding drivers of Parkinson's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.17.706269?rss=1">
<title>
<![CDATA[
Gene- and domain-aware calibration increases the clinical utility of variant effect predictors 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.17.706269?rss=1</link>
<description><![CDATA[
The utility of clinical genetic testing is limited because around 90% of missense variants in ClinVar remain of uncertain clinical significance. Variant effect predictors (VEPs) can score any missense variant, potentially empowering variant classification. Realizing this potential requires calibration to translate predictor scores into evidence. However, genome-wide calibration ignores predictor heterogeneity across genes, causing evidence misassignment. We developed an automated, data-adaptive framework that optimizes two complementary approaches: gene-specific calibration for genes with enough variants for calibration, and domain-aggregate calibration for other disease-associated genes, which groups variants from protein domains with similar predictor score distributions for calibration. Applied to three predictors across 2,769 genes, this framework assigned evidence to 10.6% more variants on average while generally improving evidence accuracy compared to genome-wide calibration. These calibrations and the resulting calibrated computational evidence are available through the PredictMD portal. Our framework substantially increases the clinical utility of VEPs for variant classification.
]]></description>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Fayer, S.</dc:creator>
<dc:creator>Jain, S.</dc:creator>
<dc:creator>Benazouz, M.</dc:creator>
<dc:creator>Sverchkov, Y.</dc:creator>
<dc:creator>Stone, J.</dc:creator>
<dc:creator>Sharma, H.</dc:creator>
<dc:creator>Bergquist, T.</dc:creator>
<dc:creator>Stewart, R.</dc:creator>
<dc:creator>Mooney, S. D.</dc:creator>
<dc:creator>Craven, M.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:creator>Starita, L. M.</dc:creator>
<dc:creator>Fowler, D. M.</dc:creator>
<dc:creator>Pejaver, V.</dc:creator>
<dc:date>2026-02-18</dc:date>
<dc:identifier>doi:10.64898/2026.02.17.706269</dc:identifier>
<dc:title><![CDATA[Gene- and domain-aware calibration increases the clinical utility of variant effect predictors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.14.705914?rss=1">
<title>
<![CDATA[
Ancestry-specific performance of variant effect predictors in clinical variant classification 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.14.705914?rss=1</link>
<description><![CDATA[
Predicting the effects of genetic variants and assessing prediction performance are key computational tasks in genomic medicine. It has been shown that well-calibrated variant effect predictors can be reliably used as evidence towards establishing pathogenicity (or benignity) of missense variants, thereby rendering these variants suitable for use in (or exclusion from) the genetic diagnosis of rare Mendelian conditions. However, most predictors have been trained or calibrated on data that may not be sufficiently representative to lead to similar performance across all genetic ancestries. This raises questions about the responsible deployment of these tools to improve human health. To better understand the utility of computational predictors, we set out to assess their ancestry-specific performance in terms of accuracy and evidence strength according to the ACMG/AMP guidelines. First, we determined that the expected count of rare variants in an individuals genome and the allele frequency distribution of these variants are the key confounders when evaluating a predictors performance across different genetic ancestries. Second, we found that a predictors accuracy itself inversely correlates with the allele frequency of the rare variant. After stratifying according to allele frequency, we show that established methods for predicting the pathogenicity of missense variants have comparable performance levels across major ancestry groups. Our results therefore support the wide deployment of such models in the context of genetic diagnosis and related applications.
]]></description>
<dc:creator>Hoffing, R.</dc:creator>
<dc:creator>Zeiberg, D.</dc:creator>
<dc:creator>Stenton, S. L.</dc:creator>
<dc:creator>Mort, M.</dc:creator>
<dc:creator>Cooper, D. N.</dc:creator>
<dc:creator>Hahn, M. W.</dc:creator>
<dc:creator>O'Donnell-Luria, A.</dc:creator>
<dc:creator>Ward, L. D.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:date>2026-02-17</dc:date>
<dc:identifier>doi:10.64898/2026.02.14.705914</dc:identifier>
<dc:title><![CDATA[Ancestry-specific performance of variant effect predictors in clinical variant classification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.14.705848?rss=1">
<title>
<![CDATA[
A scalable approach to resolving variants of uncertain significance 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.14.705848?rss=1</link>
<description><![CDATA[
Over 90% of missense variants across [~]4,000 disease-associated genes are variants of uncertain significance (VUS). Experimental variant effect measurements provide critical evidence about pathogenicity and inform disease biology, but most variants lack data and clinical translation has been limited. The Impact of Genomic Variation on Function Consortium generated experimental data for 62,215 variants across ten genes using multiplexed assays and 1,407 variants across 163 genes using arrayed assays, curated 193,139 additional community-generated variant effect measurements across 30 additional genes, and developed automated calibration methods for translating experimental data and variant effect predictions into clinical evidence. To reduce current VUS, we developed a scalable workflow using only experimental and predictive evidence, enabling reclassification of 75% of the 16,115 VUS in these genes as pathogenic or benign with <1% error. To minimize future VUS, we analyzed >90,000 unobserved variants; 62% had enough evidence to be "preclassified" as pathogenic or benign. We validated our data, evidence and classifications using All of Us and created interactive resources to enable clinical use of the calibrated data. Thus, for 40 genes, representing 1% of the clinical genome, we resolve most existing VUS and future variants, illustrating how systematic use of scalable evidence can empower genomic medicine.
]]></description>
<dc:creator>Tejura, M.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>McEwen, A. E.</dc:creator>
<dc:creator>Stewart, R.</dc:creator>
<dc:creator>Sverchkov, Y.</dc:creator>
<dc:creator>Laval, F.</dc:creator>
<dc:creator>Woo, I.</dc:creator>
<dc:creator>Zeiberg, D.</dc:creator>
<dc:creator>Shen, R.</dc:creator>
<dc:creator>Fayer, S.</dc:creator>
<dc:creator>Stone, J.</dc:creator>
<dc:creator>Smith, N.</dc:creator>
<dc:creator>Casadei, S.</dc:creator>
<dc:creator>Wang, Z. R.</dc:creator>
<dc:creator>Snyder, M.</dc:creator>
<dc:creator>Capodanno, B. J.</dc:creator>
<dc:creator>Gupta, P.</dc:creator>
<dc:creator>Benazouz, M.</dc:creator>
<dc:creator>Jain, S.</dc:creator>
<dc:creator>Heidl, S.</dc:creator>
<dc:creator>Muffley, L.</dc:creator>
<dc:creator>Dong, S.</dc:creator>
<dc:creator>Lin, K.</dc:creator>
<dc:creator>Hitz, B. C.</dc:creator>
<dc:creator>Gabdank, I.</dc:creator>
<dc:creator>Da, E. Y.</dc:creator>
<dc:creator>Best, S.</dc:creator>
<dc:creator>Grindstaff, S.</dc:creator>
<dc:creator>Reinhart, D.</dc:creator>
<dc:creator>Rodriguez-Salas, L.</dc:creator>
<dc:creator>Seid, O.</dc:creator>
<dc:creator>Vandi, A. J.</dc:creator>
<dc:creator>Wenman, C.</dc:creator>
<dc:creator>Wheelock, M. K.</dc:creator>
<dc:creator>Pendyala, S.</dc:creator>
<dc:creator>Holmes, D.</dc:creator>
<dc:creator>Xu, A.</dc:creator>
<dc:creator>Hosokai, A.</dc:creator>
<dc:creator>Tixhon, M.</dc:creator>
<dc:creator>Reno, C.</dc:creator>
<dc:creator>Ewald, J. D.</dc:creator>
<dc:creator>Spirohn-Fitzgerald, K.</dc:creator>
<dc:creator>Teelucksingh, T.</dc:creator>
<dc:creator>Hao, T.</dc:creator>
<dc:creator>Chen, Z. S.</dc:creator>
<dc:creator>Haghighi, M.</dc:creator>
<dc:creator>Hamid, A. K.</dc:creator>
<dc:creator></dc:creator>
<dc:date>2026-02-15</dc:date>
<dc:identifier>doi:10.64898/2026.02.14.705848</dc:identifier>
<dc:title><![CDATA[A scalable approach to resolving variants of uncertain significance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.05.703637?rss=1">
<title>
<![CDATA[
Short-Context Regulatory DNA Language Models with Motif-Discovery Regularization 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.05.703637?rss=1</link>
<description><![CDATA[
DNA language models (DNALMs) aim to learn representations of genomic sequence for variant interpretation, regulatory prediction, and sequence design. Most DNALMs are trained on whole genomes and long contexts, but regulatory DNA poses a distinct challenge: functional elements are sparse, context dependent, and encoded by short transcription factor motif syntax embedded in extensive background sequence. We introduce ARSENAL, a short-context masked DNA language model pretrained on ENCODE candidate cis-regulatory elements. ARSENAL recovers diverse transcription factor motifs de novo and improves zero-shot regulatory variant effect prediction relative to other DNALM foundation models. ARSENAL embeddings also improve supervised regulatory sequence models at predicting chromatin accessibility and regulatory variant scoring. Finally, ARSENAL serves as an efficient generative prior, enabling multi-objective regulatory sequence design with supervised oracles. ARSENAL shows that targeted self-supervised pretraining on regulatory regions can learn biologically meaningful and transferable regulatory representations without genome-scale training, long contexts or task-specific labels.

Code is available at https://github.com/kundajelab/regulatory_lm. Models and data are shared at https://sageb.io/ydjhqM
]]></description>
<dc:creator>Patel, A.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:date>2026-02-06</dc:date>
<dc:identifier>doi:10.64898/2026.02.05.703637</dc:identifier>
<dc:title><![CDATA[Short-Context Regulatory DNA Language Models with Motif-Discovery Regularization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.02.703413?rss=1">
<title>
<![CDATA[
Farm animal evolution demonstrates hidden molecular basis of human traits 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.02.703413?rss=1</link>
<description><![CDATA[
Most human variants identified by genome-wide association studies are believed to affect traits by altering gene expression. This belief is supported by considerable circumstantial evidence, but statistical methods are unable to link most trait-associated variants to gene expression--a problem we refer to as "missing regulation." Many explanations have been proposed, including the possibility that natural selection on gene expression limits power. Here, we take a novel approach to the question of missing regulation, beginning with the observation that the majority of trait-associated variants alter gene expression in two non-human species: cattle and pigs. We explain this discrepancy by comparing the species evolutionary histories. The observed differences in regulatory variants are consistent with selection on human gene regulation and increased genetic drift due to agricultural breeding. The differences are not limited to specific genes and reflect increased ascertainment of regulatory variants that are distal to genes. Additionally, we show that trait-associated gene regulation in cattle and pigs matches observed patterns from complex-trait genetics in humans, and may reflect currently unobserved trait-associated regulation in humans.
]]></description>
<dc:creator>Connally, N. J.</dc:creator>
<dc:creator>Sunyaev, S.</dc:creator>
<dc:date>2026-02-04</dc:date>
<dc:identifier>doi:10.64898/2026.02.02.703413</dc:identifier>
<dc:title><![CDATA[Farm animal evolution demonstrates hidden molecular basis of human traits]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.01.703129?rss=1">
<title>
<![CDATA[
Mismatch tolerance of a gRNA for CRISPR-based gene activation confers broad activity critical for cell reprogramming 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.01.703129?rss=1</link>
<description><![CDATA[
CRISPR activation and interference systems (CRISPRa/i) are widely used for programmable transcriptional control. Although these technologies are capable of highly specific single-gene activity, some applications of transcriptional network reprogramming require broad, genome-wide effects. Here, we identify a CRISPRa gRNA that robustly reprograms astrocyte transcriptional state. Unexpectedly, this activity arises from extensive off-target binding that induces expression changes in thousands of genes, unlike neighboring gRNAs targeting the same intended on-target site. We leverage this promiscuous gRNA to dissect determinants of gRNA-driven off-target dCas9 binding in the context of transcriptional reprogramming. Using ChIP-seq, high-throughput protein-binding microarrays, and gRNA-variant library screening in cells, we demonstrate that PAM-proximal bases are primary determinants of genomic binding, mismatch tolerance is both gRNA- and base-specific, and targeted mutations within the PAM-proximal region can tune gRNA specificity. We further demonstrate that CRISPRa-driven phenotypes can reflect combined contributions from widespread off-target activity and dose-dependent on-target effects. These findings highlight the potentially widespread impacts of CRISPRa off-target activity, underscore the need to account for cryptic effects when selecting and evaluating gRNAs for programming cell phenotypes, and demonstrate that multi-site binding by CRISPRa systems can be exploited as a feature for network-level perturbations in cell reprogramming.

GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/703129v1_ufig1.gif" ALT="Figure 1">
View larger version (34K):
org.highwire.dtl.DTLVardef@b697b0org.highwire.dtl.DTLVardef@1a0b390org.highwire.dtl.DTLVardef@16ce710org.highwire.dtl.DTLVardef@b5d87a_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Reisman, S. J.</dc:creator>
<dc:creator>Zhu, W.</dc:creator>
<dc:creator>Miller, S. E.</dc:creator>
<dc:creator>Halabi, D.</dc:creator>
<dc:creator>Sangvai, N.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Gordan, R.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2026-02-03</dc:date>
<dc:identifier>doi:10.64898/2026.02.01.703129</dc:identifier>
<dc:title><![CDATA[Mismatch tolerance of a gRNA for CRISPR-based gene activation confers broad activity critical for cell reprogramming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.01.703124?rss=1">
<title>
<![CDATA[
Functional Annotation of the Major Histocompatibility Complex Locus 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.01.703124?rss=1</link>
<description><![CDATA[
The human major histocompatibility complex (MHC) locus has the greatest density of disease-associations in the human genome, including links to over 100 polygenic disorders. Its complex haplotype structure, rich gene density, and high degree of linkage disequilibrium combine to make deciphering the gene regulatory logic of the MHC locus extremely challenging. Employing complementary high-throughput CRISPR interference (CRISPRi) and activation (CRISPRa) epigenetic screens coupled with single-cell transcriptome profiling across three distinct human cell types, we identified hundreds of new connections between cis-regulatory elements (CREs) and their target genes in this locus. These CRE-gene links are largely cell type-specific and act as enhancers. Additionally, some CREs have complex features, including harboring both active and repressive histone marks, lacking chromatin accessibility, targeting multiple genes, or acting as silencers. Computational methods fail to predict a majority of these CRE-gene connections. These findings emphasize the potential for functional perturbation experiments to dissect complex loci and reveal shared and cell type-specific regulatory mechanisms relevant to genomics of complex diseases. Collectively, this study provides a unique resource for understanding the complex regulatory landscape within the MHC locus and supports the need for creating new models that encompass CRE-gene interactions, cell type-specific gene expression, and disease genetics in the noncoding genome.
]]></description>
<dc:creator>Bounds, L. R.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>ter Weele, M.</dc:creator>
<dc:creator>Liu, S.</dc:creator>
<dc:creator>Wu, E.</dc:creator>
<dc:creator>Li, S.</dc:creator>
<dc:creator>Venukuttan, R.</dc:creator>
<dc:creator>Rai, R.</dc:creator>
<dc:creator>Mu, W.</dc:creator>
<dc:creator>Iglesias, N.</dc:creator>
<dc:creator>Giusti-Rodriguez, P.</dc:creator>
<dc:creator>Reddy, T. E.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Gordan, R.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Love, M. I.</dc:creator>
<dc:creator>Sullivan, P. F.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2026-02-03</dc:date>
<dc:identifier>doi:10.64898/2026.02.01.703124</dc:identifier>
<dc:title><![CDATA[Functional Annotation of the Major Histocompatibility Complex Locus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.20.700519?rss=1">
<title>
<![CDATA[
Federated single-cell QTL meta-analysis reveals novel disease mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.20.700519?rss=1</link>
<description><![CDATA[
Genetic effects on gene expression are often cell type-specific and obscured in bulk analyses. To resolve this context-dependent regulation, we performed a federated cis-eQTL meta-analysis across 12 PBMC datasets (2,032 individuals, 2.5 million cells). Across six immune cell types, we identified cis-eQTLs for 6,592 genes and fine-mapped 14,985 independent loci. Notably, the 42% of eQTLs that were undetected in a bulk eQTL study on 43,301 whole blood samples also showed stronger enrichment for disease GWAS loci. We further identified three genome-wide significant and 65 suggestive loci affecting the abundance of (rare) immune cell types and validated these using previously reported hematological GWAS and bulk-derived trans-eQTLs. Integrating single-cell cis-eQTLs with bulk trans-eQTLs enabled us to anchor 6,382 trans-eGenes (37.2% novel) to upstream regulators and reconstruct directed gene regulatory relationships. For example, a hemorrhoidal disease-associated variant showed a CD4+ T cell-specific cis-eQTL on BACH1 that colocalized with 45 immune and metabolic trans-eGenes. These results demonstrate the power of single-cell QTL meta-analysis in interpreting complex trait genetics.
]]></description>
<dc:creator>Kaptijn, D.</dc:creator>
<dc:creator>Michielsen, L.</dc:creator>
<dc:creator>Neavin, D.</dc:creator>
<dc:creator>Ripoll-Cladellas, A.</dc:creator>
<dc:creator>Alquicira-Hernandez, J. E.</dc:creator>
<dc:creator>Korshevniuk, M.</dc:creator>
<dc:creator>Lee, J. T. H.</dc:creator>
<dc:creator>Oelen, R.</dc:creator>
<dc:creator>Vochteloo, M.</dc:creator>
<dc:creator>Warmerdam, R.</dc:creator>
<dc:creator>Ando, Y.</dc:creator>
<dc:creator>Ban, M.</dc:creator>
<dc:creator>Bayaraa, O.</dc:creator>
<dc:creator>Berg, M.</dc:creator>
<dc:creator>van Blokland, I.</dc:creator>
<dc:creator>Considine, D.</dc:creator>
<dc:creator>Dieng, M. M.</dc:creator>
<dc:creator>Edahiro, R.</dc:creator>
<dc:creator>Gordon, M. G.</dc:creator>
<dc:creator>Groot, H. E.</dc:creator>
<dc:creator>van der Harst, P.</dc:creator>
<dc:creator>Heinig, M.</dc:creator>
<dc:creator>Hon, C.-C.</dc:creator>
<dc:creator>Idaghdour, Y.</dc:creator>
<dc:creator>Kathail, P.</dc:creator>
<dc:creator>de Klein, N.</dc:creator>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Losert, C.</dc:creator>
<dc:creator>Manikanda, V.</dc:creator>
<dc:creator>Moody, J.</dc:creator>
<dc:creator>Naeem, H.</dc:creator>
<dc:creator>Mokrab, Y.</dc:creator>
<dc:creator>Nawijn, M. C.</dc:creator>
<dc:creator>Netea, M.</dc:creator>
<dc:creator>Niewold, J.</dc:creator>
<dc:creator>Okada, Y.</dc:creator>
<dc:creator>Sawcer, S.</dc:creator>
<dc:creator>Soulama, I.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Tsepilov, Y.</dc:creator>
<dc:creator>Park, W.-Y.</dc:creator>
<dc:creator>Rajagopalan, D.</dc:creator>
<dc:creator>Shahin, T.</dc:creator>
<dc:creator></dc:creator>
<dc:date>2026-01-23</dc:date>
<dc:identifier>doi:10.64898/2026.01.20.700519</dc:identifier>
<dc:title><![CDATA[Federated single-cell QTL meta-analysis reveals novel disease mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.16.699909?rss=1">
<title>
<![CDATA[
An integrated, scaled approach to resolve TSC2 variants of uncertain significance 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.16.699909?rss=1</link>
<description><![CDATA[
Obtaining a precise genetic tuberous sclerosis diagnosis is a challenge as many missense TSC2 variants are variants of uncertain significance (VUS). VUS in TSC2 have been resolved by one-at-a-time functional assays, but these assays cannot scale to the 3,634 TSC2 missense VUS observed so far. To address this challenge, we used massively parallel sequencing to measure the steady-state abundance of almost 9,000 TSC2 missense variants and developed an mTOR pathway activity assay using genome editing and cell sorting to generate activity scores for 391 missense variants. 1,288 of 8,891 (14.49%) missense variants assayed had altered TSC2 abundance, and 69 of 391 (17.65%) missense variants assayed had altered mTOR pathway activity. Calibration and integration of these data into classification of variants identified in a clinical cohort putatively reclassified 212 of 276 (76.8%) TSC2 missense VUS. These datasets will lead to improved genetic diagnosis of tuberous sclerosis with potential positive impacts on the clinical management of patients and their families.
]]></description>
<dc:creator>Biar, C. G.</dc:creator>
<dc:creator>Wang, Z. R.</dc:creator>
<dc:creator>Camp, N. D.</dc:creator>
<dc:creator>Holmes, D. L.</dc:creator>
<dc:creator>Wheelock, M. K.</dc:creator>
<dc:creator>Pendyala, S.</dc:creator>
<dc:creator>McGee, A. V.</dc:creator>
<dc:creator>Gupta, P.</dc:creator>
<dc:creator>McEwen, A. E.</dc:creator>
<dc:creator>Tejura, M.</dc:creator>
<dc:creator>Richardson, M. E.</dc:creator>
<dc:creator>Weyandt, J. D.</dc:creator>
<dc:creator>Coleman, T.</dc:creator>
<dc:creator>Stewart, R.</dc:creator>
<dc:creator>Zeiberg, D.</dc:creator>
<dc:creator>Vandi, A. J.</dc:creator>
<dc:creator>Dawson, S.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:creator>Starita, L. M.</dc:creator>
<dc:creator>Carvill, G. L.</dc:creator>
<dc:creator>James, R. G.</dc:creator>
<dc:creator>Fowler, D. M.</dc:creator>
<dc:creator>Calhoun, J. D.</dc:creator>
<dc:date>2026-01-18</dc:date>
<dc:identifier>doi:10.64898/2026.01.16.699909</dc:identifier>
<dc:title><![CDATA[An integrated, scaled approach to resolve TSC2 variants of uncertain significance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.13.699328?rss=1">
<title>
<![CDATA[
3D reconstruction of spatial transcriptomics with spatial pattern enhanced graph convolutional neural network 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.13.699328?rss=1</link>
<description><![CDATA[
Spatially resolved transcriptomics (SRT) is a promising new technology that enables simultaneous analysis of gene expression and spatial information for biomedical research. However, the existing statistical and deep learning algorithms used for analyzing SRT data rely solely on two-dimensional (2D) spatial coordinates, which limits their ability to accurately identify spatial domains, spatially variable genes, cell-to-cell communications, and developmental trajectories in a three-dimensional (3D) spatial manner. To address these limitations, we introduced Spa3D, which utilized the anti-leakage Fourier transform and graph convolutional neural network model to reconstruct 3D-based spatial structures from multiple 2D SRT slices. We demonstrate that Spa3D is appliable to analyze data from various SRT technology platforms and outperforms state-of-art methods by: (I) improving spatial domain identification through 3D reconstruction, (II) elucidating cell-cell communication landscape in the 3D cellular organization, (III) modeling of organ-level tempo-spatial development patterns in a 3D fashion, and (IV) annotating 3D spatial trajectory that are not captured by 2D spatial coordinates.

Key pointsO_LIMost existing spatial omics analysis methods rely on 2D data, limiting their ability to capture full spatial and developmental tissue complexity
C_LIO_LISpa3D incorporates physical z-axis distances, enabling accurate 3D modeling even when adjacent slices vary in tissue structure and composition
C_LIO_LISpa3D reconstructs true 3D spatial structures from 2D SRT slices using graph convolutional networks and anti-leakage Fourier transforms
C_LIO_LISpa3D enhances spatial domain detection, revealing detailed cell-cell communication and organ-level development patterns across multiple spatial omics platforms
C_LIO_LISpa3D enables novel biological discoveries by revealing spatial features and trajectories not detectable using traditional 2D transcriptomic analysis approaches
C_LI
]]></description>
<dc:creator>Tang, C.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Xiao, X.</dc:creator>
<dc:creator>Dong, L.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Li, Q.</dc:creator>
<dc:creator>Xiao, G.</dc:creator>
<dc:creator>Xu, L.</dc:creator>
<dc:date>2026-01-14</dc:date>
<dc:identifier>doi:10.64898/2026.01.13.699328</dc:identifier>
<dc:title><![CDATA[3D reconstruction of spatial transcriptomics with spatial pattern enhanced graph convolutional neural network]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.20.695738?rss=1">
<title>
<![CDATA[
Predicting interaction-specific protein-protein interaction perturbations by missense variants with MutPred-PPI 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.20.695738?rss=1</link>
<description><![CDATA[
Disruption of protein-protein interactions (PPIs) is a major mechanism of a variants deleterious effect. Computational tools are needed to assess such variants at scale, yet existing predictors rarely consider loss of specific interactions, particularly when variants perturb binding interfaces without significantly affecting protein stability. To address this problem, we present MutPred-PPI, a graph attention network that predicts interaction-specific (edgetic) effects of missense variants by operating on AlphaFold 3-based protein complex contact graphs with protein language model embeddings imposed upon nodes. We systematically evaluated our model with stringent group cross-validation as well as benchmark data recently collected within the IGVF Consortium. MutPred-PPI outperformed all baseline methods across all evaluation criteria, achieving an AUC of 0.85 on seen proteins and 0.72 on previously unseen proteins in cross-validation, demonstrating strong generalizability despite scarce training data. To demonstrate biomedical relevance, we applied MutPred-PPI to variants from ClinVar, HGMD, COSMIC, gnomAD, and two de novo neurodevelopmental disorder-linked datasets. Disease-associated variants from Clin-Var and HGMD showed strong enrichment for both quasi-null and edgetic effects, whereas population variants from gnomAD increasingly preserved interactions with higher allele frequencies. Notably, we observed a strong edgetic disruption signature in highly recurrent cancer variants from both the full COSMIC dataset and a subset of variants from oncogenes. Recurrent tumor suppressor gene variants and autism spectrum disorder-associated variants exhibited moderate quasi-null enrichment, whilst neurodevelopmental disorder-linked variants showed a weak edgetic disruption signature. These results indicate distinct PPI perturbation mechanisms across disease types and show that MutPred-PPI captures functionally relevant molecular effects of pathogenic variants.
]]></description>
<dc:creator>Stewart, R.</dc:creator>
<dc:creator>Laval, F.</dc:creator>
<dc:creator>Coppin, G.</dc:creator>
<dc:creator>Spirohn-Fitzgerald, K.</dc:creator>
<dc:creator>Tixhon, M.</dc:creator>
<dc:creator>Hao, T.</dc:creator>
<dc:creator>Calderwood, M. A.</dc:creator>
<dc:creator>Mort, M.</dc:creator>
<dc:creator>Cooper, D. N.</dc:creator>
<dc:creator>Vidal, M.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:date>2025-12-23</dc:date>
<dc:identifier>doi:10.64898/2025.12.20.695738</dc:identifier>
<dc:title><![CDATA[Predicting interaction-specific protein-protein interaction perturbations by missense variants with MutPred-PPI]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.19.695550?rss=1">
<title>
<![CDATA[
High false sign rates in transcriptome-wide association studies 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.19.695550?rss=1</link>
<description><![CDATA[
Transcriptome-wide association studies (TWAS) are widely used to identify genes involved in complex traits and to infer the direction of gene effects on traits. However, despite their popularity, it remains unclear how accurately TWAS recover the true direction of a genes effect on a trait. Here, we estimate the false sign rate (FSR) of TWAS for plasma proteins, leveraging the expectation that increased gene expression should generally increase protein expression. We then extend this framework to complex traits, where loss-of-function burden tests provide the expected direction-of-effect. In both analyses, we observe high discordance with expectations, with TWAS showing an FSR of 23% for plasma proteins and 33% for complex traits. While colocalization-based filtering reduced the FSR, substantial discordance remained, and with substantial loss of recall. However, when we restricted gene-direction assignments for plasma proteins to using only relevant tissues in combination with colocalization-based filtering, the FSR dropped to 11%, and to just 5% if we excluded brain-specific proteins. We propose that much of the sign discordance arises when eQTLs in non-trait-relevant tissues tag GWAS-associated haplotypes via distinct, tightly-linked regulatory variants, yielding spurious TWAS associations with the correct genes but with unreliable direction-of-effect. These findings show that TWAS-based direction-of-effect estimates should be interpreted with caution and raise concerns about the reliability of TWAS more broadly.
]]></description>
<dc:creator>Gerlach, P. A.</dc:creator>
<dc:creator>Milind, N.</dc:creator>
<dc:creator>Spence, J. P.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2025-12-20</dc:date>
<dc:identifier>doi:10.64898/2025.12.19.695550</dc:identifier>
<dc:title><![CDATA[High false sign rates in transcriptome-wide association studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.15.694070?rss=1">
<title>
<![CDATA[
Comprehensive perturbation of transcription factors in human cardiomyocytes reveals the regulatory architecture of congenital heart disease 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.15.694070?rss=1</link>
<description><![CDATA[
Transcription factors (TFs), including DNA binding proteins and epigenetic co-regulators, control the timing of gene programs during lineage commitment1. However, systematically defining the dynamic activities of the human genomes nearly 2000 TFs during development remains challenging2,3. Here, we use Perturb-Seq to map the transcriptional impact of nearly all human TFs and a subset of enhancers during cardiomyocyte differentiation. Our results suggest that developmental regulatory networks are distributed across highly connected hub TFs4-6 that are dynamic across lineage and time, rather than organizing into top-down hierarchies directed by "master regulators". We also identify distinct TF ensembles that regulate sequential decision points during cardiac cell-fate specification by coordinating lineage-specific activation with alternate lineage repression. Separately, analysis of TF-TF cooperativity uncovers a dynamic interaction between MEF2 family TFs7 and members of the Polycomb Repressive complex 18-10 to execute alternative fate repression. Building on these regulatory interactions, we construct a deep learning transformer model to accurately predict perturbed TFs driving altered regulatory networks in patient-derived transcriptomes. Together, our results define the regulatory network architecture of human lineage specification and provide a platform for predicting TF function and interpreting disease mechanisms.
]]></description>
<dc:creator>Takeuchi, C.</dc:creator>
<dc:creator>Sivakumar, S.</dc:creator>
<dc:creator>Sundarrajan, A.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Goetsch, S. C.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Nzima, M.</dc:creator>
<dc:creator>Deng, M.</dc:creator>
<dc:creator>Kulkarni, K. N.</dc:creator>
<dc:creator>Xu, L.</dc:creator>
<dc:creator>Wu, J.</dc:creator>
<dc:creator>Posner, B. A.</dc:creator>
<dc:creator>Chahrour, M. H.</dc:creator>
<dc:creator>Kraus, W. L.</dc:creator>
<dc:creator>Munshi, N. V.</dc:creator>
<dc:creator>Hon, G. C.</dc:creator>
<dc:date>2025-12-17</dc:date>
<dc:identifier>doi:10.64898/2025.12.15.694070</dc:identifier>
<dc:title><![CDATA[Comprehensive perturbation of transcription factors in human cardiomyocytes reveals the regulatory architecture of congenital heart disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.12.693799?rss=1">
<title>
<![CDATA[
SEEK-VEC: Robust Latent Structure Discovery via Ensemble Topic Modeling 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.12.693799?rss=1</link>
<description><![CDATA[
Count data are ubiquitous across many applications in which understanding latent patterns is of interest. Topic modeling is a powerful tool for detecting latent structure in count data. However, standard topic modeling methods are often constrained by their restrictive assumptions, susceptible to noise, and sensitive to misspecification of the number of topics. Here, we introduce SEEK-VEC (Spectral Ensembling of topic models with Eigenscore for K-agnostic Vocabulary Embedding and Classification), an ensemble topic modeling framework that integrates insights from multiple candidate topic models through a spectral ensembling procedure. SEEK-VEC produces a meta-structure matrix containing prioritization scores and grouping scores that enable variable classification, interactive pattern discovery, and model diagnostics. Through simulations, we demonstrate that SEEK-VEC augments the performance of standard topic models for identifying important vocabulary words and understanding the relationships among them, particularly when signal strength is weak. We apply SEEK-VEC to the MADStat dataset of statistical abstracts and demonstrate its utility for evaluating the proposed interpretation of a topic model.
]]></description>
<dc:creator>Danning, R.</dc:creator>
<dc:creator>Ke, Z. T.</dc:creator>
<dc:creator>Ma, R.</dc:creator>
<dc:creator>Lin, X.</dc:creator>
<dc:date>2025-12-14</dc:date>
<dc:identifier>doi:10.64898/2025.12.12.693799</dc:identifier>
<dc:title><![CDATA[SEEK-VEC: Robust Latent Structure Discovery via Ensemble Topic Modeling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.21.689845?rss=1">
<title>
<![CDATA[
Determining gene specificity from multivariate single-cell RNA sequencing data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.21.689845?rss=1</link>
<description><![CDATA[
An important application of single-cell genomics experiments is to identify genes specific to biological categories or experimental conditions. We develop ember (Entropy Metrics for Biological ExploRation), an entropy-based framework that uses Shannon's chain rule across nested biological partitions. Four axioms characterize its Psi score within a class of normalized entropy-decomposition scores. Applying ember to eight tissues from eight founder mouse strains, we find that gene specificity is often unintuitive: canonical markers can be supplanted, housekeeping genes are context-dependent, and mouse strain can drive unexpected cell type switching. Unsupervised learning on entropy metrics uncovers shared genes specialized to male gonads and kidney, as well as genes specific to non-consecutive developmental stages in the kidney. To facilitate further exploration of gene specificity in mice, we have also developed a comprehensive specificity database, along with a web interface, API and MCP server. Extending ember to a human PBMC dataset collected from 255 diverse individuals, we find that variation in PBMCs is largely localized to classical monocytes. We also find genes with unique specificity by sex, age and ancestral background. Together, these applications establish ember as a powerful tool and provide a roadmap for elucidating the impact of human genetic variation using the murine model.
]]></description>
<dc:creator>Swarna, N. P.</dc:creator>
<dc:creator>Booeshaghi, A. S.</dc:creator>
<dc:creator>Rebboah, E.</dc:creator>
<dc:creator>Gordon, M. G.</dc:creator>
<dc:creator>Kathail, P.</dc:creator>
<dc:creator>Li, T.</dc:creator>
<dc:creator>Alvarez, M.</dc:creator>
<dc:creator>Ye, C. J.</dc:creator>
<dc:creator>Wold, B. J.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2025-11-24</dc:date>
<dc:identifier>doi:10.1101/2025.11.21.689845</dc:identifier>
<dc:title><![CDATA[Determining gene specificity from multivariate single-cell RNA sequencing data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.18.688830?rss=1">
<title>
<![CDATA[
Systematic and proactive evaluation of AIRE missense variant effects 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.18.688830?rss=1</link>
<description><![CDATA[
Pathogenic variants in the Autoimmune Regulator (AIRE) gene cause Autoimmune Polyendocrine Syndrome Type 1 (APS-1), a rare primary immunodeficiency disease with symptoms including hypoparathyroidism, adrenal insufficiency, and chronic mucocutaneous candidiasis. AIRE increases the expression and presentation of tissue-specific genes expressing  self antigens in the developing T cell niche, thus triggering the elimination of self-reactive T cells and preventing autoimmunity. Earlier diagnoses can benefit patients, and APS-1 diagnosis by AIRE sequencing is increasingly common. However, two thirds of reported clinical variants are missense, and more than half of these are "variants of uncertain significance" (VUS). Cell-based variant functional assays can provide strong evidence towards more informative variant classification, but these are carried out reactively, often years after clinical presentation. By contrast, proactively assessing all possible missense variants could provide immediate evidence to guide genetic diagnosis, even for never-before-seen variants. Here we used an insulin promoter-driven reporter to proactively assess the function of 9790 AIRE missense variants. The resulting AIRE variant effect map both validates and extends current biochemical knowledge, concords with pathogenicity annotations, and provides proactive evidence for 70% of previously-reported VUS. Placing our map in the context of both an international APS-1 cohort and the UK BioBank revealed quantitative genotype-phenotype correlations. Using current guidelines, we provide classifications for 32% of current VUS. Together, our proactive resource of AIRE variant impacts offers the potential to improve patient outcomes via more rapid and definitive APS-1 diagnosis.
]]></description>
<dc:creator>Axakova, A.</dc:creator>
<dc:creator>Berger, A. H.</dc:creator>
<dc:creator>van Loggerenberg, W.</dc:creator>
<dc:creator>Kishore, N.</dc:creator>
<dc:creator>Gebbia, M.</dc:creator>
<dc:creator>Ding, M. X.</dc:creator>
<dc:creator>Douville, S. V.</dc:creator>
<dc:creator>Tabet, D. R.</dc:creator>
<dc:creator>Cote, A. G.</dc:creator>
<dc:creator>Weile, J.</dc:creator>
<dc:creator>Johansson, S.</dc:creator>
<dc:creator>Bratland, E.</dc:creator>
<dc:creator>Roth, F. P.</dc:creator>
<dc:date>2025-11-18</dc:date>
<dc:identifier>doi:10.1101/2025.11.18.688830</dc:identifier>
<dc:title><![CDATA[Systematic and proactive evaluation of AIRE missense variant effects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.13.688264?rss=1">
<title>
<![CDATA[
Characterizing spatial functional microniches with SpaceTravLR 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.13.688264?rss=1</link>
<description><![CDATA[
The advent of spatial omics has revolutionized our understanding of tissue biology; however, these technologies remain largely descriptive and do not capture how changes in gene regulation propagate across spatial neighborhoods. While in-silico perturbation methods and foundation models aim to model the impact of genetic perturbations, these methods are limited to single-cell approaches that lack spatial resolution. Other studies can delineate morphological domains based on transcriptional similarity, but not spatial functional microniches. We address this major unmet need by developing SpaceTravLR (Spatially perturbing Transcription factors, Ligands and Receptors), a novel interpretable machine learning approach that generalizes across tissues and species, uncovering spatial features linked to functional outcomes, thereby capturing functional microniches with spatial resolution. SpaceTravLR infers how single or combinatorial genetic perturbations rewire signals across the tissue neighborhood, by propagating effects through underlying spatially resolved molecular networks, thereby modeling how perturbations can reshape both the targeted cell and its surrounding neighborhood. SpaceTravLR defines novel spatial microniches across a range of tissues at different scales of organization (niches, neighborhoods and tissues), disease and developmental contexts. SpaceTravLRs perturbation predictions are made solely from spatial omics data and closely align with experimental validation or known outcomes based on mechanistic studies. Critically, our approach enables the generation of mechanistic hypotheses underlying identified niches. We show SpaceTravLR discovered a novel mechanism for Ccr4 that drives the spatial location of a pathogenic population of allergen-specific T helper 2 (Th2) cells as they develop in the lymph node, which was experimentally validated in a murine model. Overall, SpaceTravLR provides a novel interpretable and experimentally validated framework for uncovering how genes act individually and combinatorially through cell-intrinsic and cell-extrinsic circuits to shape spatial tissue organization and function.
]]></description>
<dc:creator>Ramjattun, K.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Lee, H.</dc:creator>
<dc:creator>Giri, S.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>MacDonald, W. A.</dc:creator>
<dc:creator>Lord, N.</dc:creator>
<dc:creator>Poholek, A. C.</dc:creator>
<dc:creator>Lee, Y.</dc:creator>
<dc:creator>Das, J.</dc:creator>
<dc:date>2025-11-14</dc:date>
<dc:identifier>doi:10.1101/2025.11.13.688264</dc:identifier>
<dc:title><![CDATA[Characterizing spatial functional microniches with SpaceTravLR]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.04.686611?rss=1">
<title>
<![CDATA[
Large-scale discovery of neural enhancers for cis-regulation therapies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.04.686611?rss=1</link>
<description><![CDATA[
CRISPR-based gene activation (CRISPRa) has emerged as a promising therapeutic approach for neurodevelopmental disorders (NDD) caused by haploinsufficiency. However, scaling this cis-regulatory therapy (CRT) paradigm requires pinpointing which candidate cis-regulatory elements (cCREs) are active in human neurons, and which can be targeted with CRISPRa to yield specific and therapeutic levels of target gene upregulation. Here, we combine Massively Parallel Reporter Assays (MPRAs) and a multiplex single cell CRISPRa screen to discover functional human neural enhancers whose CRISPRa targeting yields specific upregulation of NDD risk genes. First, we tested 5,425 candidate neuronal enhancers with MPRA, identifying 2,422 that are active in human neurons. Selected cCREs also displayed specific, autonomous in vivo activity in the developing mouse central nervous system. Next, we applied multiplex single-cell CRISPRa screening with 15,643 gRNAs to test all MPRA-prioritized cCREs and 761 promoters of NDD genes in their endogenous genomic contexts. We identified hundreds of promoter- and enhancer-targeting CRISPRa gRNAs that upregulated 200 of the 337 NDD genes in human neurons, including 91 novel enhancer-gene pairs. Finally, we confirmed that several of the CRISPRa gRNAs identified here demonstrated selective and therapeutically relevant upregulation of SCN2A, CHD8, CTNND2 and TCF4 when delivered virally to patient cell lines, human cerebral organoids, and a humanized mouse model of hTcf4. Our results provide a comprehensive resource of active, target-linked human neural enhancers for NDD genes and corresponding gRNA reagents for CRT development. More broadly, this work advances understanding of neural gene regulation and establishes a generalizable strategy for discovering CRT gRNA candidates across cell types and haploinsufficient disorders.
]]></description>
<dc:creator>McDiarmid, T. A.</dc:creator>
<dc:creator>Page, N. F.</dc:creator>
<dc:creator>Chardon, F. M.</dc:creator>
<dc:creator>Daza, R. M.</dc:creator>
<dc:creator>Chen, G. T.</dc:creator>
<dc:creator>Kosicki, M.</dc:creator>
<dc:creator>James, L. M.</dc:creator>
<dc:creator>Nourie, H. C.</dc:creator>
<dc:creator>Laboy-Cintron, D.</dc:creator>
<dc:creator>Lee, A. S.</dc:creator>
<dc:creator>Vij, P.</dc:creator>
<dc:creator>Calderon, D.</dc:creator>
<dc:creator>Lalanne, J.-B.</dc:creator>
<dc:creator>Martin, B. K.</dc:creator>
<dc:creator>Fink, K.</dc:creator>
<dc:creator>Talkowski, M. E.</dc:creator>
<dc:creator>Muotri, A. R.</dc:creator>
<dc:creator>Philpot, B. D.</dc:creator>
<dc:creator>Pennacchio, L. A.</dc:creator>
<dc:creator>Geschwind, D. H.</dc:creator>
<dc:creator>Sanders, S. J.</dc:creator>
<dc:creator>Ahituv, N.</dc:creator>
<dc:creator>Shendure, J.</dc:creator>
<dc:date>2025-11-05</dc:date>
<dc:identifier>doi:10.1101/2025.11.04.686611</dc:identifier>
<dc:title><![CDATA[Large-scale discovery of neural enhancers for cis-regulation therapies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.15.680997?rss=1">
<title>
<![CDATA[
Deep learning the dynamic regulatory sequence code of cardiac organoid differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.15.680997?rss=1</link>
<description><![CDATA[
Defining temporal gene regulatory programs driving human organogenesis is essential for understanding congenital defects. We combined a time-resolved, single-cell multi-omic atlas of human induced pluripotent stem cell-derived cardiac organoids with deep learning models of chromatin accessibility, enabling systematic discovery of cis-regulatory syntax underlying heart development and disease. This framework identified cell-state-specific motif syntax, linked motif instances to candidate target genes, and resolved programs governing lineage divergence. Integrating cell-state-resolved molecular profiles with computationally predicted variant effects from congenital heart disease (CHD) cases enabled the prioritization of noncoding variants predicted to disrupt developmental transitions, supporting the paradigm that disease etiology derives from perturbations to regulatory networks governing cardiogenesis. Experimental validation demonstrated that an intronic ANGPTL2 variant altered differentiation outcomes, implicating ANGPTL2 in CHD. This study bridges developmental regulation with disease genetics, establishing a framework for discovering the genetic and molecular basis of congenital disorders.
]]></description>
<dc:creator>Metzl-Raz, E.</dc:creator>
<dc:creator>Zhao, R.</dc:creator>
<dc:creator>Deshpande, S.</dc:creator>
<dc:creator>Powell, J.</dc:creator>
<dc:creator>Porter, E. G.</dc:creator>
<dc:creator>Zouaghi, Y.</dc:creator>
<dc:creator>Liu, B. B.</dc:creator>
<dc:creator>Kim, S. H.</dc:creator>
<dc:creator>Abdi, I.</dc:creator>
<dc:creator>Evergreen, I.</dc:creator>
<dc:creator>Agarwal, M.</dc:creator>
<dc:creator>Sheth, M. U.</dc:creator>
<dc:creator>Rico, J.</dc:creator>
<dc:creator>Miyamoto, M.</dc:creator>
<dc:creator>Sanchez, J. M.</dc:creator>
<dc:creator>Engreitz, J. M.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Greenleaf, W. J.</dc:creator>
<dc:creator>Gifford, C. A.</dc:creator>
<dc:date>2025-10-15</dc:date>
<dc:identifier>doi:10.1101/2025.10.15.680997</dc:identifier>
<dc:title><![CDATA[Deep learning the dynamic regulatory sequence code of cardiac organoid differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.11.681829?rss=1">
<title>
<![CDATA[
RELB Reprograms Exhausted Tumor-Infiltrating Lymphocytes for Improved Adoptive Cell Therapy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.11.681829?rss=1</link>
<description><![CDATA[
Tumor-infiltrating lymphocytes (TILs) are a promising autologous cell therapy to treat solid tumors. TILs are manufactured by expanding and reinfusing tumor-reactive T cells from tumor biopsies. Efficacy of TIL therapies has been limited by the heterogeneity of expanded TIL products and the high prevalence of dysfunctional exhausted CD8+ T cells (TEX). While a subset of CD8+ TILs co-expressing CD103 and CD39 are enriched for tumor-reactive TILs across multiple cancer types, these cells are often in the TEX state with low proliferative potential. To identify regulators of human TIL proliferation, we screened an open reading frame library encoding for all human transcription factors (TFs). RELB emerged as the dominant driver of human TIL expansion with a skew towards CD8+ cells. TCR diversity was maintained after multiple days of in vitro expansion driven by RELB. Transcriptome profiling of multiple RELB-expressing TIL subtypes revealed a shift towards a memory/costimulatory-like phenotype. Using a HER2-targeting CAR and tumor co-culture model, RELB conferred improved persistence after multiple tumor challenges in vitro and improved solid tumor control in mouse xenografts in vivo. Finally, co-culture of RELB-overexpressing TILs with patient-matched tumor organoids showed an increase in TIL product polyfunctionality, tumor reactivity, and tumor killing. Collectively these results support promoting RELB expression as a strategy for broadly enabling TIL therapy for treating solid tumors.
]]></description>
<dc:creator>McRoberts Amador, C. D.</dc:creator>
<dc:creator>Conover, R. E.</dc:creator>
<dc:creator>Brown, M. C.</dc:creator>
<dc:creator>Lyniv, L. S.</dc:creator>
<dc:creator>Noldner, P. K.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Gao, A. R.</dc:creator>
<dc:creator>McCutcheon, S. R.</dc:creator>
<dc:creator>Antonia, S. J.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2025-10-12</dc:date>
<dc:identifier>doi:10.1101/2025.10.11.681829</dc:identifier>
<dc:title><![CDATA[RELB Reprograms Exhausted Tumor-Infiltrating Lymphocytes for Improved Adoptive Cell Therapy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.11.681828?rss=1">
<title>
<![CDATA[
Comprehensive profiling of transcription factors for reprogramming human astrocytes to neuronal cells through endogenous CRISPR-based gene activation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.11.681828?rss=1</link>
<description><![CDATA[
Neuronal loss is a hallmark of neurodegeneration and brain injury. Direct reprogramming of astrocytes into neurons has emerged as a promising approach to restore lost neurons. Comprehensive mapping and characterization of candidate astrocyte-to-neuron reprogramming factors is an essential step to realizing the potential of this strategy. Here, we established a CRISPR activation (CRISPRa)-based approach for neuronal reprogramming of primary human astrocytes. We conducted high-throughput CRISPRa screens of all human genes encoding transcription factors (TFs) to identify novel and efficient reprogramming factors. scRNA-seq characterization of top hits revealed that single TFs reprogram primary human astrocytes into multiple neuronal subtypes with distinct cell type-specific gene signatures. We demonstrate that INSM1 reprograms astrocytes to a glutamatergic neuron-like state and has broad neurogenic activity across different cell types and across human and mouse contexts. Finally, we conduct paired CRISPRa screens to identify cofactors that cooperate with INSM1 to enhance neuronal reprogramming and subtype specification, and elucidate genomic mechanisms of interaction and downstream regulators.
]]></description>
<dc:creator>Reisman, S. J.</dc:creator>
<dc:creator>Halabi, D.</dc:creator>
<dc:creator>Miller, S. E.</dc:creator>
<dc:creator>Song, L.</dc:creator>
<dc:creator>Geraghty, S.</dc:creator>
<dc:creator>Sangvai, N.</dc:creator>
<dc:creator>Rice, G.</dc:creator>
<dc:creator>Safi, A.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2025-10-12</dc:date>
<dc:identifier>doi:10.1101/2025.10.11.681828</dc:identifier>
<dc:title><![CDATA[Comprehensive profiling of transcription factors for reprogramming human astrocytes to neuronal cells through endogenous CRISPR-based gene activation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.05.680562?rss=1">
<title>
<![CDATA[
Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.05.680562?rss=1</link>
<description><![CDATA[
T cell exhaustion limits the efficacy of cancer immunotherapies. Here, we performed genome-wide loss-of-function screening in repetitively stimulated human T cells and identified the mulitfunctional ubiquitin-modifying protein A20/TNFAIP3 as a major negative regulator of exhausted T cell persistence. Protein large language modeling, deep base-editing mutagenesis, and studies in immunocompetent mice with domain-specific inactivating mutations revealed A20s non-enzymatic M1 ubiquitin-binding zinc finger 7 (A20ZF7) motif as critical to suppression of anti-tumor immunity. A20ZF7-deficient CD8+ tumor-infiltrating lymphocytes (TILs) resisted terminal exhaustion and circumvented an unappreciated mechanism restraining perforin degranulation in terminally exhausted cells. Human chimeric antigen receptor (CAR)-T cells engineered via base-editing to inactivate A20ZF7 via a single missense mutation also resisted exhaustion, secreted more perforin and robustly suppressed cancer in vivo. These studies pinpoint A20ZF7 as a novel T cell checkpoint and reveal precision base-editing of missense mutations as an effective approach to enhance CAR-T cell therapy.
]]></description>
<dc:creator>Blaisdell, A.</dc:creator>
<dc:creator>Bachl, S.</dc:creator>
<dc:creator>Sandoval, L. R.</dc:creator>
<dc:creator>Ching, C.</dc:creator>
<dc:creator>Bowman, C. J.</dc:creator>
<dc:creator>Kale, N.</dc:creator>
<dc:creator>Prabandham, M.</dc:creator>
<dc:creator>Diolaiti, M.</dc:creator>
<dc:creator>Havig, C.</dc:creator>
<dc:creator>Advincula, R.</dc:creator>
<dc:creator>Lenci, N.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Yamashita, E.</dc:creator>
<dc:creator>Wang, C. H.</dc:creator>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Liu, Q.</dc:creator>
<dc:creator>Achacoso, P.</dc:creator>
<dc:creator>Stibor, D.</dc:creator>
<dc:creator>Oynebraten, I.</dc:creator>
<dc:creator>Seo, J.</dc:creator>
<dc:creator>Ashworth, A.</dc:creator>
<dc:creator>Marson, A.</dc:creator>
<dc:creator>Ye, C. J.</dc:creator>
<dc:creator>Malynn, B. A.</dc:creator>
<dc:creator>Eyquem, J.</dc:creator>
<dc:creator>Carnevale, J.</dc:creator>
<dc:creator>Ma, A.</dc:creator>
<dc:date>2025-10-06</dc:date>
<dc:identifier>doi:10.1101/2025.10.05.680562</dc:identifier>
<dc:title><![CDATA[Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.03.680360?rss=1">
<title>
<![CDATA[
Gradient-aware modeling advances AI-driven prediction of genetic perturbation effects 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.03.680360?rss=1</link>
<description><![CDATA[
Predicting the transcriptional effects of genetic perturbations across diverse contexts is a central challenge in functional genomics. While single-cell perturbational assays such as Perturb-seq have generated valuable datasets, exhaustively profiling all perturbations is infeasible, underscoring the need for predictive models. We present GARM (Gradient Aligned Regression with Multi-decoder), a machine learning (ML) framework that leverages gradient-aware supervision to capture both absolute and relative perturbational effects. Across multiple large-scale datasets, GARM consistently outperforms leading approaches--including GEARS, scGPT, and GenePert--in predicting responses to unseen perturbations within and across contexts. Complementing this, we show that widely used evaluation metrics substantially overestimate performance, allowing trivial models to appear predictive. To address this, we introduce perturbation-ranking criteria (PrtR) that better reflect model utility for experimental design. Finally, we provide insight into gene-specific predictability, revealing pathways and gene classes systematically easier or harder to predict, with implications for model development and biological interpretation. Together, these advances establish a unified methodological and conceptual framework that improves perturbation modeling, sets rigorous evaluation standards, and provides biological insight into gene-specific predictability in functional genomics.
]]></description>
<dc:creator>Jerby, L.</dc:creator>
<dc:creator>Zhu, D.</dc:creator>
<dc:date>2025-10-05</dc:date>
<dc:identifier>doi:10.1101/2025.10.03.680360</dc:identifier>
<dc:title><![CDATA[Gradient-aware modeling advances AI-driven prediction of genetic perturbation effects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.02.680094?rss=1">
<title>
<![CDATA[
Segregating DNA lesions point to high selective advantage of tumor initiating cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.02.680094?rss=1</link>
<description><![CDATA[
The complications with identifying cells at the origin of cancer and tracking their early divisions impede studies of cancer initiation. Recently, it was shown that some DNA lesions generated by a pulse of damage-inducing mutagen persist over multiple rounds of replication. Segregation of DNA lesions in the early genealogy of an expanding clone leaves a statistically interpretable footprint of cancer initiating events. Specifically, it allows for estimating the number of cell divisions between the initiating DNA lesion and the most recent common ancestor of the tumor. Here, we analyze footprints of segregating lesions from a previously published experimental mouse system, as well as post-chemotherapy human metastatic tumors and the blood of chemotherapy treated patients. In all contexts, clones tend to start early, usually within the span of 4 cell generations from mutagen exposure. Using a branching process model, we show that fitness advantage of early cancer drivers exceeds 30%, with each early division leading to at least 1.3 self-renewing cells. We highlight an example of a blood-derived single cell phylogeny with major subclones separated by just two cell divisions. Broadly, our approach allows inference of tumor initiation and growth parameters based on events preceding the most recent common ancestor of the initiating clone as opposed to characteristics of fully grown tumors.
]]></description>
<dc:creator>Seplyarskiy, V.</dc:creator>
<dc:creator>Shady, M.</dc:creator>
<dc:creator>Andrianova, M. A.</dc:creator>
<dc:creator>Chapman, M. S.</dc:creator>
<dc:creator>Van Allen, E.</dc:creator>
<dc:creator>Sunyaev, S. R.</dc:creator>
<dc:date>2025-10-04</dc:date>
<dc:identifier>doi:10.1101/2025.10.02.680094</dc:identifier>
<dc:title><![CDATA[Segregating DNA lesions point to high selective advantage of tumor initiating cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.25.678548?rss=1">
<title>
<![CDATA[
Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflow 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.25.678548?rss=1</link>
<description><![CDATA[
As researchers and clinicians seek to identify human genomic alterations relevant to traits and disorders, identifying and aggregating evidence providing mechanistic support for associations between alterations and phenotypes remains challenging. In particular, the study of non-coding genomic variation remains a major challenge due to the lack of accurate functional annotation for activity in a given context and across alleles. Experimental evidence is critical for prioritizing and interpreting functional effects of genetic alterations. Massively Parallel Reporter Assays (MPRAs) have emerged as a powerful high-throughput approach, enabling quantification of regulatory element activity and allelic effects, and systematic dissection of gene regulatory logic and variant effects across different contexts. However, the diversity of MPRA designs, lack of standardized formats, and many potential processing parameters hamper data integration, reproducibility, and meta-analyses across studies.

To address these challenges, the Impact of Genomic Variation on Function (IGVF) Consortium established an MPRA focus group to develop community standards, including harmonized file formats, and robust analysis pipelines for a wide range of library types and experimental designs. Here, we present these formats and comprehensive computational tools, MPRAlib and MPRAsnakeflow, for uniform processing from raw sequencing reads to counts, processing and visualization. Using diverse MPRA datasets, we characterize technical variability sources including barcode sequence bias, outlier barcodes, and delivery method (episomal vs. lentiviral). Our results establish best practices for MPRA data generation and analysis, facilitating robust, reproducible research and large-scale integration. The presented tools and standards are publicly available, providing a foundation for future collaborative efforts in regulatory genomics.
]]></description>
<dc:creator>Rosen, J. D.</dc:creator>
<dc:creator>Vasanthakumari, A. D.</dc:creator>
<dc:creator>Salomon, K.</dc:creator>
<dc:creator>de Lange, N.</dc:creator>
<dc:creator>Dash, P. M.</dc:creator>
<dc:creator>Keukeleire, P.</dc:creator>
<dc:creator>Hassan, A.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>Kircher, M.</dc:creator>
<dc:creator>Love, M. I.</dc:creator>
<dc:creator>Schubach, M.</dc:creator>
<dc:date>2025-09-28</dc:date>
<dc:identifier>doi:10.1101/2025.09.25.678548</dc:identifier>
<dc:title><![CDATA[Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflow]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.25.678665?rss=1">
<title>
<![CDATA[
Sensitive, direct detection of non-coding off-target base editor unwinding and editing in primary cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.25.678665?rss=1</link>
<description><![CDATA[
Base editors create precise nucleotide changes in DNA, but their off-target activity remains challenging to quantify. Here, we develop and deploy a direct, in cellulo sequencing assay that simultaneously measures both Cas9-mediated unwinding and deaminase editing of genomic DNA (beCasKAS). Our strategy nominates >460-fold more potential off-target sites than other methods by enriching for Cas9-dependent R-loops immediately preceding editing. Using beCasKAS in primary human T-cells, we observe that mRNA-encoded ABE8e and PAMless ABE8e-SpRY base editors have distinct off-target profiles that can be mitigated by optimizing mRNA dose. Finally, we combine beCasKAS with base-resolution deep learning models to risk-stratify off-target edits by their likelihood of epigenetic dysregulation. Collectively, beCasKAS offers a sensitive and facile tool to optimize the balance between base editor on- and off-target activity.
]]></description>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Jessa, S.</dc:creator>
<dc:creator>Marinov, G. K.</dc:creator>
<dc:creator>Klemm, S.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Greenleaf, W. J.</dc:creator>
<dc:date>2025-09-25</dc:date>
<dc:identifier>doi:10.1101/2025.09.25.678665</dc:identifier>
<dc:title><![CDATA[Sensitive, direct detection of non-coding off-target base editor unwinding and editing in primary cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.23.677874?rss=1">
<title>
<![CDATA[
Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.23.677874?rss=1</link>
<description><![CDATA[
Regulatory T cells (Tregs), characterized by FOXP3 expression, are essential for maintaining immune homeostasis by controlling inflammation. However, in autoimmune diseases such as rheumatoid arthritis (RA), impaired Treg function contributes to immune dysregulation and disease pathology. While most studies of human Tregs have focused on blood, here we analyzed Tregs in synovial tissues from RA patients using single cell RNA sequencing (scRNAseq). We identified two predominant Treg states, CD25hiCXCR6pos Tregs with strong suppressive function, and CD25loAREGpos Tregs, a dysfunctional state exclusively enriched in synovial tissues but not in blood. Computational and in vitro analyses revealed that cortisol induced AREG expression, suppressed glycolysis, and impaired the suppressive function of CD25loAREGpos Tregs. In turn, AREG promoted an IL-33+ inflammatory phenotype in synovial fibroblasts. Importantly, we found that TNFR2 engagement can prevent or reverse this dysfunctional Treg state. In contrast to CD25loAREGpos Tregs, CD25hiCXCR6pos Tregs were highly suppressive, showed coordinated abundance with macrophages in synovial tissue, and functionally interacted with membrane-bound TNF expressed by macrophages, which promoted their functional suppressive state. These two Treg subsets were similarly found in the synovial tissue in Juvenile Idiopathic Arthritis (JIA), another inflammatory arthritic disorder, indicating conserved mechanisms across arthritic diseases. Together, our findings define distinct pathways driving divergent functional and dysfunctional Treg states in inflamed tissues and point to interventions that may prevent or reverse the development of the dysfunctional state.
]]></description>
<dc:creator>Koh, B.</dc:creator>
<dc:creator>Gal Oz, S. T.</dc:creator>
<dc:creator>Sato, R.</dc:creator>
<dc:creator>Nguyen, H.</dc:creator>
<dc:creator>Dunlap, G. S.</dc:creator>
<dc:creator>Mahony, C.</dc:creator>
<dc:creator>Bolton, C.</dc:creator>
<dc:creator>Wedderburn, L. R.</dc:creator>
<dc:creator>Croft, A.</dc:creator>
<dc:creator>Donlin, L.</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:creator>Korsunskiy, I.</dc:creator>
<dc:creator>Rao, D. A.</dc:creator>
<dc:creator>Brenner, M. B.</dc:creator>
<dc:date>2025-09-25</dc:date>
<dc:identifier>doi:10.1101/2025.09.23.677874</dc:identifier>
<dc:title><![CDATA[Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.17.675534?rss=1">
<title>
<![CDATA[
Cryo-mtscATAC-seq for single-cell mitochondrial DNA genotyping and clonal tracing in archived human tissues 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.17.675534?rss=1</link>
<description><![CDATA[
High-throughput clonal tracing of primary human samples relies on naturally occurring barcodes, such as somatic mitochondrial DNA (mtDNA) mutations detected via single-cell ATAC-seq (mtscATAC-seq). Fresh-frozen clinical specimens preserve tissue architecture but compromise cell integrity, thereby precluding their use in multi- omic approaches such as mitochondrial genotyping at single-cell resolution. Here, we introduce Cryo-mtscATAC-seq, a broadly applicable method for diverse pathophysiological contexts to isolate nuclei with their associated mitochondria ("CryoCells") from frozen samples for high-throughput clonal analysis. We applied Cryo-mtscATAC-seq to the neurodegenerated human brain, glioblastoma (GBM), pediatric neuroblastoma, and human aorta, and implemented mitobender, a computational tool to reduce ambient mtDNA in single-cell assays. Our approach revealed regional clonal gliogenesis and microglial expansions in amyotrophic lateral sclerosis (ALS), persistence of oligodendrocyte progenitor cell (OPC)-like clones in GBM recurrence, mtDNA depth heterogeneity after neuroblastoma chemotherapy, and oligoclonal proliferation of smooth muscle cells in human aorta. In conclusion, Cryo-mtscATAC-seq broadly extends mtDNA genotyping to archival frozen specimens across tissue types, opening new avenues for investigation of cell state- informed clonality in human health and disease.
]]></description>
<dc:creator>Salla, M.</dc:creator>
<dc:creator>Obermayer, B.</dc:creator>
<dc:creator>Cotta, M.</dc:creator>
<dc:creator>Friebel, E.</dc:creator>
<dc:creator>Campo-Garcia, J.</dc:creator>
<dc:creator>Charalambous, G.</dc:creator>
<dc:creator>Bueno, R. J.</dc:creator>
<dc:creator>Lieu, D.</dc:creator>
<dc:creator>Dabek, P.</dc:creator>
<dc:creator>Helmuth, A.</dc:creator>
<dc:creator>Tellides, G.</dc:creator>
<dc:creator>Assi, R.</dc:creator>
<dc:creator>Bankov, K.</dc:creator>
<dc:creator>Lodrini, M.</dc:creator>
<dc:creator>Deubzer, H.</dc:creator>
<dc:creator>Chung, H.</dc:creator>
<dc:creator>Beule, D.</dc:creator>
<dc:creator>Radbruch, H.</dc:creator>
<dc:creator>Capper, D.</dc:creator>
<dc:creator>Heppner, F.</dc:creator>
<dc:creator>Starossom, S. C.</dc:creator>
<dc:creator>Lareau, C.</dc:creator>
<dc:creator>Liu, I.</dc:creator>
<dc:creator>Ludwig, L. S.</dc:creator>
<dc:date>2025-09-20</dc:date>
<dc:identifier>doi:10.1101/2025.09.17.675534</dc:identifier>
<dc:title><![CDATA[Cryo-mtscATAC-seq for single-cell mitochondrial DNA genotyping and clonal tracing in archived human tissues]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.16.676677?rss=1">
<title>
<![CDATA[
An unbiased survey of distal element-gene regulatory interactions with direct-capture targeted Perturb-seq 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.16.676677?rss=1</link>
<description><![CDATA[
Identifying the impact of distal regulatory elements on gene expression is a core challenge in human genetics. Large-scale CRISPR screens have not captured lower effect size element-gene interactions due to selection bias and limited statistical power. We developed a framework for highly powered CRISPR screens, consisting of Direct-Capture Targeted Perturb-seq (DC-TAP-seq), unbiased target selection, and a pipeline accounting for statistical power. Surveying 9,666 random distal element-gene pairs revealed that most elements that reduced gene expression had effect sizes <10%, which prior studies were underpowered to detect. Out of the 84 interactions with negative effects, 45 (53.6%) occurred within 100 Kb of the promoter of the target gene. Many elements were bound by CTCF without classical enhancer chromatin, and both housekeeping and non-housekeeping genes had similar frequencies of distal regulatory elements. We highlight limitations of predictive models and suggest that new models consider elements with smaller effect sizes. Our study provides an expanded view of distal regulatory elements and a framework for building more comprehensive maps of distal regulation.
]]></description>
<dc:creator>Ray, J.</dc:creator>
<dc:creator>Jagoda, E.</dc:creator>
<dc:creator>Sheth, M. U.</dc:creator>
<dc:creator>Galante, J.</dc:creator>
<dc:creator>Amgalan, D.</dc:creator>
<dc:creator>Gschwind, A. R.</dc:creator>
<dc:creator>Munger, C. J.</dc:creator>
<dc:creator>Huang, J.</dc:creator>
<dc:creator>Munson, G.</dc:creator>
<dc:creator>Murphy, M.</dc:creator>
<dc:creator>Mattei, E.</dc:creator>
<dc:creator>Barry, T.</dc:creator>
<dc:creator>Singh, V.</dc:creator>
<dc:creator>Baskaran, A.</dc:creator>
<dc:creator>Kang, H.</dc:creator>
<dc:creator>Katsevich, E.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:creator>Engreitz, J.</dc:creator>
<dc:date>2025-09-17</dc:date>
<dc:identifier>doi:10.1101/2025.09.16.676677</dc:identifier>
<dc:title><![CDATA[An unbiased survey of distal element-gene regulatory interactions with direct-capture targeted Perturb-seq]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.09.675271?rss=1">
<title>
<![CDATA[
Shared and distinct sequence-function signatures define different modes of human TpoR activation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.09.675271?rss=1</link>
<description><![CDATA[
The human thrombopoietin receptor (hTpoR) exists primarily as JAK2-associated monomers that become activated when converted to dimeric forms that support JAK trans-phosphorylation. This can be achieved by several different modes of stimuli, including the natural ligand Tpo, biologic agonists that bind the same site as Tpo, small-molecule drugs that bind the transmembrane (TM) domain, oncogenic mutations in and near the TM domain, and by association with constitutively active JAK V617F or a mutant form of the chaperone protein calreticulin. It is unclear how the dimeric structures induced by synthetic agonists and mutations relate to one another, and whether any of these induce the same active structure as the native ligand Tpo, yet this has important implications both for fundamental cytokine receptor biology and for development of targeted interventions for hTpoR-driven myeloproliferative diseases. Here we used deep mutational scanning (DMS) across the TM and juxtamembrane (JM) regions of hTpoR to extract feature-rich sequence-function signatures across a variety of different activating contexts. While each displayed some unique features, synthetic agonists and activating mutations all exhibited strong dependence on a common TM interface that is consistent with previous models of a left-handed, near-parallel helix dimer with H499 facing lipid. In contrast, Tpo-mediated activation was broadly insensitive to TM-JM substitutions, indicating that it does not rely on the same interface. Modeling with AlphaFold 3 (AF3) consistently yielded a right-handed, "splayed" helix dimer that is close at the extracellular face, contains H499 in the interface and diverges toward the cytosolic face, resting on an intracellular amphipathic JM helix that lies parallel to the membrane, which is also observed in a DMS/AF3 analysis of human erythropoietin receptor. This splayed Tpo-bound dimer could be stably inserted into a lipid bilayer with associated JAK2 using molecular dynamics and is supported by experiments showing that most or all of the TM domain can be replaced by poly-valine, with little effect on Tpo-driven activation but catastrophic effects on responses to synthetic ligands. Our data support at least two different structural modes of hTpoR activation that reconcile prior biochemical models, rationalize patient variants, and inform mechanism-based agonist and antagonist design.
]]></description>
<dc:creator>Wu, X.</dc:creator>
<dc:creator>McLeod, H.</dc:creator>
<dc:creator>Malinovitch, A.</dc:creator>
<dc:creator>Hunter, S.</dc:creator>
<dc:creator>Ramesh, S.</dc:creator>
<dc:creator>Go, M.</dc:creator>
<dc:creator>Nguyen, J. V.</dc:creator>
<dc:creator>Rubin, A. F.</dc:creator>
<dc:creator>Burger, W. A.</dc:creator>
<dc:creator>Blombery, P.</dc:creator>
<dc:creator>Call, M. E.</dc:creator>
<dc:creator>Call, M. J.</dc:creator>
<dc:date>2025-09-13</dc:date>
<dc:identifier>doi:10.1101/2025.09.09.675271</dc:identifier>
<dc:title><![CDATA[Shared and distinct sequence-function signatures define different modes of human TpoR activation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.19.670906?rss=1">
<title>
<![CDATA[
A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.19.670906?rss=1</link>
<description><![CDATA[
T follicular helper (Tfh) cells are central to the adaptive immune response and exhibit remarkable functional diversity and plasticity. The complex nature of Tfh cell populations, inconsistent findings across experimental systems and potential differences across species have fueled ongoing debate regarding core regulatory pathways that govern Tfh differentiation. Many studies have experimentally investigated individual proteins and circuits involved in Tfh differentiation in limited contexts, each providing only a partial understanding of the process. To address this, we adopted a novel multi-scale network systems approach that incorporates both regulatory and protein-protein interactions. Our approach integrates diverse data types, captures regulation across multiple levels of immune system organization, and recapitulates known drivers. Further, we discover a core Tfh gene set that is conserved across tissue types and disease contexts, and is consistent across data modalities - bulk, single-cell and spatial. While components of this set have been individually reported, a novel aspect of our work lies in the discovery, characterization, and connectivity of this core signature using a single unbiased approach. Using this method, we also uncover a novel function of IL-12, a molecule with reported conflicting functions, in the regulation of Tfh differentiation. Notably, we find that, in both humans and mice, IL-12 is permissive for the differentiation of Tfh precursors, but blocks subsequent differentiation into GC Tfh cells. Overall, this work elucidates novel networks with unexplored roles in governing Tfh cell differentiation across species and tissues, paving the way for novel -therapeutic interventions.
]]></description>
<dc:creator>Omelchenko, A. A.</dc:creator>
<dc:creator>Rahman, S. A.</dc:creator>
<dc:creator>Viswanadham, V. V.</dc:creator>
<dc:creator>Yuen, G. J.</dc:creator>
<dc:creator>Del Rio Estrada, P. M.</dc:creator>
<dc:creator>D'Onofrio, V.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Sun, N.</dc:creator>
<dc:creator>Mattoo, H.</dc:creator>
<dc:creator>Varma, C. G.</dc:creator>
<dc:creator>Salgado, G.</dc:creator>
<dc:creator>Nava, M. S.</dc:creator>
<dc:creator>Ruiz, L. C.</dc:creator>
<dc:creator>Rivera, D. D.</dc:creator>
<dc:creator>Rios, S. A.</dc:creator>
<dc:creator>Kasturi, S. P.</dc:creator>
<dc:creator>Ribeiro, S. P.</dc:creator>
<dc:creator>Shlomchik, M. J.</dc:creator>
<dc:creator>Poholek, A. C.</dc:creator>
<dc:creator>Pillai, S. S.</dc:creator>
<dc:creator>Elsner, R. A.</dc:creator>
<dc:creator>Mahajan, V. S.</dc:creator>
<dc:creator>Das, J.</dc:creator>
<dc:date>2025-08-24</dc:date>
<dc:identifier>doi:10.1101/2025.08.19.670906</dc:identifier>
<dc:title><![CDATA[A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.20.671277?rss=1">
<title>
<![CDATA[
TCR germline diversity reveals evidence of natural selection on variable and joining alpha chain genes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.20.671277?rss=1</link>
<description><![CDATA[
T cell receptors (TCRs) orchestrate adaptive immunity, yet the complex, repetitive architecture of the TCR loci has impeded systematic characterization of human genetic variation in the genes encoding the TCR. Using public long-read sequencing data from 2,668 donors, we build a near-complete map of common alleles in TCR V, D, and J genes, revealing amino acid variation at almost every position within V genes. We discover pervasive evidence of natural selection on TCR genes, including balancing selection on a TRAJ gene recognizing an immunodominant influenza epitope and positive selection on a TRAV gene. We find TCR allelic polymorphism alters core functional properties of T cells, including thymic fate commitment, phenotypes in diseased tissues, and cell-surface receptor abundance. Collectively, our findings position inherited variation in TCR genes as a key axis of immunological diversity that may shape interindividual differences in immune responses.
]]></description>
<dc:creator>Mantena, S.</dc:creator>
<dc:creator>Akbari, A.</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:date>2025-08-24</dc:date>
<dc:identifier>doi:10.1101/2025.08.20.671277</dc:identifier>
<dc:title><![CDATA[TCR germline diversity reveals evidence of natural selection on variable and joining alpha chain genes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.11.669723?rss=1">
<title>
<![CDATA[
Functional evidence for G6PD variant classification from mutational scanning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.11.669723?rss=1</link>
<description><![CDATA[
G6PD deficiency is one of the most common enzyme deficiencies worldwide, and increases the likelihood of adverse reactions to certain drugs and foods. Identifying people at risk is challenging, since most are asymptomatic until they encounter a trigger. This is further complicated since over 60% of 1,559 known genetic variants in G6PD are variants of uncertain significance and thus cannot guide drug prescribing and dosing. To resolve which variants are clinically meaningful and avoid harm from adverse drug reactions, we conducted two high-throughput functional assays: one for G6PD activity, and one for abundance. We measured the function of 9,527 missense, nonsense, and synonymous G6PD variants. The patterns of variant effect on activity and abundance confirmed the importance of structural NADP+ for G6PD activity and abundance, and G6PD dimerization for G6PD activity. Based on the ability of our functional assay scores to accurately classify G6PD variants of known clinical effect, we generated evidence that 4,870 missense variants contribute to G6PD deficiency and 2,245 are unlikely to contribute to G6PD deficiency. Our data can be used to deepen our understanding of G6PD as a protein, and to close the gap in classification for variants of uncertain significance to improve implementation of genetic medicine for G6PD deficiency.
]]></description>
<dc:creator>Geck, R. C.</dc:creator>
<dc:creator>Wheelock, M. K.</dc:creator>
<dc:creator>Powell, R. L.</dc:creator>
<dc:creator>Wang, Z. R.</dc:creator>
<dc:creator>Holmes, D. L.</dc:creator>
<dc:creator>Fayer, S.</dc:creator>
<dc:creator>Boyle, G. E.</dc:creator>
<dc:creator>Vandi, A. J.</dc:creator>
<dc:creator>Amorosi, C. J.</dc:creator>
<dc:creator>Moore, N.</dc:creator>
<dc:creator>Rubin, A. F.</dc:creator>
<dc:creator>Fowler, D. M.</dc:creator>
<dc:creator>Dunham, M. J.</dc:creator>
<dc:date>2025-08-14</dc:date>
<dc:identifier>doi:10.1101/2025.08.11.669723</dc:identifier>
<dc:title><![CDATA[Functional evidence for G6PD variant classification from mutational scanning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.12.669924?rss=1">
<title>
<![CDATA[
Regulatory network topology and the genetic architecture of gene expression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.12.669924?rss=1</link>
<description><![CDATA[
In human populations, most of the genetic variance in gene expression can be attributed to trans-acting expression quantitative trait loci (eQTLs) spread across the genome. However, in practice it is difficult to discover these eQTLs, and their cumulative effects on gene expression and complex traits are yet to be fully understood. Here, we assess how properties of the genetic architecture of gene expression constrain the space of plausible gene regulatory networks. We describe a structured causal model of gene expression regulation and consider how it interacts with biologically relevant properties of the gene regulatory network to alter the genomic distribution of expression heritability. Under our model, we find that the genetic architecture of gene expression is shaped in large part by local network motifs and by hub regulators that shorten paths through the network and act as key sources of trans-acting variance. Further, simulated networks with an enrichment of motifs and hub regulators best recapitulate the distribution of cis and trans heritability of gene expression as measured in a recent twin study. Taken together, our results suggest that the architecture of gene expression is sparser and more pleiotropic across genes than would be suggested by naive models of regulatory networks, which has important implications for future studies of complex traits.
]]></description>
<dc:creator>Aguirre, M.</dc:creator>
<dc:creator>Spence, J. P.</dc:creator>
<dc:creator>Sella, G.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2025-08-13</dc:date>
<dc:identifier>doi:10.1101/2025.08.12.669924</dc:identifier>
<dc:title><![CDATA[Regulatory network topology and the genetic architecture of gene expression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.05.668745?rss=1">
<title>
<![CDATA[
Higher eQTL power reveals signals that boost GWAS colocalization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.05.668745?rss=1</link>
<description><![CDATA[
Expression quantitative trait locus (eQTL) studies in human cohorts typically detect at least one regulatory signal per gene, and have been proposed as a way to explain mechanisms of genetic liability for other traits, as discovered in genome-wide association studies (GWAS). In particular, eQTL signals may colocalize with GWAS signals, suggesting gene expression as a possible mediator. However, recent studies have noted colocalization occurs infrequently, even when expression is measured in biologically relevant tissues. Most eQTL studies to date include only hundreds of individuals, and are underpowered to discover distal regulatory signals explaining smaller fractions of gene expression variance. We integrate evidence from recent eQTL studies and demonstrate that limited statistical power due to sample size skews the detection of eQTL signals identified at various signal strengths. We estimate that a sample size of 500 detects <0.1 to 60% of eQTL for a range of signal strengths and that a sample size of 2,000 would detect 36.8% of all eQTL. We show that eQTL signals that can only be discovered in larger studies exhibit characteristics more similar to those of GWAS signals, including greater distance to the regulated gene and higher probability of loss intolerance. Finally, using results from recent eQTL studies and meta-analyses, we observe a large increase in detected colocalizations with GWAS signals compared to previous studies. These findings caution against overinterpreting the absence of colocalization in underpowered studies and provide guidance for designing future eQTL experiments, to improve power and complement perturbation-based approaches in characterizing gene-trait mechanisms.
]]></description>
<dc:creator>Rosen, J. D.</dc:creator>
<dc:creator>Broadaway, K. A.</dc:creator>
<dc:creator>Brotman, S. M.</dc:creator>
<dc:creator>Mohlke, K. L.</dc:creator>
<dc:creator>Love, M. I.</dc:creator>
<dc:date>2025-08-05</dc:date>
<dc:identifier>doi:10.1101/2025.08.05.668745</dc:identifier>
<dc:title><![CDATA[Higher eQTL power reveals signals that boost GWAS colocalization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.24.666684?rss=1">
<title>
<![CDATA[
An automated ATAC-seq method reveals sequence determinants of transcription factor dose response in the open chromatin 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.24.666684?rss=1</link>
<description><![CDATA[
Transcription factor (TF) dosage is a critical determinant of cellular identity. However, the quantitative relationship between TF dosage and its regulation of chromatin accessibility and gene expression remains poorly understood. To address this, we developed RoboATAC, a scalable, automated ATAC-seq platform for high-throughput accessibility profiling. We then systematically profiled genome-wide chromatin accessibility and gene expression changes induced by graded overexpression of 22 TFs in HEK293T cells (246 total samples), observing dose-dependent changes in accessibility and aggregate TF footprints. Modeling accessibility as a function of sequence and chromatin states revealed that DNA sequence alone accurately predicts dosage sensitivity at elements that become accessible, with low-affinity motifs requiring higher TF levels to induce accessibility. Interpretable deep learning models revealed contributions of motif orientation, spacing, and flanking bases to accessibility, both recapitulating known motifs and nominating novel dosage-sensitive motif arrangements. Nucleosome positioning analysis uncovered two distinct, TF identity dependent patterns by which accessibility is established by changing nucleosome position and occupancy.
]]></description>
<dc:creator>Liu, B. B.</dc:creator>
<dc:creator>Shimasawa, M.</dc:creator>
<dc:creator>Vermeulen, S.</dc:creator>
<dc:creator>Kim, S. H.</dc:creator>
<dc:creator>Iremadze, N.</dc:creator>
<dc:creator>Lipson, D.</dc:creator>
<dc:creator>Shipony, Z.</dc:creator>
<dc:creator>Greenleaf, W. J.</dc:creator>
<dc:date>2025-07-27</dc:date>
<dc:identifier>doi:10.1101/2025.07.24.666684</dc:identifier>
<dc:title><![CDATA[An automated ATAC-seq method reveals sequence determinants of transcription factor dose response in the open chromatin]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.16.665245?rss=1">
<title>
<![CDATA[
Clonal lineage tracing of innate immune cells in human cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.16.665245?rss=1</link>
<description><![CDATA[
Innate immune cells constitute the majority of the tumor microenvironment (TME), where they mediate both natural anti-tumor immunity and immunotherapy responses. While single-cell T- and B-cell receptor sequencing has provided fundamental insights into the clonal dynamics of human adaptive immunity, the lack of appropriate tools has precluded similar analysis of innate immune cells. Here, we describe a method that leverages somatic mitochondrial DNA (mtDNA) mutations to reconstruct clonal lineage relationships between single cells across cell types in native human tissues. We jointly sequenced single-cell transposase-accessible chromatin and mtDNA to profile n=124,958 cells from matched tumor, non-involved lung tissue (NILT), and peripheral blood of early-stage non-small cell lung cancer (NSCLC) patients, as well as n=93,757 cells from matched tumor and peripheral blood of ovarian cancer patients. Single-cell concomitant profiling of lineage and cell states of thousands of immune cells resolved clonality across cell types, tissue sites, and malignancies. Clonal tracing of innate immune cells demonstrates that TME-resident myeloid subsets, including macrophages and type 3 dendritic cells (DC3), are clonally linked to both circulating and tissue-infiltrating monocytes. Further, we identify distinct DC-biased and macrophage-biased myeloid clones, enriched in the tumor and NILT, respectively, and find that their circulating monocyte precursors exhibit distinct epigenetic profiles, suggesting that myeloid differentiation fate may be predetermined before TME infiltration. These results delineate the clonal pathways of intratumoral myeloid cell recruitment and differentiation in human cancer and suggest that remodeling of the tumor myeloid compartment may be peripherally programmed.
]]></description>
<dc:creator>Liu, V.</dc:creator>
<dc:creator>Sandor, K.</dc:creator>
<dc:creator>Yan, P. K.</dc:creator>
<dc:creator>Miao, M.</dc:creator>
<dc:creator>Yin, Y.</dc:creator>
<dc:creator>Stickels, R. R.</dc:creator>
<dc:creator>Chen, A. Y.</dc:creator>
<dc:creator>Hiam-Galvez, K.</dc:creator>
<dc:creator>Gutierrez, J.</dc:creator>
<dc:creator>Zhang, W.</dc:creator>
<dc:creator>Sajjath, S. M.</dc:creator>
<dc:creator>Valbuena, R.</dc:creator>
<dc:creator>Wang, S.</dc:creator>
<dc:creator>Daniel, B.</dc:creator>
<dc:creator>Ludwig, L. S.</dc:creator>
<dc:creator>Howitt, B. E.</dc:creator>
<dc:creator>Lareau, C. A.</dc:creator>
<dc:creator>Satpathy, A. T.</dc:creator>
<dc:date>2025-07-21</dc:date>
<dc:identifier>doi:10.1101/2025.07.16.665245</dc:identifier>
<dc:title><![CDATA[Clonal lineage tracing of innate immune cells in human cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.19.665672?rss=1">
<title>
<![CDATA[
A gene regulatory element modulates myosin expression and controls cardiomyocyte response to stress 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.19.665672?rss=1</link>
<description><![CDATA[
A hallmark of heart disease is gene dysregulation and reactivation of fetal gene programs. Reactivation of these fetal programs has compensatory effects during heart failure, depending on the type and stage of the underlying cardiomyopathy. Thousands of putative cardiac gene regulatory elements have been identified that may control these programs, but their functions are largely unknown. We profile genome-wide changes to gene expression and chromatin structure in cardiomyocytes derived from human pluripotent stem cells. We identify and characterize a gene regulatory element essential for the regulation of MYH6, which encodes human fetal myosin. Using chromatin conformation assays in combination with epigenome editing, we find that gene regulation is mediated by direct interaction between MYH6 and the enhancer. We also find that enhancer activation alters cardiomyocyte response to the hypertrophy-inducing peptide endothelin-1. Enhancer activation prevents polyploidization and changes in calcium dynamics following stress with endothelin-1. Collectively, these results identify regulatory mechanisms of cardiac gene expression programs that modulate cardiomyocyte maturation, cellular stress response, and could serve as potential therapeutic targets.
]]></description>
<dc:creator>Anglen, T.</dc:creator>
<dc:creator>Kaplow, I. M.</dc:creator>
<dc:creator>Choi, B.</dc:creator>
<dc:creator>Dewars, E.</dc:creator>
<dc:creator>Perelli, R. M.</dc:creator>
<dc:creator>Hagy, K. T.</dc:creator>
<dc:creator>Tran, D.</dc:creator>
<dc:creator>Ramaker, M. E.</dc:creator>
<dc:creator>Shah, S.</dc:creator>
<dc:creator>Jung, I.</dc:creator>
<dc:creator>Landstrom, A. P.</dc:creator>
<dc:creator>Karra, R.</dc:creator>
<dc:creator>Diao, Y.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2025-07-20</dc:date>
<dc:identifier>doi:10.1101/2025.07.19.665672</dc:identifier>
<dc:title><![CDATA[A gene regulatory element modulates myosin expression and controls cardiomyocyte response to stress]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.14.664734?rss=1">
<title>
<![CDATA[
Comprehensively Testing the Function of Missense Variation in the STK11 Tumour Suppressor 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.14.664734?rss=1</link>
<description><![CDATA[
The tumor suppressor gene STK11 encoding Serine/Threonine Kinase 11 (STK11) is associated with Peutz-Jeghers Syndrome (PJS), a heritable gastrointestinal disease that increases lifetime cancer risk, and with somatic variation that contributes to [~]30% of lung and 20% of cervical cancers. Although identifying pathogenic variants is clinically actionable, over 94% of STK11 missense variants that have been observed clinically lack a definitive classification. We therefore measured the impact of STK11 variants at scale in a mammalian cell-based assay, scoring 6,026 (73% of all possible) amino acid substitutions across the full-length gene. Functional scores--which were consistent with biochemical properties, smaller-scale assays, and pathogenicity annotations--identified a subset of PJS patients with germline STK11 variants diagnosed later in life, as well as somatic STK11 variants found in cancer patients that had comparable overall survival estimates to wild-type STK11. Our scores provided new evidence for 350 annotated VUS STK11 missense variants and [~]80% of missense variants that have not yet been reported clinically, but we might expect to observe in the future. Thus, our effect map provides a proactive resource for gaining sequence-structure-function insights and evidence for actionable interpretation of clinical missense variants.
]]></description>
<dc:creator>Zimmerman, D.</dc:creator>
<dc:creator>Cote, A.</dc:creator>
<dc:creator>van Loggerenberg, W.</dc:creator>
<dc:creator>Gebbia, M.</dc:creator>
<dc:creator>Kishore, N.</dc:creator>
<dc:creator>Weile, J.</dc:creator>
<dc:creator>Li, R.</dc:creator>
<dc:creator>Reno, C.</dc:creator>
<dc:creator>Marsh, A.</dc:creator>
<dc:creator>Hernandez, F.</dc:creator>
<dc:creator>Shahagadkar, P.</dc:creator>
<dc:creator>Grove, L.</dc:creator>
<dc:creator>Meier, S.</dc:creator>
<dc:creator>Wu, H.-J.</dc:creator>
<dc:creator>Fengolia, S.</dc:creator>
<dc:creator>Ahronian, L.</dc:creator>
<dc:creator>Teng, T.</dc:creator>
<dc:creator>Waters, A. J.</dc:creator>
<dc:creator>Seward, D.</dc:creator>
<dc:creator>Taipale, M.</dc:creator>
<dc:creator>Aronson, M.</dc:creator>
<dc:creator>Richardson, M. E.</dc:creator>
<dc:creator>Adams, D.</dc:creator>
<dc:creator>Roth, F.</dc:creator>
<dc:date>2025-07-18</dc:date>
<dc:identifier>doi:10.1101/2025.07.14.664734</dc:identifier>
<dc:title><![CDATA[Comprehensively Testing the Function of Missense Variation in the STK11 Tumour Suppressor]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.09.662874?rss=1">
<title>
<![CDATA[
Expanding the DNA Motif Lexicon of the Transcriptional Regulatory Code 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.09.662874?rss=1</link>
<description><![CDATA[
Cis-regulatory sequences in metazoan genomes contain elaborate combinations of transcription factor (TF) motifs. Stereospecific arrangements of simple motifs constitute composite elements (CEs) that enhance DNA-protein interaction specificity and enable combinatorial regulatory logic. Despite their importance, CEs remain underexplored. We integrate genome-scale computational discovery (CEseek) with customized massively parallel reporter assays (MPRAs) to uncover cell type-specific and shared CEs, corroborated by coincident and/or cooperative TF binding in vivo and in vitro. A deep learning model, GRACE, trained on MPRA data at single-nucleotide resolution, learns the CE lexicon and predicts activities of variants and alternative stereospecific CE configurations not included in the experimental design. Comparative analysis with models trained on orthogonal features such as chromatin accessibility, demonstrates convergence within the CE lexicon while resolving how individual motifs contribute to transcription versus chromatin accessibility. The expanded lexicon enables CE-aware predictions and interpretation of the impact of disease-associated non-coding variants in. the human genome.
]]></description>
<dc:creator>Fan, J.</dc:creator>
<dc:creator>Chaudhri, V. K.</dc:creator>
<dc:creator>Bisht, D.</dc:creator>
<dc:creator>Pease, N. A.</dc:creator>
<dc:creator>Hall, D. R.</dc:creator>
<dc:creator>Gerges, P.</dc:creator>
<dc:creator>Yi, V. F.</dc:creator>
<dc:creator>Kales, S.</dc:creator>
<dc:creator>Ho, C.-H.</dc:creator>
<dc:creator>Das, J.</dc:creator>
<dc:creator>Ray, J. P.</dc:creator>
<dc:creator>Tewhey, R.</dc:creator>
<dc:creator>Meyer, C. A.</dc:creator>
<dc:creator>Sahni, N.</dc:creator>
<dc:creator>Singh, H.</dc:creator>
<dc:date>2025-07-15</dc:date>
<dc:identifier>doi:10.1101/2025.07.09.662874</dc:identifier>
<dc:title><![CDATA[Expanding the DNA Motif Lexicon of the Transcriptional Regulatory Code]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.26.661849?rss=1">
<title>
<![CDATA[
Simultaneous epigenomic profiling and regulatory activity measurement using e2MPRA 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.26.661849?rss=1</link>
<description><![CDATA[
Cis-regulatory elements (CREs) have a major effect on phenotypes including disease. They are identified in a genome-wide manner by analyzing the binding of transcription factors (TFs), various co-factors and histone modifications in DNA using assays such as ChIP-seq, Cut&Tag and ATAC-seq. However, these assays are descriptive and require high-throughput technologies, such as massively parallel reporter assays (MPRAs), to test the functional activity and variant effect on these sequences. Currently, technologies that can simultaneously analyze both the regulatory function of a specific sequence and the TFs, cofactors and epigenomic modifications that determine it do not exist. Here, we developed enrichment followed by epigenomic profiling MPRA (e2MPRA), a novel technology that utilizes lentivirus-based MPRA to enrich for the integration of specific CREs into the genome followed by Cut&Tag or ATAC-seq targeted specifically for these sequences. This method allows to simultaneously analyze in a high-throughput manner regulatory activity, protein binding and epigenetic modification of thousands of candidate CREs and their variants. We demonstrate that e2MPRA can be used to dissect the epigenetic functions of TF motifs arranged in synthetic enhancers, as well as to analyze the effect of enhancer sequence variants on epigenetic modifications. In summary, this technology will increase our understanding of the regulatory code, its effect on the epigenome and how its alteration can lead to a variety of phenotypes including human disease.
]]></description>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Georgakopoulos Soares, I.</dc:creator>
<dc:creator>Bourque, G.</dc:creator>
<dc:creator>Ahituv, N.</dc:creator>
<dc:creator>Inoue, F.</dc:creator>
<dc:date>2025-06-30</dc:date>
<dc:identifier>doi:10.1101/2025.06.26.661849</dc:identifier>
<dc:title><![CDATA[Simultaneous epigenomic profiling and regulatory activity measurement using e2MPRA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.11.658967?rss=1">
<title>
<![CDATA[
Capture-C MPRA: A high-throughput method to simultaneously characterize promoter interactions and regulatory activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.11.658967?rss=1</link>
<description><![CDATA[
Cis regulatory elements (CREs) interact with their target promoters over long genomic distances and can be identified using chromatin conformation capture (3C) assays. Their regulatory activity can be functionally characterized in a high-throughput manner using massively parallel reporter assays (MPRAs) that generally test an enhancer alongside a minimal promoter. Here, we developed a novel technology called Capture-C MPRA (ccMPRA) that combines both technologies and can simultaneously obtain chromatin interactions and measure CRE activity alongside their target promoters. We utilized ccMPRA to analyze the regulatory activity of 650 promoters interacting with 42,719 sequences. As C-based techniques also capture isolated promoters, we were able to obtain promoter baseline activity, enabling the identification of both enhancers and silencers. Analysis of CREs interacting with more than one promoter showed significant activity differences depending on the promoter. In summary, ccMPRA can simultaneously characterize chromatin interactions and regulatory activity, allowing to further dissect regulatory grammar.
]]></description>
<dc:creator>Arnould, C.</dc:creator>
<dc:creator>Keukeleire, P.</dc:creator>
<dc:creator>Inoue, F.</dc:creator>
<dc:creator>Cui, X.</dc:creator>
<dc:creator>An, K.</dc:creator>
<dc:creator>Murray, E.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Drmanac, R.</dc:creator>
<dc:creator>Peters, B.</dc:creator>
<dc:creator>Shendure, J.</dc:creator>
<dc:creator>Shen, Y.</dc:creator>
<dc:creator>Kircher, M.</dc:creator>
<dc:creator>Ahituv, N.</dc:creator>
<dc:date>2025-06-14</dc:date>
<dc:identifier>doi:10.1101/2025.06.11.658967</dc:identifier>
<dc:title><![CDATA[Capture-C MPRA: A high-throughput method to simultaneously characterize promoter interactions and regulatory activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.05.658097?rss=1">
<title>
<![CDATA[
Robust self-supervised machine learning for single cell embeddings and annotations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.05.658097?rss=1</link>
<description><![CDATA[
Dimensionality reduction and clustering are critical steps in single-cell and spatial genomics studies. Here, we show that existing dimensionality reduction and clustering methods suffer from: (1) overfitting to the dominant patterns while missing unique ones, which impairs the detection and annotation of rare cell types and states, and (2) fitting to technical noise over biological signal. To address this, we developed DR-GEM, a self-supervised meta-algorithm that combines principles in distributionally robust optimization with balanced consensus machine learning. DR-GEM supervises itself by (1) using the reconstruction error to identify and reorient its attention to samples/cells that are otherwise poorly embedded, and (2) using balanced consensus learning as a mechanism to increase robustness and mitigate the impact of low-quality samples/cells. Applied to synthetic and real-world single cell  omics data, single cell resolution spatial transcriptomics, and Perturb-seq datasets, DR-GEM markedly and consistently outperforms existing methods in obtaining reliable embeddings, recovering rare cell types, filtering noise, and uncovering the underlying biology. In summary, this study surfaces and addresses a gap in single cell genomics and brings self-supervision to the realm of dimensionality reduction and clustering to better support data-driven discoveries.
]]></description>
<dc:creator>Yeh, C. Y.</dc:creator>
<dc:creator>Sun, M. W.</dc:creator>
<dc:creator>Zhu, D.</dc:creator>
<dc:creator>Jerby, L.</dc:creator>
<dc:date>2025-06-08</dc:date>
<dc:identifier>doi:10.1101/2025.06.05.658097</dc:identifier>
<dc:title><![CDATA[Robust self-supervised machine learning for single cell embeddings and annotations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.04.657941?rss=1">
<title>
<![CDATA[
Dogme: A nextflow pipeline for reprocessing nanopore RNA and DNA modifications 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.04.657941?rss=1</link>
<description><![CDATA[
MotivationThe Oxford Nanopore Technologies (ONT) platform allows for the direct detection of RNA and DNA modifications from unamplified nucleic acids, which is a significant advantage over other platforms. However, the rapid updates to ONT basecalling models and the evolving landscape of computational tools for modification detection bring about challenges for reproducible and standardized analyses. To address these challenges, we developed Dogme, which is a Nextflowbased workflow that automates the processing of ONT data, including basecalling, alignment, modification detection, and transcript quantification. Dogme automates the reprocessing of ONT POD5 files by integrating basecalling using Dorado, read mapping using minimap2 and subsequent analysis steps such as running modkit. The pipeline supports three major types of ONT sequencing data - direct RNA (dRNA), complementary DNA (cDNA), and genomic DNA (gDNA) - enabling comprehensive analyses across different library preparations. Dogme facilitates detection of diverse RNA modifications supported by Dorado such as N6-methyladenosine (m6A), 5-methylcytosine (m5C), inosine, pseudouridine, 2-Omethylation (Nm) and DNA methylation, while concurrently quantifying full-length transcript isoforms LR-Kallisto for transcript quantification for dRNA and cDNA.

ResultsWe applied Dogme to three separate mouse C2C12 myoblast replicates using direct RNA sequencing on MinION flow cells. We detected an average of 147,879 m6A, 86,673 m5C, 21,242 inosine, 24,540 pseudouridine, and 83,841 2- O-methylation sites per replicate with 96,581 m6A, 43,446 m5C, 8,825 inosine, 10,048 pseudouridine, and 30,157 2-O- methylation sites detected in all three biological replicates. The pipeline produced reproducible modification profiles and transcript expression levels across replicates, demonstrating its utility for integrative long-read transcriptomic and epigenomic analyses.

AvailabilityDogme is implemented in Nextflow and is freely available under the MIT license at https://github.com/mortazavilab/dogme, with documentation provided for installation and usage.
]]></description>
<dc:creator>Abdollahzadeh, E.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:date>2025-06-08</dc:date>
<dc:identifier>doi:10.1101/2025.06.04.657941</dc:identifier>
<dc:title><![CDATA[Dogme: A nextflow pipeline for reprocessing nanopore RNA and DNA modifications]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.06.658175?rss=1">
<title>
<![CDATA[
Focus on single gene effects limits discovery and interpretation of complex trait-associated variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.06.658175?rss=1</link>
<description><![CDATA[
Standard QTL mapping approaches consider variant effects on a single gene at a time, despite abundant evidence for allelic pleiotropy, where a single variant can affect multiple genes simultaneously. While allelic pleiotropy describes variant effects on both local and distal genes or a mixture of molecular effects on a single gene, here we specifically investigate allelic expression "proxitropy": where a single variant influences the expression of multiple, neighboring genes. We introduce a multi-gene eQTL mapping framework--cis-principal component expression QTL (cis-pc eQTL or pcQTL)--to identify variants associated with shared axes of expression variation across a cluster of neighboring genes. We perform pcQTL mapping in 13 GTEx human tissues and discover novel loci undetected by single-gene approaches. In total, we identify an average of 1396 pcQTLs/tissue, 27% of which were not discovered by single-gene methods. These novel pcQTL colocalized with an additional 142 GWAS trait-associated variants and increased the number of colocalizations by 34% over single-gene QTL mapping. These findings highlight that moving beyond single-gene-at-a-time approaches toward multi-gene methods can offer a more comprehensive view of gene regulation and complex trait-associated variation.
]]></description>
<dc:creator>Lawrence, K. A.</dc:creator>
<dc:creator>Gjorgjieva, T.</dc:creator>
<dc:creator>Montgomery, S. B.</dc:creator>
<dc:date>2025-06-06</dc:date>
<dc:identifier>doi:10.1101/2025.06.06.658175</dc:identifier>
<dc:title><![CDATA[Focus on single gene effects limits discovery and interpretation of complex trait-associated variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.04.655863?rss=1">
<title>
<![CDATA[
Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.04.655863?rss=1</link>
<description><![CDATA[
Vascular smooth muscle cells (SMC) contribute to heritable coronary artery disease (CAD) risk and undergo complex cell state transitions to multiple disease related phenotypes. To investigate the genetic basis of SMC state trajectories that underlie the SMC component of CAD causality we have developed a dense timecourse single cell transcriptomic and epigenetic map of atherosclerosis in a murine disease animal model. Cellular trajectories were derived from the temporal data and probabilistic fate modeling with Waddington-Optimal Transport (WOT). We created transcription factor (TF) centered regulons mapped across the developmental timeline and through network-based prioritization with WOT predicted TFs and in silico TF perturbation, identified key drivers of cell state changes associated with EMT, vascular development, and circadian clock functions. Integration of mouse disease data with human CAD genetic findings identified transition SMC phenotypes that mediate disease risk and point to causal disease mechanisms. Parallel studies using knockout of the validated CAD gene Tcf21 revealed its impact on SMC transition cellular phenotypes and disease risk genes, due in part to a role regulating the transition of SMC precursor cells in the secondary heart field. Together, these studies characterize atherosclerosis trajectories at single cell resolution and identify genetic causal transcriptomic and epigenomic mechanisms of CAD risk.
]]></description>
<dc:creator>Li, D. Y.</dc:creator>
<dc:creator>Kundu, S.</dc:creator>
<dc:creator>Cheng, P.</dc:creator>
<dc:creator>Gu, W.</dc:creator>
<dc:creator>Jackson, W. R.</dc:creator>
<dc:creator>Zhao, Q.</dc:creator>
<dc:creator>Nguyen, T.</dc:creator>
<dc:creator>Worssam, M.</dc:creator>
<dc:creator>Monteiro, J. P.</dc:creator>
<dc:creator>Caceres, R. D.</dc:creator>
<dc:creator>Dale, S.</dc:creator>
<dc:creator>Palmisano, B.</dc:creator>
<dc:creator>Weldy, C. S.</dc:creator>
<dc:creator>Kundu, R.</dc:creator>
<dc:creator>Wirka, R. C.</dc:creator>
<dc:creator>Quertermous, T.</dc:creator>
<dc:date>2025-06-06</dc:date>
<dc:identifier>doi:10.1101/2025.06.04.655863</dc:identifier>
<dc:title><![CDATA[Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.16.654442?rss=1">
<title>
<![CDATA[
Long-term Reprogramming and Altered Ontogeny of Classical Monocytes Mediates Enhanced Lung Injury in Sepsis Survivor Mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.16.654442?rss=1</link>
<description><![CDATA[
Patients who survive sepsis are predisposed to new hospitalizations for respiratory failure, but the underlying mechanisms are unknown. Using a murine model in which prior sepsis predisposes to enhanced lung injury, we previously discovered that classical monocytes persist in the lungs after long-term recovery from sepsis and exhibit enhanced cytokine expression after secondary challenge with intra-nasal lipopolysaccharide. Here, we hypothesized that immune reprogramming of post-sepsis monocytes and altered ontogeny predispose to enhanced lung injury. Monocyte depletion and/or adoptive transfer was performed three weeks and three months after sepsis. Monocytes from post-sepsis mice were necessary and sufficient for enhanced LPS-induced lung injury and promoted neutrophil degranulation. Prior sepsis enhanced JAK-STAT signaling and AP-1 binding in monocytes and shifted monocytes toward the neutrophil-like monocyte lineage. In human sepsis and/or pneumonia survivors, monocytes were predictive of 90-day mortality and exhibit transcriptional and proteomic neutrophil-like signatures. We conclude that sepsis reprograms monocytes into a pro-inflammatory phenotype and skews bone marrow progenitors and monocytes toward the neutrophil-like lineage, predisposing to neutrophil degranulation and lung injury.
]]></description>
<dc:creator>Denstaedt, S. J.</dc:creator>
<dc:creator>McBean, B.</dc:creator>
<dc:creator>Boyle, A. P.</dc:creator>
<dc:creator>Arenberg, B. C.</dc:creator>
<dc:creator>Mack, M.</dc:creator>
<dc:creator>Moore, B. B.</dc:creator>
<dc:creator>Newstead, M. W.</dc:creator>
<dc:creator>Singer, B. H.</dc:creator>
<dc:creator>Cano, J.</dc:creator>
<dc:creator>Prescott, H. C.</dc:creator>
<dc:creator>Goodridge, H. S.</dc:creator>
<dc:creator>Zemans, R. L.</dc:creator>
<dc:date>2025-05-21</dc:date>
<dc:identifier>doi:10.1101/2025.05.16.654442</dc:identifier>
<dc:title><![CDATA[Long-term Reprogramming and Altered Ontogeny of Classical Monocytes Mediates Enhanced Lung Injury in Sepsis Survivor Mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.14.654043?rss=1">
<title>
<![CDATA[
Cell modeling and rescue of a novel non-coding genetic cause of Glycogen Storage Disease IX 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.14.654043?rss=1</link>
<description><![CDATA[
Delayed diagnosis of Mendelian disease substantially prevents early therapeutic intervention that could improve symptoms and prognosis. One major contributing challenge is the functional interpretation of non-coding variants that cause disease by altering splicing and/or gene expression. We identified two siblings with glycogen storage disease (GSD) type IX {gamma}2, both of whom had a classic clinical presentation, enzyme deficiency, and a known pathogenic splice acceptor variant on one allele of PHKG2. Despite the autosomal recessive nature of the disease, no variant on the second allele was identified by gene panel sequencing. To identify a potential missing second pathogenic variant, we completed whole genome sequencing (WGS) and detected putative deep intronic splicing variant in PHKG2 in both siblings. We confirmed the functional splicing effects of this variant using short-read and long-read RNA-seq on patient blood and a HEK293T cell model in which we installed the variant using CRISPR editing. Using the cell model, we demonstrated multiple biochemical and cellular impacts that are consistent with GSD IX {gamma}2, and a reversal of aberrant splicing using antisense splice-switching oligonucleotides. In doing so, we demonstrate a novel and robust pathway for detecting, validating, and reversing the impacts of novel non-coding causes of rare disease.
]]></description>
<dc:creator>Iyengar, A. K.</dc:creator>
<dc:creator>Zou, X.</dc:creator>
<dc:creator>Dai, J.</dc:creator>
<dc:creator>Francis, R. A.</dc:creator>
<dc:creator>Safi, A.</dc:creator>
<dc:creator>Patterson, K.</dc:creator>
<dc:creator>Koch, R. L.</dc:creator>
<dc:creator>Clarke, S.</dc:creator>
<dc:creator>Beaman, M. M.</dc:creator>
<dc:creator>Chong, J. X.</dc:creator>
<dc:creator>Bamshad, M. J.</dc:creator>
<dc:creator>Majoros, W. H.</dc:creator>
<dc:creator>Rehder, R. C.</dc:creator>
<dc:creator>Bali, D. S.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Kishnani, P. S.</dc:creator>
<dc:creator>Reddy, T. E.</dc:creator>
<dc:date>2025-05-17</dc:date>
<dc:identifier>doi:10.1101/2025.05.14.654043</dc:identifier>
<dc:title><![CDATA[Cell modeling and rescue of a novel non-coding genetic cause of Glycogen Storage Disease IX]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.14.653991?rss=1">
<title>
<![CDATA[
VEFill: a model for accurate and generalizable deep mutational scanning score imputation across protein domains 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.14.653991?rss=1</link>
<description><![CDATA[
BackgroundDeep Mutational Scanning (DMS) assays can systematically assess the effects of amino acid substitutions on protein function. While DMS datasets have been generated for many targets, they often suffer from incomplete variant coverage due to technical constraints, limiting their utility in variant interpretation and downstream analyses.

ResultsWe developed VEFill, a gradient boosting model for imputing missing DMS scores across protein domains. VEFill is trained on the Human Domainome 1 dataset, a large, standardized set of DMS experiments using a uniform stability-based assay, and integrates a broad set of additional biologically informative features including ESM-1v sequence embeddings, evolutionary conservation (EVE scores), amino acid substitution matrices, and physicochemical descriptors. The model achieved robust predictive performance (R2 = 0.64, Pearson r = 0.80). It also demonstrated reliable generalization to unseen proteins in other stability-based datasets, while showing weaker performance on activity-based assays. Per-protein models further confirmed VEFills effectiveness under limited-data conditions. A reduced two-feature version using only ESM-1v embeddings and mean DMS scores performed comparably to the full model, suggesting a computationally efficient alternative. However, true zeroshot prediction without positional context remains a challenge, particularly for functionally complex proteins.

ConclusionsVEFill offers an interpretable, scalable framework for DMS score imputation, especially effective in stability-focused and sparse-data settings. It enables systematic mutation prioritization and may support the design of efficient experimental libraries for variant effect studies.
]]></description>
<dc:creator>Polunina, P. V.</dc:creator>
<dc:creator>Maier, W.</dc:creator>
<dc:creator>Rubin, A. F.</dc:creator>
<dc:date>2025-05-14</dc:date>
<dc:identifier>doi:10.1101/2025.05.14.653991</dc:identifier>
<dc:title><![CDATA[VEFill: a model for accurate and generalizable deep mutational scanning score imputation across protein domains]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.08.652986?rss=1">
<title>
<![CDATA[
Developing a general AI model for integrating diverse genomic modalities and comprehensive genomic knowledge 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.08.652986?rss=1</link>
<description><![CDATA[
Advances in next-generation sequencing technologies have vastly expanded the availability of diverse genomic, epigenomic and transcriptomic data, presenting the opportunity to develop a general AI model that integrates comprehensive genomic knowledge into a unified model. Unlike previous predictive models, which are typically specialized to certain tasks, our general AI model unifies a wide range of genomic modalities, such as nascent RNA and ultra-high-resolution chromatin organization, within a multi-task architecture. Using ATAC-seq and DNA sequences as inputs, we incorporated diverse genomic modalities as output, and the model exhibits strong generalizability across different cell types and tissues in all tasks we trained. It accurately predicts gene-level transcription measured by various nascent RNA assays, and effectively captures enhancer-associated transcription. Additionally, it also accurately captures the potential functions of non-coding genetic variants and regulatory elements. Additionally, we extended the model trained on human data to a mouse general model, achieving accurate predictions of genomic modalities, such as high resolution chromatin contact maps with limited data availability, which are further validated using an established mouse inner-ear study. This comprehensive approach offers a powerful tool for understanding genome regulation in both human and mouse species.
]]></description>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Bao, X.</dc:creator>
<dc:creator>Jiang, L.</dc:creator>
<dc:creator>Luo, X.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Comai, A.</dc:creator>
<dc:creator>Waldhaus, J.</dc:creator>
<dc:creator>Hansen, A. S.</dc:creator>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:date>2025-05-14</dc:date>
<dc:identifier>doi:10.1101/2025.05.08.652986</dc:identifier>
<dc:title><![CDATA[Developing a general AI model for integrating diverse genomic modalities and comprehensive genomic knowledge]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.11.653354?rss=1">
<title>
<![CDATA[
Pseudoassembly of k-mers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.11.653354?rss=1</link>
<description><![CDATA[
We introduce a pseudoassembly approach to identifying variation in sets of genomic sequences via colored de Bruijn graphs. Our pseudoassembly method is implemented in a program called klue that assembles k-mers into sequences compatible with a variant-aware extension of pseudoalignment. We show that this approach can be used to identify cell-type specific de novo variants from single-cell RNA-seq in a mouse melanoma model.
]]></description>
<dc:creator>Sullivan, D. K.</dc:creator>
<dc:creator>Boffelli, M.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2025-05-13</dc:date>
<dc:identifier>doi:10.1101/2025.05.11.653354</dc:identifier>
<dc:title><![CDATA[Pseudoassembly of k-mers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.30.651435?rss=1">
<title>
<![CDATA[
Cellular and Regional Vulnerability Shapes the Molecular Landscape of Psychosis in Alzheimers Disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.30.651435?rss=1</link>
<description><![CDATA[
Approximately 40 percent of Alzheimers disease patients develop psychosis (AD+P), yet the molecular and cellular basis of these symptoms remains poorly understood. Here we profiled single-nucleus transcriptomes and epigenomes from 48 postmortem Alzheimers brains stratified by psychiatric diagnosis. Across cell types, AD+P was distinguished by transcriptional programs in upper-layer cortical pyramidal neurons consistent with re-engagement of developmental and structural plasticity pathways. These neurons exhibited greater loss in AD+P cortex, indicating that such programs emerge in a context of heightened vulnerability. Integrating these findings with functional perturbation screens in stem-cell-derived brain organoids, we found that activation of these programs alters cortico-cortical network connectivity and can exacerbate network dysfunction. Our data suggest that compensatory neuronal plasticity, shaped by glial inflammatory responses, may paradoxically contribute to circuit instability and selective vulnerability underlying neuropsychiatric symptoms in dementia.

HighlightsO_LICell-type- and brain-region-specific transcriptional changes in AD with psychosis (AD+P)
C_LIO_LIUpper-layer pyramidal dysfunction and metabolic vulnerability marks the pathophysiology of AD+P
C_LIO_LICircuit wiring programs are evoked in AD+P as maladaptive compensatory responses
C_LIO_LIAD+P-associated IL-6 signaling impairs neuronal network function in brain organoids
C_LI
]]></description>
<dc:creator>Victor, M. B.</dc:creator>
<dc:creator>Sun, N.</dc:creator>
<dc:creator>Galani, K.</dc:creator>
<dc:creator>Leary, N.</dc:creator>
<dc:creator>Tanigawa, Y.</dc:creator>
<dc:creator>Scannail, A. N.</dc:creator>
<dc:creator>Ho, L.-L.</dc:creator>
<dc:creator>Prosper, S.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Kofler, J. K.</dc:creator>
<dc:creator>Sweet, R.</dc:creator>
<dc:creator>Tsai, L.-H.</dc:creator>
<dc:creator>Kellis, M.</dc:creator>
<dc:date>2025-05-07</dc:date>
<dc:identifier>doi:10.1101/2025.04.30.651435</dc:identifier>
<dc:title><![CDATA[Cellular and Regional Vulnerability Shapes the Molecular Landscape of Psychosis in Alzheimers Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.29.651326?rss=1">
<title>
<![CDATA[
Gene-based calibration of high-throughput functional assays for clinical variant classification 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.29.651326?rss=1</link>
<description><![CDATA[
High-throughput assays measure a broad range of variant effects on gene function and hold promise for supporting genomic medicine. Current clinical guidelines for rare Mendelian diseases rely on establishing gene-specific score thresholds for each assay that separate pathogenic from benign variants. This introduces inconsistencies and subjectivity, ultimately lacking the rigor of calibration; i.e., mapping a variant score to a probability of pathogenicity. To address this problem, we introduce a semi-supervised framework for calibrating experimental assay data and propose Experimental score CALIBRator (ExCALIBR), a method that jointly models pathogenic, benign, synonymous, and population variants using skew normal mixtures to produce variant-specific probabilities of pathogenicity. Evaluated across 80 datasets from 39 genes, all meeting fit quality criteria, ExCALIBR substantially outperformed existing field standards and was further validated on the All of Us biobank data. Our results demonstrate that calibrated experimental assays generate indispensable evidence that will dramatically reduce variants of uncertain significance.
]]></description>
<dc:creator>Zeiberg, D.</dc:creator>
<dc:creator>Tejura, M.</dc:creator>
<dc:creator>McEwen, A. E.</dc:creator>
<dc:creator>Fayer, S.</dc:creator>
<dc:creator>Pejaver, V.</dc:creator>
<dc:creator>Rubin, A. F.</dc:creator>
<dc:creator>Starita, L. M.</dc:creator>
<dc:creator>Fowler, D. M.</dc:creator>
<dc:creator>O'Donnell-Luria, A.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:date>2025-05-04</dc:date>
<dc:identifier>doi:10.1101/2025.04.29.651326</dc:identifier>
<dc:title><![CDATA[Gene-based calibration of high-throughput functional assays for clinical variant classification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.23.650307?rss=1">
<title>
<![CDATA[
cellSTAAR: Incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of non-coding regions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.23.650307?rss=1</link>
<description><![CDATA[
Whole genome sequencing (WGS) studies have identified hundreds of millions of rare variants (RVs) and have enabled RV association tests (RVATs) of these variants with complex traits and diseases. Analysis of non-coding variants is challenged by the considerable variability in regulatory function which candidate Cis-Regulatory Elements (cCREs) exhibit across cell types. We propose cellSTAAR, which integrates WGS data with single-cell ATAC-seq data to capture variability in chromatin accessibility across cell types via the construction of cell-type-specific functional annotations and variant sets. To reflect the uncertainty in cCRE-gene linking, cellSTAAR also links cCREs to their target genes using an omnibus framework which aggregates results from a variety of popular linking approaches. We applied cellSTAAR on Freeze 8 (N = 60,000) of the NHLBI Trans-Omics for Precision Medicine (TOPMed) consortium data to four lipids phenotypes: LDL cholesterol, a binary variable corresponding to high LDL cholesterol, HDL cholesterol, and triglycerides. We also provide replication results for all four phenotypes using UK Biobank (N = 190,000). Evidence from simulation studies and our real data analysis demonstrates that cellSTAAR boosts power and improves interpretation of RVATs of cCREs.
]]></description>
<dc:creator>Van Buren, E.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Selvaraj, M. S.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Zhou, H.</dc:creator>
<dc:creator>Palmer, N. D.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Carlson, J. C.</dc:creator>
<dc:creator>Carson, A. P.</dc:creator>
<dc:creator>Chen, Y.-D. I.</dc:creator>
<dc:creator>Curran, J.</dc:creator>
<dc:creator>Duggirala, R.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Franceschini, N.</dc:creator>
<dc:creator>Graff, M.</dc:creator>
<dc:creator>Gu, C.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Heard-Cosa, N.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Hung, Y.-J.</dc:creator>
<dc:creator>Kalyani, R. R.</dc:creator>
<dc:creator>Kardia, S. L. R.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Kral, B. G.</dc:creator>
<dc:creator>Lange, L.</dc:creator>
<dc:creator>Li, C.</dc:creator>
<dc:creator>Liu, S.</dc:creator>
<dc:creator>Lloyd-Jones, D.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Manichaikul, A. W.</dc:creator>
<dc:creator>Martin, L. W.</dc:creator>
<dc:creator>Mathias, R.</dc:creator>
<dc:creator>Minster, R.</dc:creator>
<dc:creator>Mitchell, B. D.</dc:creator>
<dc:creator>Mychaleckyj, J. C.</dc:creator>
<dc:creator>Naseri, T.</dc:creator>
<dc:creator>North, K.</dc:creator>
<dc:creator>O'Connell, J.</dc:creator>
<dc:creator>Perry, J. A.</dc:creator>
<dc:creator>Peyse</dc:creator>
<dc:date>2025-04-26</dc:date>
<dc:identifier>doi:10.1101/2025.04.23.650307</dc:identifier>
<dc:title><![CDATA[cellSTAAR: Incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of non-coding regions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.21.649844?rss=1">
<title>
<![CDATA[
Systematic cell-type resolved transcriptomes of 8 tissues in 8 lab and wild-derived mouse strains captures global and local expression variation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.21.649844?rss=1</link>
<description><![CDATA[
Mapping the impact of genomic variation on gene expression facilitates an understanding of the molecular basis of complex phenotypic traits and disease predisposition. Mouse models provide a controlled and reproducible framework for capturing the breadth of genomic variation observed in different genotypes across a wide variety of tissues. As part of the IGVF consortiums effort to catalog the effects of genetic variation, we uniformly characterized the transcriptomes of eight tissues from each mouse founder strain used to derive the Collaborative Cross strains, comprising five classical laboratory inbred strains and three wild-derived inbred strains. We sequenced samples from four male and four female replicates per tissue using single-nucleus RNA-seq to generate an "8-cube" dataset of 5.2 million nuclei across 106 cell types and cell states. As expected, the overall extent of transcriptome variation correlates positively with genetic divergence across the strains with the greatest differential between PWK/PhJ and CAST/EiJ. At the individual tissue level, heart and brain are relatively more similar across strains compared with gonads, adrenal, skeletal muscle, kidney, and liver. Further analyses revealed substantial strain variation, often concentrated in a few cell types as well as cell-state signatures that especially reflect strain-associated immune and metabolic trait differences. The founder 8-cube dataset provides rich transcriptome variation signatures to help explain strain-specific phenotypic traits and disease states, as illustrated by examples in tissue-resident immune cells, muscle degeneration, kidney sex differences, and the hypothalamicpituitary-adrenal axis. This data further provides a systematic foundation for the analysis of these tissues in the founder strains as well as the Collaborative Cross.
]]></description>
<dc:creator>Rebboah, E.</dc:creator>
<dc:creator>Weber, R.</dc:creator>
<dc:creator>Abdollahzadeh, E.</dc:creator>
<dc:creator>Swarna, N. P.</dc:creator>
<dc:creator>Sullivan, D. K.</dc:creator>
<dc:creator>Trout, D.</dc:creator>
<dc:creator>Reese, F.</dc:creator>
<dc:creator>Liang, H. Y.</dc:creator>
<dc:creator>Filimban, G.</dc:creator>
<dc:creator>Mahdipour, P.</dc:creator>
<dc:creator>Duffield, M.</dc:creator>
<dc:creator>Mojaverzargar, R.</dc:creator>
<dc:creator>Taghizadeh, E.</dc:creator>
<dc:creator>Fattahi, N.</dc:creator>
<dc:creator>Mojgani, N.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Loving, R. K.</dc:creator>
<dc:creator>Carilli, M.</dc:creator>
<dc:creator>Booeshaghi, A. S.</dc:creator>
<dc:creator>Kawauchi, S.</dc:creator>
<dc:creator>Hallgrimsdottir, I. B.</dc:creator>
<dc:creator>Williams, B. A.</dc:creator>
<dc:creator>MacGregor, G.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:creator>Wold, B.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:date>2025-04-24</dc:date>
<dc:identifier>doi:10.1101/2025.04.21.649844</dc:identifier>
<dc:title><![CDATA[Systematic cell-type resolved transcriptomes of 8 tissues in 8 lab and wild-derived mouse strains captures global and local expression variation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.23.649973?rss=1">
<title>
<![CDATA[
Cell cycle-coupled transcriptional network orchestrates human B cell fate bifurcation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.23.649973?rss=1</link>
<description><![CDATA[
Bifurcation of activated human B cells into plasmablast (PB) and germinal center precursor (preGC) fates underlies protective and autoimmune antibody responses, yet gene regulatory networks (GRNs) governing the alternative trajectories remain poorly defined. Using temporal single-cell multiomics, we assembled state-specific human B cell GRNs spanning four scales: transcription factor (TF)-to-fate, TF-to-gene, cis-regulatory element (CRE)-to-gene and nucleotide-to-CRE. Applying the framework to in vitro differentiated and tonsil B cells revealed concordant regulatory architectures and impacts of in silico TF perturbations. CRISPR perturbations validated many TF-to-fate and TF-to-gene predictions and revealed a mutually repressive BATF-IRF4/PRDM1 network module. The GRNs were used to predict and interpret effects of autoimmune disease variants, uncovering partitioning of disease risk at distinct TF motifs and B cell states. Predicted functional variants were independently supported by chromatin and expression QTLs and reporter assays. A web application enables exploration of B cell regulatory determinants of vaccine responses and autoimmune diseases.
]]></description>
<dc:creator>Pease, N. A.</dc:creator>
<dc:creator>Fan, J.</dc:creator>
<dc:creator>Keshari, S.</dc:creator>
<dc:creator>Stratton, J.</dc:creator>
<dc:creator>Gerges, P.</dc:creator>
<dc:creator>Ann Varghese, B.</dc:creator>
<dc:creator>Nampoothiri VP, N.</dc:creator>
<dc:creator>McGinnnis, C. S.</dc:creator>
<dc:creator>Zhang, W.</dc:creator>
<dc:creator>Geirlack, S. B.</dc:creator>
<dc:creator>Swaminathan, T.</dc:creator>
<dc:creator>Sachan, A.</dc:creator>
<dc:creator>Manakkat Vijay, G.</dc:creator>
<dc:creator>Mena Hernandez, L.</dc:creator>
<dc:creator>Heidari Rarani, Z.</dc:creator>
<dc:creator>Macedo, C.</dc:creator>
<dc:creator>Metes, D.</dc:creator>
<dc:creator>Satpathy, A. T.</dc:creator>
<dc:creator>Jain, A. K.</dc:creator>
<dc:creator>Sahni, N.</dc:creator>
<dc:creator>Stallaert, W.</dc:creator>
<dc:creator>Das, J.</dc:creator>
<dc:creator>Singh, H.</dc:creator>
<dc:date>2025-04-24</dc:date>
<dc:identifier>doi:10.1101/2025.04.23.649973</dc:identifier>
<dc:title><![CDATA[Cell cycle-coupled transcriptional network orchestrates human B cell fate bifurcation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.02.646871?rss=1">
<title>
<![CDATA[
Defining effective strategies to integrate multi-sample single-nucleus ATAC-seq datasets via a multimodal-guided approach 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.02.646871?rss=1</link>
<description><![CDATA[
BackgroundChromatin accessibility, measured via single-nucleus Assay for Transposase-Accessible Chromatin with sequencing (snATAC-seq), can reveal the underpinnings of transcriptional regulation across heterogeneous cell states. As the number and scale of snATAC-seq datasets increases, we need robust computational pipelines to integrate samples within a dataset and datasets across studies. These integration pipelines should correct cell-state-obfuscating technical effects while conserving underlying biological cell states, as has been shown for single-cell RNA-seq (scRNA-seq) pipelines. However, scRNA-seq integration methods have performed inconsistently on snATAC-seq datasets, potentially due to sparsity and genomic feature differences.

ResultsUsing single-nucleus multimodal datasets profiling ATAC and RNA simultaneously, we can measure snATAC-seq integration method performance by comparison to independently integrated snRNA-seq gold standard embeddings and annotations. Here, we benchmark 58 pipelines, incorporating 7 integration methods plus 1 embedding correction method with 5 feature sets. Using our command-line tool, we assessed 5 multimodal datasets at 3 different resolutions using 2 novel metrics to determine the best practices for multi-sample snATAC-seq integration. ATAC features outperformed Gene Activity Score (GAS) features, and embedding correction with Harmony was generally useful. SnapATAC2, PeakVI, and ArchRs iterative Latent Semantic Indexing (LSI) performed well.

ConclusionsWe recommend SnapATAC2 + Harmony with pre-defined ENCODE candidate cis-regulatory element (cCRE) features as a first-pass pipeline given its metric performance, generalizability of features, and method resource-efficiency. This and other high-performing pipelines will guide future comprehensive gene regulation maps.
]]></description>
<dc:creator>Weinand, K.</dc:creator>
<dc:creator>Langan, E. M.</dc:creator>
<dc:creator>Curtis, M.</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:date>2025-04-03</dc:date>
<dc:identifier>doi:10.1101/2025.04.02.646871</dc:identifier>
<dc:title><![CDATA[Defining effective strategies to integrate multi-sample single-nucleus ATAC-seq datasets via a multimodal-guided approach]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.26.645108?rss=1">
<title>
<![CDATA[
Defining the host dependencies and the transcriptional landscape of RSV infection and bystander activation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.26.645108?rss=1</link>
<description><![CDATA[
Respiratory syncytial virus (RSV) is a globally prevalent pathogen, causes severe disease in older adults, and is the leading cause of bronchiolitis and pneumonia in the United States for children during their first year of life [1]. Despite its prevalence worldwide, RSV-specific treatments remain unavailable for most infected patients. Here, we leveraged a combination of genome-wide CRISPR knockout screening and single-cell RNA sequencing to improve our understanding of the host determinants of RSV infection and the host response in both infected cells, and uninfected bystanders. These data reveal temporal transcriptional patterns that are markedly different between RSV infected and bystander activated cells. Our data show that expression of interferon-stimulated genes is primarily observed in bystander activated cells, while genes implicated in the unfolded protein response and cellular stress are upregulated specifically in RSV infected cells. Furthermore, genome-wide CRISPR screens identified multiple host factors important for viral infection, findings which we contextualize relative to 29 previously published screens across 17 additional viruses. These unique data complement and extend prior studies that investigate the proinflammatory response to RSV infection, and juxtaposed to other viral infections, provide a rich resource for further hypothesis testing.

ImportanceRespiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants and the elderly. Despite its substantial global health burden, RSV-targeted treatments remain unavailable for the majority of individuals. While vaccine development is underway, a detailed understanding of the host response to RSV infection and identification of required human host factors for RSV may provide insight into combatting this pathogen. Here, we utilized single-cell RNA sequencing and functional genomics to understand the host response in both RSV infected and bystander cells, identify what host factors mediate infection, and contextualize these findings relative to dozens of previously reported screens across 17 additional viruses.
]]></description>
<dc:creator>Sunshine, S.</dc:creator>
<dc:creator>Puschnik, A.</dc:creator>
<dc:creator>Retallack, H.</dc:creator>
<dc:creator>Laurie, M. T.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Peng, D.</dc:creator>
<dc:creator>Knopp, K.</dc:creator>
<dc:creator>Zinter, M. S.</dc:creator>
<dc:creator>Ye, C. J.</dc:creator>
<dc:creator>DeRisi, J. L.</dc:creator>
<dc:date>2025-03-26</dc:date>
<dc:identifier>doi:10.1101/2025.03.26.645108</dc:identifier>
<dc:title><![CDATA[Defining the host dependencies and the transcriptional landscape of RSV infection and bystander activation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.21.644686?rss=1">
<title>
<![CDATA[
Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.21.644686?rss=1</link>
<description><![CDATA[
Insufficient infiltration of cytotoxic lymphocytes to solid tumors limits the efficacy of immunotherapies and cell therapies. Here, we report a programmable mechanism to mobilize Natural Killer (NK) and T cells to breast cancer tumors by engineering these cells to express orphan and metabolite-sensing G protein-coupled receptors (GPCRs). First, in vivo and in vitro CRISPR activation screens in NK-92 cells identified GPR183, GPR84, GPR34, GPR18, FPR3, and LPAR2 as top enhancers of both tumor infiltration and chemotaxis to breast cancer. These genes equip NK and T cells with the ability to sense and migrate to chemoattracting metabolites such as 7,25-dihydroxycholesterol and other factors released from breast cancer. Based on Perturb-seq and functional investigations, GPR183 also enhances effector functions, such that engineering NK and CAR NK cells to express GPR183 enhances their ability to migrate to, infiltrate, and control breast cancer tumors. Our study uncovered metabolite-based tumor immune recruitment mechanisms, opening avenues for spatially targeted cell therapies.
]]></description>
<dc:creator>Kim, Y. M.</dc:creator>
<dc:creator>Akana, R.</dc:creator>
<dc:creator>Sun, C.</dc:creator>
<dc:creator>Laveroni, O.</dc:creator>
<dc:creator>Jerby, L.</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:identifier>doi:10.1101/2025.03.21.644686</dc:identifier>
<dc:title><![CDATA[Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.25.640191?rss=1">
<title>
<![CDATA[
Landscapes of missense variant impact for human superoxide dismutase 1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.25.640191?rss=1</link>
<description><![CDATA[
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease for which important subtypes are caused by variation in the Superoxide Dismutase 1 gene SOD1. Diagnosis based on SOD1 sequencing can not only be definitive but also indicate specific therapies available for SOD1-associated ALS (SOD1-ALS). Unfortunately, SOD1-ALS diagnosis is limited by the fact that a substantial fraction (currently 26%) of ClinVar SOD1 missense variants are classified as "variants of uncertain significance" (VUS). Although functional assays can provide strong evidence for clinical variant interpretation, SOD1 assay validation is challenging, given the current incomplete and controversial understanding of SOD1-ALS disease mechanism. Using saturation mutagenesis and multiplexed cell-based assays, we measured the functional impact of over two thousand SOD1 amino acid substitutions on both enzymatic function and protein abundance. The resulting  missense variant effect maps not only reflect prior biochemical knowledge of SOD1 but also provide sequence-structure-function insights. Importantly, our variant abundance assay can discriminate pathogenic missense variation and provides new evidence for 41% of missense variants that had been previously reported as VUS, offering the potential to identify additional patients who would benefit from therapy approved for SOD1-ALS.
]]></description>
<dc:creator>Axakova, A.</dc:creator>
<dc:creator>Ding, M. X.</dc:creator>
<dc:creator>Cote, A. G.</dc:creator>
<dc:creator>Subramaniam, R.</dc:creator>
<dc:creator>Senguttuvan, V.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Weile, J.</dc:creator>
<dc:creator>Douville, S. V.</dc:creator>
<dc:creator>Gebbia, M.</dc:creator>
<dc:creator>Al-Chalabi, A.</dc:creator>
<dc:creator>Wahl, A.</dc:creator>
<dc:creator>Reuter, J.</dc:creator>
<dc:creator>Hurt, J.</dc:creator>
<dc:creator>Mitchell, A.</dc:creator>
<dc:creator>Fradette, S.</dc:creator>
<dc:creator>Andersen, P. M.</dc:creator>
<dc:creator>van Loggerenberg, W.</dc:creator>
<dc:creator>Roth, F. P.</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:identifier>doi:10.1101/2025.02.25.640191</dc:identifier>
<dc:title><![CDATA[Landscapes of missense variant impact for human superoxide dismutase 1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.24.640007?rss=1">
<title>
<![CDATA[
Geospatially informed representation of spatial genomics data with SpatialFeatureExperiment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.24.640007?rss=1</link>
<description><![CDATA[
SpatialFeatureExperiment is a Bioconductor package that leverages the versatility of Simple Features for spatial data analysis and SpatialExperiment for single-cell -omics to provide an expansive and convenient S4 class for working with spatial -omics data.

SpatialFeatureExperiment can be used to store and analyze a variety of spatial -omics data types, including data from the Visium, Xenium, MERFISH, SeqFish, and Slide-seq platforms, bringing spatial operations to the SingleCellExperiment ecosystem.
]]></description>
<dc:creator>Moses, L.</dc:creator>
<dc:creator>Huseynov, A.</dc:creator>
<dc:creator>Rich, J.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:identifier>doi:10.1101/2025.02.24.640007</dc:identifier>
<dc:title><![CDATA[Geospatially informed representation of spatial genomics data with SpatialFeatureExperiment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.24.639351?rss=1">
<title>
<![CDATA[
Early and late RNA eQTL are driven by different genetic mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.24.639351?rss=1</link>
<description><![CDATA[
Understanding the genetic regulation of RNA abundance is essential to defining disease mechanisms. However, conventional expression quantitative loci (eQTL) studies quantify RNA molecules across the transcript lifecycle. While most eQTL likely affect transcription by altering promoter or enhancer function within the nucleus, it is also possible that they modulate any processes after transcription, including chemical modifications and RNA stability in the cytosol. To elucidate distinct eQTL mechanisms of early versus late RNA, we compared eQTL from mature cellular RNA and nascent nuclear RNA in the brain and the kidney. Across tissues, we identified different causal variants for cellular and nuclear eQTL for the same eGene. Cellular eQTL were enriched in transcribed regions (P=3.3x10-126), suggesting the importance of post-transcriptional regulation. Conversely, nuclear eQTL were enriched in distal regulatory elements (P=7.0x10-32), highlighting the role of DNA transcriptional regulation. For example, we identified stop-gain eQTL variants likely acting through nonsense-mediated decay in cellular eQTL that had no effect in nuclear eQTL. Cellular eQTL were enriched for loci with multiple causal variants in linkage disequilibrium within the transcribed regions, where they may in concert affect RNA stability. We also identified examples of nuclear eQTL variants within enhancers that had no effect in cellular eQTL. We show that such eQTL (e.g., TUBGCP4) sometimes uniquely colocalize with disease alleles (schizophrenia). This study reveals key differences in the genetic mechanisms of cellular and nuclear eQTL.
]]></description>
<dc:creator>Sakaue, S.</dc:creator>
<dc:creator>Accelerating Medicines Partnership: RA/SLE Network,</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:identifier>doi:10.1101/2025.02.24.639351</dc:identifier>
<dc:title><![CDATA[Early and late RNA eQTL are driven by different genetic mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.17.638766?rss=1">
<title>
<![CDATA[
SpaFun: Discovering Domain-specific Spatial Expression Patterns and New Disease-Relevant Genes using Functional Principal Component Analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.17.638766?rss=1</link>
<description><![CDATA[
SpaFun is a novel, non-model-based method developed to address limitations in existing spatially variable gene (SVG) detection techniques, particularly for large-scale spatially resolved transcriptomics (SRT) datasets. These limitations include computational inefficiency, limited statistical power with increasing data size, and the inability to capture spatial heterogeneity and co-expression patterns among genes. Built on functional principal component analysis (fPCA), SpaFun identifies domain-representative genes (DRGs) with significantly better computational efficiency and greater statistical power while accounting for spatial heterogeneity and co-expression patterns among genes. We applied SpaFun to three SRT datasets and demonstrated that SpaFun outperformed state-of-the-art algorithms for identifying representative genes for tumor regions (e.g., DESeq, edgeR, and limma), as well as recently developed novel algorithms designed for spatial omics to identify the representative genes (e.g., SPARK and CSIDE). This highlights SpaFuns ability to accurately identify genes most representative of each spatial domain (e.g., tumor, immune, or stroma regions). By uncovering novel disease-relevant genes overlooked by existing algorithms, SpaFun could provide insights into new molecular mechanisms and propose innovative therapeutic strategies to improve patient outcomes.

Key PointsO_LISpaFun is the first method dedicated to identifying DRGs, capturing spatially representative expression patterns within annotated tissue regions, setting it apart from all traditional SVG detection methods.
C_LIO_LIIt leverages fPCA to model gene expression as a function of spatial location, avoiding reliance on predefined spatial distribution assumptions.
C_LIO_LIThe non-model-based framework ensures compatibility with different SRT platforms and experimental designs, making it a scalable and widely applicable tool for SRT research.
C_LI
]]></description>
<dc:creator>Jiang, X.</dc:creator>
<dc:creator>Guo, Y.</dc:creator>
<dc:creator>Guo, L.</dc:creator>
<dc:creator>Zhong, L.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Xiao, G.</dc:creator>
<dc:creator>Li, Q.</dc:creator>
<dc:creator>Xu, L.</dc:creator>
<dc:date>2025-02-21</dc:date>
<dc:identifier>doi:10.1101/2025.02.17.638766</dc:identifier>
<dc:title><![CDATA[SpaFun: Discovering Domain-specific Spatial Expression Patterns and New Disease-Relevant Genes using Functional Principal Component Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.18.638922?rss=1">
<title>
<![CDATA[
Mapping the regulatory effects of common and rare non-coding variants across cellular and developmental contexts in the brain and heart 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.18.638922?rss=1</link>
<description><![CDATA[
Whole genome sequencing has identified over a billion non-coding variants in humans, while GWAS has revealed the non-coding genome as a significant contributor to disease. However, prioritizing causal common and rare non-coding variants in human disease, and understanding how selective pressures have shaped the non-coding genome, remains a significant challenge. Here, we predicted the effects of 15 million variants with deep learning models trained on single-cell ATAC-seq across 132 cellular contexts in adult and fetal brain and heart, producing nearly two billion context-specific predictions. Using these predictions, we distinguish candidate causal variants underlying human traits and diseases and their context-specific effects. While common variant effects are more cell-type-specific, rare variants exert more cell-type-shared regulatory effects, with selective pressures particularly targeting variants affecting fetal brain neurons. To prioritize de novo mutations with extreme regulatory effects, we developed FLARE, a context-specific functional genomic model of constraint. FLARE outperformed other methods in prioritizing case mutations from autism-affected families near syndromic autism-associated genes; for example, identifying mutation outliers near CNTNAP2 that would be missed by alternative approaches. Overall, our findings demonstrate the potential of integrating single-cell maps with population genetics and deep learning-based variant effect prediction to elucidate mechanisms of development and disease-ultimately, supporting the notion that genetic contributions to neurodevelopmental disorders are predominantly rare.
]]></description>
<dc:creator>Marderstein, A. R.</dc:creator>
<dc:creator>Kundu, S.</dc:creator>
<dc:creator>Padhi, E. M.</dc:creator>
<dc:creator>Deshpande, S.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Robb, E.</dc:creator>
<dc:creator>Sun, Y.</dc:creator>
<dc:creator>Yun, C. M.</dc:creator>
<dc:creator>Pomales-Matos, D.</dc:creator>
<dc:creator>Xie, Y.</dc:creator>
<dc:creator>Nachun, D.</dc:creator>
<dc:creator>Jessa, S.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Montgomery, S. B.</dc:creator>
<dc:date>2025-02-19</dc:date>
<dc:identifier>doi:10.1101/2025.02.18.638922</dc:identifier>
<dc:title><![CDATA[Mapping the regulatory effects of common and rare non-coding variants across cellular and developmental contexts in the brain and heart]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.13.638099?rss=1">
<title>
<![CDATA[
Clonal memory of colitis accumulates and promotes tumor growth 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.13.638099?rss=1</link>
<description><![CDATA[
Chronic inflammation is a well-established risk factor for cancer, but the underlying molecular mechanisms remain unclear. Using a mouse model of colitis, we demonstrate that colonic stem cells retain an epigenetic memory of inflammation following disease resolution, characterized by a cumulative gain of activator protein 1 (AP-1) transcription factor activity. Further, we develop SHARE-TRACE, a method that enables simultaneous profiling of gene expression, chromatin accessibility and clonal history in single cells, enabling high resolution tracking of epigenomic memory. This reveals that inflammatory memory is propagated cell-intrinsically and inherited through stem cell lineages, with certain clones demonstrating dramatically stronger memory than others. Finally, we show that colitis primes stem cells for amplified expression of regenerative gene programs following oncogenic mutation that accelerate tumor growth. This includes a subpopulation of tumors that have exceptionally high AP-1 activity and the additional upregulation of pro-oncogenic programs. Together, our findings provide a mechanistic link between chronic inflammation and malignancy, revealing how long-lived epigenetic alterations in regenerative tissues may contribute to disease susceptibility and suggesting potential therapeutic strategies to mitigate cancer risk in patients with chronic inflammatory conditions.
]]></description>
<dc:creator>Nagaraja, S.</dc:creator>
<dc:creator>Ojeda-Miron, L.</dc:creator>
<dc:creator>Zhang, R.</dc:creator>
<dc:creator>Oreskovic, E.</dc:creator>
<dc:creator>Hu, Y.</dc:creator>
<dc:creator>Zeve, D.</dc:creator>
<dc:creator>Sharma, K.</dc:creator>
<dc:creator>Hyman, R. R.</dc:creator>
<dc:creator>Zhang, Q.</dc:creator>
<dc:creator>Castillo, A.</dc:creator>
<dc:creator>Breault, D. T.</dc:creator>
<dc:creator>Yilmaz, O. H.</dc:creator>
<dc:creator>Buenrostro, J. D.</dc:creator>
<dc:date>2025-02-17</dc:date>
<dc:identifier>doi:10.1101/2025.02.13.638099</dc:identifier>
<dc:title><![CDATA[Clonal memory of colitis accumulates and promotes tumor growth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.02.636107?rss=1">
<title>
<![CDATA[
Worm Perturb-Seq: massively parallel whole-animal RNAi and RNA-seq 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.02.636107?rss=1</link>
<description><![CDATA[
The transcriptome provides a highly informative molecular phenotype to connect genotype to phenotype and is most frequently measured by RNA-sequencing (RNA-seq). Therefore, an ultimate goal is to perturb every gene and measure changes in the transcriptome. However, this remains challenging, especially in intact organisms due to different experimental and computational challenges. Here, we present  Worm Perturb-Seq (WPS), which provides high-resolution RNA-seq profiles for hundreds of replicate perturbations at a time in a living animal. WPS introduces multiple experimental advances that combine strengths of bulk and single cell RNA-seq, and that further provides an analytical framework, EmpirDE, that leverages the unique power of the large WPS datasets. EmpirDE identifies differentially expressed genes (DEGs) by using gene-specific empirical null distributions, rather than control conditions alone, thereby systematically removing technical biases and improving statistical rigor. We applied WPS to 103 Caenhorhabditis elegans nuclear hormone receptors (NHRs) to delineate a Gene Regulatory Network (GRN) and found that this GRN presents a striking  pairwise modularity where pairs of NHRs regulate shared target genes. We envision that the experimental and analytical advances of WPS should be useful not only for C. elegans, but will be broadly applicable to other models, including human cells.
]]></description>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Song, D.</dc:creator>
<dc:creator>Yukselen, O.</dc:creator>
<dc:creator>Nanda, S.</dc:creator>
<dc:creator>Kucukural, A.</dc:creator>
<dc:creator>Li, J. J.</dc:creator>
<dc:creator>Garber, M.</dc:creator>
<dc:creator>Walhout, A. J. M.</dc:creator>
<dc:date>2025-02-03</dc:date>
<dc:identifier>doi:10.1101/2025.02.02.636107</dc:identifier>
<dc:title><![CDATA[Worm Perturb-Seq: massively parallel whole-animal RNAi and RNA-seq]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.22.634424?rss=1">
<title>
<![CDATA[
Causal modeling of gene effects from regulators to programs to traits: integration of genetic associations and Perturb-seq 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.22.634424?rss=1</link>
<description><![CDATA[
AbstractGenetic association studies provide a unique tool for identifying causal links from genes to human traits and diseases. However, it is challenging to determine the biological mechanisms underlying most associations, and we lack genome-scale approaches for inferring causal mechanistic pathways from genes to cellular functions to traits. Here we propose new approaches to bridge this gap by combining quantitative estimates of gene-trait relationships from loss-of-function burden tests with gene-regulatory connections inferred from Perturb-seq experiments in relevant cell types. By combining these two forms of data, we aim to build causal graphs in which the directional associations of genes with a trait can be explained by their regulatory effects on biological programs or direct effects on the trait. As a proof-of-concept, we constructed a causal graph of the gene regulatory hierarchy that jointly controls three partially co-regulated blood traits. We propose that perturbation studies in trait-relevant cell types, coupled with gene-level effect sizes for traits, can bridge the gap between genetics and biology.
]]></description>
<dc:creator>Ota, M.</dc:creator>
<dc:creator>Spence, J. P.</dc:creator>
<dc:creator>Zeng, T.</dc:creator>
<dc:creator>Dann, E.</dc:creator>
<dc:creator>Marson, A.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2025-01-24</dc:date>
<dc:identifier>doi:10.1101/2025.01.22.634424</dc:identifier>
<dc:title><![CDATA[Causal modeling of gene effects from regulators to programs to traits: integration of genetic associations and Perturb-seq]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.21.633969?rss=1">
<title>
<![CDATA[
Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.21.633969?rss=1</link>
<description><![CDATA[
Perturb-seq is a powerful approach to systematically assess how genes and enhancers impact the molecular and cellular pathways of development and disease. However, technical challenges have limited its application in stem cell-based systems. Here, we benchmarked Perturb-seq across multiple CRISPRi modalities, on diverse genomic targets, in multiple human pluripotent stem cells, during directed differentiation to multiple lineages, and across multiple sgRNA delivery systems. To ensure cost-effective production of large-scale Perturb-seq datasets as part of the Impact of Genomic Variants on Function (IGVF) consortium, our optimized protocol dynamically assesses experiment quality across the weeks-long procedure. Our analysis of 1,996,260 sequenced cells across benchmarking datasets reveals shared regulatory networks linking disease-associated enhancers and genes with downstream targets during cardiomyocyte differentiation. This study establishes open tools and resources for interrogating genome function during stem cell differentiation.
]]></description>
<dc:creator>Sivakumar, S.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Goetsch, S. C.</dc:creator>
<dc:creator>Pandit, V.</dc:creator>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:creator>Sundarrajan, A.</dc:creator>
<dc:creator>Armendariz, D. A.</dc:creator>
<dc:creator>Takeuchi, C.</dc:creator>
<dc:creator>Nzima, M.</dc:creator>
<dc:creator>Chen, W.-C.</dc:creator>
<dc:creator>Dederich, A. E.</dc:creator>
<dc:creator>El Hayek, L.</dc:creator>
<dc:creator>Gao, T.</dc:creator>
<dc:creator>Ghazawi, R.</dc:creator>
<dc:creator>Gogate, A.</dc:creator>
<dc:creator>Kaur, K.</dc:creator>
<dc:creator>Kim, H. B.</dc:creator>
<dc:creator>McCoy, M.</dc:creator>
<dc:creator>Niederstrasser, H.</dc:creator>
<dc:creator>Oura, S.</dc:creator>
<dc:creator>Pinzon-Arteaga, C. A.</dc:creator>
<dc:creator>Sanghvi, M.</dc:creator>
<dc:creator>Schmitz, D. A.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Zhou, Q.</dc:creator>
<dc:creator>Kraus, W. L.</dc:creator>
<dc:creator>Xu, L.</dc:creator>
<dc:creator>Wu, J.</dc:creator>
<dc:creator>Posner, B. A.</dc:creator>
<dc:creator>Chahrour, M. H.</dc:creator>
<dc:creator>Hon, G. C.</dc:creator>
<dc:creator>Munshi, N. V.</dc:creator>
<dc:date>2025-01-23</dc:date>
<dc:identifier>doi:10.1101/2025.01.21.633969</dc:identifier>
<dc:title><![CDATA[Benchmarking and optimizing Perturb-seq in differentiating human pluripotent stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.07.631688?rss=1">
<title>
<![CDATA[
NERINE reveals rare variant associations in gene networks across multiple phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.07.631688?rss=1</link>
<description><![CDATA[
There are two primary approaches to study the genetic basis of human phenotypes. Experiments in model systems generate interpretable gene networks but, in isolation, do not establish relevance to the human condition. Statistical genetics identifies relevant association signals at the variant or gene level but lacks tools to test specific mechanistic models, as existing methods do not incorporate the topology of gene-gene interactions. We bridge these two strategies by introducing a method that competitively tests network hypotheses with rare variant associations. A hierarchical model-based association test NERINE for the first time incorporates gene network topology while remaining resilient to network inaccuracies. We demonstrate NERINEs ability to test network hypotheses derived from both canonical pathway databases and model system screens. Comprehensive database-wide search of pathway networks with NERINE uncovers compelling associations for breast cancer, cardiovascular diseases, and type II diabetes, which are undetected by single-gene tests. Testing bespoke networks from experimental screens targeting key PD pathologies: dopaminergic neuron survival and -synuclein pathobiology, NERINE highlights rare variant burden in gene modules related to autophagy, vesicle traiicking, and protein homeostasis. Genome-scale CRISPRi-screening of -synuclein toxicity modifiers in human neurons and NERINE converge on PRL, revealing an intraneuronal -synuclein/prolactin stress response that may impact resilience to PD pathologies.
]]></description>
<dc:creator>Nazeen, S.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Morrow, A.</dc:creator>
<dc:creator>Strom, R.</dc:creator>
<dc:creator>Ethier, E.</dc:creator>
<dc:creator>Ritter, D.</dc:creator>
<dc:creator>Henderson, A.</dc:creator>
<dc:creator>Afroz, J.</dc:creator>
<dc:creator>Stitziel, N. O.</dc:creator>
<dc:creator>Gupta, R. M.</dc:creator>
<dc:creator>Luk, K.</dc:creator>
<dc:creator>Studer, L.</dc:creator>
<dc:creator>Khurana, V.</dc:creator>
<dc:creator>Sunyaev, S. R.</dc:creator>
<dc:date>2025-01-10</dc:date>
<dc:identifier>doi:10.1101/2025.01.07.631688</dc:identifier>
<dc:title><![CDATA[NERINE reveals rare variant associations in gene networks across multiple phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.09.631797?rss=1">
<title>
<![CDATA[
Inherent instability of simple DNA repeats shapes an evolutionarily stable distribution of repeat lengths 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.09.631797?rss=1</link>
<description><![CDATA[
Using the Telomere-to-Telomere reference, we assembled the distribution of simple repeat lengths present in the human genome. Analyzing over two hundred mammalian genomes, we found remarkable consistency in the shape of the distribution across evolutionary epochs. All observed genomes harbor an excess of long repeats, which are potentially prone to developing into repeat expansion disorders. We measured mutation rates for repeat length instability, quantitatively modeled the per-generation action of mutations, and observed the corresponding long-term behavior shaping the repeat length distribution. We found that short repetitive sequences appear to be a straightforward consequence of random substitution. Evolving largely independently, longer repeats (above roughly 10 nt) emerge and persist in a rapidly mutating dynamic balance between expansion, contraction and interruption. These mutational processes, collectively, are sufficient to explain the abundance of long repeats, without invoking natural selection. Our analysis constrains properties of molecular mechanisms responsible for maintaining genome fidelity that underlie repeat instability.
]]></description>
<dc:creator>McGinty, R. J.</dc:creator>
<dc:creator>Balick, D. J.</dc:creator>
<dc:creator>Mirkin, S. M.</dc:creator>
<dc:creator>Sunyaev, S. R.</dc:creator>
<dc:date>2025-01-10</dc:date>
<dc:identifier>doi:10.1101/2025.01.09.631797</dc:identifier>
<dc:title><![CDATA[Inherent instability of simple DNA repeats shapes an evolutionarily stable distribution of repeat lengths]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.06.631510?rss=1">
<title>
<![CDATA[
Wnt signaling drives stromal inflammation in inflammatory arthritis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.06.631510?rss=1</link>
<description><![CDATA[
The concept that fibroblasts are critical mediators of inflammation is an emerging paradigm. In rheumatoid arthritis (RA), they are the main producers of IL-6 as well as a host of other cytokines and chemokines. Their pathologic activation also directly causes cartilage and bone degradation. Yet, therapeutic agents specifically targeting fibroblasts are not available. Here, we find that Wnt receptors and modulators are predominantly expressed in stromal populations in the synovium. Importantly, non-canonical Wnt activation induces robust inflammatory gene expression including an abundance of cytokines and chemokines in synovial fibroblasts in vitro. Strikingly, the addition of Wnt ligands or inhibition of Wnt secretion exacerbates or reduces arthritis severity, respectively, in vivo in a murine model of inflammatory arthritis. These observations are relevant in human disease, as Wnt activation signatures are enhanced in fibroblasts derived from inflamed RA synovial tissue as well as fibroblasts across other inflammatory diseases. Together, these findings implicate Wnt signaling as a major driver of fibroblast-mediated inflammation and joint pathology. They further suggest that targeting the Wnt pathway is a therapeutically relevant approach to rheumatoid arthritis, particularly in patients who do not respond to conventional treatments and who often express fibroblast-predominant synovial phenotypes.
]]></description>
<dc:creator>Mueller, A. A.</dc:creator>
<dc:creator>Zou, A. E.</dc:creator>
<dc:creator>Marsh, L.-J.</dc:creator>
<dc:creator>Kemble, S.</dc:creator>
<dc:creator>Nayar, S.</dc:creator>
<dc:creator>Watts, G. F. M.</dc:creator>
<dc:creator>Murphy, C. L.</dc:creator>
<dc:creator>Taylor, E.</dc:creator>
<dc:creator>Major, T.</dc:creator>
<dc:creator>Gardner, D.</dc:creator>
<dc:creator>Buckley, C. D.</dc:creator>
<dc:creator>Wei, K.</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:creator>Korsunsky, I.</dc:creator>
<dc:creator>Filer, A.</dc:creator>
<dc:creator>Croft, A. P.</dc:creator>
<dc:creator>Brenner, M. B.</dc:creator>
<dc:date>2025-01-08</dc:date>
<dc:identifier>doi:10.1101/2025.01.06.631510</dc:identifier>
<dc:title><![CDATA[Wnt signaling drives stromal inflammation in inflammatory arthritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.25.630221?rss=1">
<title>
<![CDATA[
ChromBPNet: bias factorized, base-resolution deep learning models of chromatin accessibility reveal cis-regulatory sequence syntax, transcription factor footprints and regulatory variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.25.630221?rss=1</link>
<description><![CDATA[
Despite extensive mapping of cis-regulatory elements (cREs) across cellular contexts with chromatin accessibility assays, the sequence syntax and genetic variants that regulate transcription factor (TF) binding and chromatin accessibility at context-specific cREs remain elusive. We introduce ChromBPNet, a deep learning DNA sequence model of base-resolution accessibility profiles that detects, learns and deconvolves assay-specific enzyme biases from regulatory sequence determinants of accessibility, enabling robust discovery of compact TF motif lexicons, cooperative motif syntax and precision footprints across assays and sequencing depths. Extensive benchmarks show that ChromBPNet, despite its lightweight design, is competitive with much larger contemporary models at predicting variant effects on chromatin accessibility, pioneer TF binding and reporter activity across assays, cell contexts and ancestry, while providing interpretation of disrupted regulatory syntax. ChromBPNet also helps prioritize and interpret regulatory variants that influence complex traits and rare diseases, thereby providing a powerful lens to decode regulatory DNA and genetic variation.
]]></description>
<dc:creator>Pampari, A.</dc:creator>
<dc:creator>Shcherbina, A.</dc:creator>
<dc:creator>Kvon, E.</dc:creator>
<dc:creator>Kosicki, M.</dc:creator>
<dc:creator>Nair, S.</dc:creator>
<dc:creator>Kundu, S.</dc:creator>
<dc:creator>Kathiria, A. S.</dc:creator>
<dc:creator>Risca, V. I.</dc:creator>
<dc:creator>Kuningas, K.</dc:creator>
<dc:creator>Alasoo, K.</dc:creator>
<dc:creator>Greenleaf, W.</dc:creator>
<dc:creator>Pennacchio, L.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:date>2024-12-25</dc:date>
<dc:identifier>doi:10.1101/2024.12.25.630221</dc:identifier>
<dc:title><![CDATA[ChromBPNet: bias factorized, base-resolution deep learning models of chromatin accessibility reveal cis-regulatory sequence syntax, transcription factor footprints and regulatory variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.12.628073?rss=1">
<title>
<![CDATA[
Specificity, length, and luck: How genes are prioritized by rare and common variant association studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.12.628073?rss=1</link>
<description><![CDATA[
Standard genome-wide association studies (GWAS) and rare variant burden tests are essential tools for identifying trait-relevant genes. Although these methods are conceptually similar, we show by analyzing association studies of 209 quantitative traits in the UK Biobank that they systematically prioritize different genes. This raises the question of how genes should ideally be prioritized. We propose two prioritization criteria: 1) trait importance -- how much a gene quantitatively affects a trait; and 2) trait specificity -- a genes importance for the trait under study relative to its importance across all traits. We find that GWAS prioritize genes near trait-specific variants, while burden tests prioritize trait-specific genes. Because non-coding variants can be context specific, GWAS can prioritize highly pleiotropic genes, while burden tests generally cannot. Both study designs are also affected by distinct trait-irrelevant factors, complicating their interpretation. Our results illustrate that burden tests and GWAS reveal different aspects of trait biology and suggest ways to improve their interpretation and usage.
]]></description>
<dc:creator>Spence, J. P.</dc:creator>
<dc:creator>Mostafavi, H.</dc:creator>
<dc:creator>Ota, M.</dc:creator>
<dc:creator>Milind, N.</dc:creator>
<dc:creator>Gjorgjieva, T.</dc:creator>
<dc:creator>Smith, C. J.</dc:creator>
<dc:creator>Simons, Y. B.</dc:creator>
<dc:creator>Sella, G.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2024-12-16</dc:date>
<dc:identifier>doi:10.1101/2024.12.12.628073</dc:identifier>
<dc:title><![CDATA[Specificity, length, and luck: How genes are prioritized by rare and common variant association studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.01.621925?rss=1">
<title>
<![CDATA[
Directionality of Transcriptional Regulatory Elements 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.01.621925?rss=1</link>
<description><![CDATA[
Divergent transcription is a critical marker of active transcriptional regulatory elements (TREs), including enhancers and promoters, in mammals. However, distal elements with unidirectional transcriptional patterns are often overlooked, leaving their identity and function poorly understood. Here, we performed a systematic comparison between divergent and unidirectional elements, revealing their distinct architectural and functional features. Our analysis also shows that unidirectional elements have younger sequence ages and are under weaker evolutionary constraints than divergent elements, indicating that they may represent a unique category of genomic regulatory function with more recent origins. Notably, we observed that some transcription factors, including CTCF, AP1, SP, and NFY, exhibit dual roles in modulating the directionality of TREs, either activating or repressing nascent transcription in a position-dependent manner. Overall, the elucidation of directionality enhances our understanding of the diverse architectural models, functional features, evolutionary dynamics, and regulatory logic of TREs.
]]></description>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Shah, S. R.</dc:creator>
<dc:creator>Leung, A.</dc:creator>
<dc:creator>Paramo, M. I.</dc:creator>
<dc:creator>Cochran, K.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Clark, A. G.</dc:creator>
<dc:creator>Lis, J. T.</dc:creator>
<dc:creator>Yu, H.</dc:creator>
<dc:date>2024-12-02</dc:date>
<dc:identifier>doi:10.1101/2024.12.01.621925</dc:identifier>
<dc:title><![CDATA[Directionality of Transcriptional Regulatory Elements]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.23.624931?rss=1">
<title>
<![CDATA[
Mapping enhancer-gene regulatory interactions from single-cell data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.23.624931?rss=1</link>
<description><![CDATA[
Mapping enhancers and their target genes in specific cell types is crucial for understanding gene regulation and human disease genetics. However, accurately predicting enhancer-gene regulatory interactions from single-cell datasets has been challenging. Here, we introduce a new family of classification models, scE2G, to predict enhancer-gene regulation. These models use features from single-cell ATAC-seq or multiomic RNA and ATAC-seq data and are trained on a CRISPR perturbation dataset including >10,000 evaluated element-gene pairs. We benchmark scE2G models against CRISPR perturbations, fine-mapped eQTLs, and GWAS variant-gene associations and demonstrate state-of-the-art performance at prediction tasks across multiple cell types and categories of perturbations. We apply scE2G to build maps of enhancer-gene regulatory interactions in heterogeneous tissues and interpret noncoding variants associated with complex traits, nominating regulatory interactions linking INPP4B and IL15 to lymphocyte counts. The scE2G models will enable accurate mapping of enhancer-gene regulatory interactions across thousands of diverse human cell types.
]]></description>
<dc:creator>Sheth, M. U.</dc:creator>
<dc:creator>Qiu, W.-L.</dc:creator>
<dc:creator>Ma, X. R.</dc:creator>
<dc:creator>Gschwind, A. R.</dc:creator>
<dc:creator>Jagoda, E.</dc:creator>
<dc:creator>Tan, A. S.</dc:creator>
<dc:creator>Einarsson, H.</dc:creator>
<dc:creator>Gorissen, B. L.</dc:creator>
<dc:creator>Dubocanin, D.</dc:creator>
<dc:creator>McGinnis, C. S.</dc:creator>
<dc:creator>Amgalan, D.</dc:creator>
<dc:creator>Satpathy, A. T.</dc:creator>
<dc:creator>Jones, T. R.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Ustun, B.</dc:creator>
<dc:creator>Engreitz, J. M.</dc:creator>
<dc:creator>Andersson, R.</dc:creator>
<dc:date>2024-11-24</dc:date>
<dc:identifier>doi:10.1101/2024.11.23.624931</dc:identifier>
<dc:title><![CDATA[Mapping enhancer-gene regulatory interactions from single-cell data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.14.618256?rss=1">
<title>
<![CDATA[
SPLENDID incorporates continuous genetic ancestry in biobank-scale data to improve polygenic risk prediction across diverse populations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.14.618256?rss=1</link>
<description><![CDATA[
Polygenic risk scores are widely used in disease risk stratification, but their accuracy varies across diverse populations. Recent methods large-scale leverage multi-ancestry data to improve accuracy in under-represented populations but require labelling individuals by ancestry for prediction. This poses challenges for practical use, as clinical practices are typically not based on ancestry. We propose SPLENDID, a novel penalized regression framework for diverse biobank-scale data. Our method utilizes ancestry principal component interactions to model genetic ancestry as a continuum within a single prediction model for all ancestries, eliminating the need for discrete labels. In extensive simulations and analyses of 9 traits from the All of Us Research Program (N=224,364) and UK Biobank (N=340,140), SPLENDID significantly outperformed existing methods in prediction accuracy and model sparsity. By directly incorporating continuous genetic ancestry in model training, SPLENDID stands as a valuable tool for robust risk prediction across diverse populations and fairer clinical implementation.
]]></description>
<dc:creator>Chen, T.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Mazumder, R.</dc:creator>
<dc:creator>Lin, X.</dc:creator>
<dc:date>2024-10-17</dc:date>
<dc:identifier>doi:10.1101/2024.10.14.618256</dc:identifier>
<dc:title><![CDATA[SPLENDID incorporates continuous genetic ancestry in biobank-scale data to improve polygenic risk prediction across diverse populations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.19.613754?rss=1">
<title>
<![CDATA[
scooby: Modeling multi-modal genomic profiles from DNA sequence at single-cell resolution 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.19.613754?rss=1</link>
<description><![CDATA[
Understanding how regulatory DNA elements shape gene expression across individual cells is a fundamental challenge in genomics. Joint RNA-seq and epigenomic profiling provides opportunities to build unifying models of gene regulation capturing sequence determinants across steps of gene expression. However, current models, developed primarily for bulk omics data, fail to capture the cellular heterogeneity and dynamic processes revealed by single-cell multi-modal technologies. Here, we introduce scooby, the first framework to model scRNA-seq coverage and scATAC-seq insertion profiles along the genome from sequence at single-cell resolution. For this, we leverage the pre-trained multi-omics profile predictor Borzoi as a foundation model, equip it with a cell-specific decoder, and fine-tune its sequence embeddings. Specifically, we condition the decoder on the cell position in a precomputed single-cell embedding resulting in strong generalization capability. Applied to a hematopoiesis dataset, scooby recapitulates cell-specific expression levels of held-out genes, and identifies regulators and their putative target genes through in silico motif deletion. Moreover, accurate variant effect prediction with scooby allows for breaking down bulk eQTL effects into single-cell effects and delineating their impact on chromatin accessibility and gene expression. We anticipate scooby to aid unraveling the complexities of gene regulation at the resolution of individual cells.
]]></description>
<dc:creator>Gagneur, J.</dc:creator>
<dc:creator>Hingerl, J. C.</dc:creator>
<dc:creator>Martens, L. D.</dc:creator>
<dc:creator>Manz, T.</dc:creator>
<dc:creator>Theis, F. J.</dc:creator>
<dc:creator>Buenrostro, J. D.</dc:creator>
<dc:creator>Karollus, A.</dc:creator>
<dc:date>2024-09-22</dc:date>
<dc:identifier>doi:10.1101/2024.09.19.613754</dc:identifier>
<dc:title><![CDATA[scooby: Modeling multi-modal genomic profiles from DNA sequence at single-cell resolution]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.17.611902?rss=1">
<title>
<![CDATA[
Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.17.611902?rss=1</link>
<description><![CDATA[
PurposeWe previously developed an approach to calibrate computational tools for clinical variant classification, updating recommendations for the reliable use of variant impact predictors to provide evidence strength up to Strong. A new generation of tools using distinctive approaches have since been released, and these methods must be independently calibrated for clinical application.

MethodUsing our local posterior probability-based calibration and our established data set of ClinVar pathogenic and benign variants, we determined the strength of evidence provided by three new tools (AlphaMissense, ESM1b, VARITY) and calibrated scores meeting each evidence strength. Results

All three tools reached the Strong level of evidence for variant pathogenicity and Moderate for benignity, though sometimes for few variants. Compared to previously recommended tools, these yielded at best only modest improvements in the tradeoffs of evidence strength and false positive predictions.

ConclusionAt calibrated thresholds, three new computational predictors provided evidence for variant pathogenicity at similar strength to the four previously recommended predictors (and comparable with functional assays for some variants). This calibration broadens the scope of computational tools for application in clinical variant classification. Their new approaches offer promise for future advancement of the field.
]]></description>
<dc:creator>Bergquist, T.</dc:creator>
<dc:creator>Stenton, S. L.</dc:creator>
<dc:creator>Nadeau, E. A. W.</dc:creator>
<dc:creator>Byrne, A. B.</dc:creator>
<dc:creator>Greenblatt, M. S.</dc:creator>
<dc:creator>Harrison, S. M.</dc:creator>
<dc:creator>Tavtigian, S. V.</dc:creator>
<dc:creator>O'Donnell-Luria, A.</dc:creator>
<dc:creator>Biesecker, L. G.</dc:creator>
<dc:creator>Radivojac, P.</dc:creator>
<dc:creator>Brenner, S. E.</dc:creator>
<dc:creator>Pejaver, V.</dc:creator>
<dc:creator>ClinGen Sequence Variant Interpretation Working Group,</dc:creator>
<dc:date>2024-09-21</dc:date>
<dc:identifier>doi:10.1101/2024.09.17.611902</dc:identifier>
<dc:title><![CDATA[Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.10.612293?rss=1">
<title>
<![CDATA[
A cell and transcriptome atlas of the human arterial vasculature 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.10.612293?rss=1</link>
<description><![CDATA[
Contiguous arterial segments show different propensities for different vascular pathologies, yet mechanisms explaining these fundamental differences remain unknown. We sought to build a transcriptomic, cellular, and spatial atlas of human arterial cells across multiple different arterial segments to understand these underlying differences.

Analysis of multiple isogenic arterial segments from healthy donors reveals a significant stereotyped pattern of cell type-specific segmental heterogeneity in healthy arteries. Combining single cell analysis with spatial transcriptomic data reveals cellular heterogeneity not captured by commonly used cell-type marker genes. Determinants of arterial transcriptomic identities are predominantly encoded in fibroblasts and smooth muscle cells (SMC), and their differentially expressed genes are particularly enriched for different vascular disease-associated genetic risk- loci and risk-genes. Adventitial fibroblast-specific heterogeneity in gene expression coincides with a disproportionally large number of vascular disease genetic signals, suggesting a previously unrecognized role for this cell type in disease risk. Adult arterial cells from different segments cluster not by anatomical proximity, but by embryonic origin. Global regulon analysis of disease related segment-specific gene expression program in fibroblast and SMC enriches for binding sites of transcription factors that are developmental master regulators whose expression persists into adulthood, suggesting an important functional role of the same developmental master regulators in adult gene expression and disease. Lastly, non-coding transcriptomes across arterial cells contain extensive variation in lncRNAs expressed in cell type- and segment-specific patterns, rivaling heterogeneity in protein coding transcriptomes. Differentially expressed LncRNA demonstrate enrichment for non-coding genetic signals for vascular diseases, suggesting a potential global role of segmental specific LncRNAs in regulating inherited human vascular disease risk.
]]></description>
<dc:creator>Zhao, Q.</dc:creator>
<dc:creator>Pedroza, A.</dc:creator>
<dc:creator>Sharma, D.</dc:creator>
<dc:creator>Gu, W.</dc:creator>
<dc:creator>Dalal, A.</dc:creator>
<dc:creator>Weldy, C.</dc:creator>
<dc:creator>Jackson, W.</dc:creator>
<dc:creator>Li, D. Y.</dc:creator>
<dc:creator>Ryan, Y.</dc:creator>
<dc:creator>Nguyen, T.</dc:creator>
<dc:creator>Shad, R.</dc:creator>
<dc:creator>Palmisano, B. T.</dc:creator>
<dc:creator>Monteiro, J. P.</dc:creator>
<dc:creator>Worssam, M.</dc:creator>
<dc:creator>Berezwitz, A.</dc:creator>
<dc:creator>Iyer, M.</dc:creator>
<dc:creator>Shi, H.</dc:creator>
<dc:creator>Kundu, R.</dc:creator>
<dc:creator>Limbu, L.</dc:creator>
<dc:creator>Kim, J. B.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Fischbein, M.</dc:creator>
<dc:creator>Wirka, R.</dc:creator>
<dc:creator>Quertermous, T.</dc:creator>
<dc:creator>Cheng, P.</dc:creator>
<dc:date>2024-09-10</dc:date>
<dc:identifier>doi:10.1101/2024.09.10.612293</dc:identifier>
<dc:title><![CDATA[A cell and transcriptome atlas of the human arterial vasculature]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.09.612085?rss=1">
<title>
<![CDATA[
CRISPR-CLEAR: Nucleotide-Resolution Mapping of Regulatory Elements via Allelic Readout of Tiled Base Editing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.09.612085?rss=1</link>
<description><![CDATA[
CRISPR tiling screens have advanced the identification and characterization of regulatory sequences but are limited by low resolution arising from the indirect readout of editing via guide RNA sequencing. This study introduces CRISPR-CLEAR, an end-to-end experimental assay and computational pipeline, which leverages targeted sequencing of CRISPR-introduced alleles at the endogenous target locus following dense base-editing mutagenesis. This approach enables the dissection of regulatory elements at nucleotide resolution, facilitating a direct assessment of genotype-phenotype effects.
]]></description>
<dc:creator>Becerra, B.</dc:creator>
<dc:creator>Wittibschlager, S.</dc:creator>
<dc:creator>Patel, Z. M.</dc:creator>
<dc:creator>Kutschat, A.</dc:creator>
<dc:creator>Delano, J.</dc:creator>
<dc:creator>Karjalainen, A.</dc:creator>
<dc:creator>Wu, T.</dc:creator>
<dc:creator>Starrs, M.</dc:creator>
<dc:creator>Jankowiak, M.</dc:creator>
<dc:creator>Bauer, D.</dc:creator>
<dc:creator>Seruggia, D.</dc:creator>
<dc:creator>Pinello, L.</dc:creator>
<dc:date>2024-09-09</dc:date>
<dc:identifier>doi:10.1101/2024.09.09.612085</dc:identifier>
<dc:title><![CDATA[CRISPR-CLEAR: Nucleotide-Resolution Mapping of Regulatory Elements via Allelic Readout of Tiled Base Editing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.06.611737?rss=1">
<title>
<![CDATA[
Mutagenesis Sensitivity Mapping of HumanEnhancers In Vivo 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.06.611737?rss=1</link>
<description><![CDATA[
Distant-acting enhancers are central to human development. However, our limited understanding of their functional sequence features prevents the interpretation of enhancer mutations in disease. Here, we determined the functional sensitivity to mutagenesis of human developmental enhancers in vivo. Focusing on seven enhancers active in the developing brain, heart, limb and face, we created over 1700 transgenic mice for over 260 mutagenized enhancer alleles. Systematic mutation of 12-basepair blocks collectively altered each sequence feature in each enhancer at least once. We show that 69% of all blocks are required for normal in vivo activity, with mutations more commonly resulting in loss (60%) than in gain (9%) of function. Using predictive modeling, we annotated critical nucleotides at base-pair resolution. The vast majority of motifs predicted by these machine learning models (88%) coincided with changes to in vivo function, and the models showed considerable sensitivity, identifying 59% of all functional blocks. Taken together, our results reveal that human enhancers contain a high density of sequence features required for their normal in vivo function and provide a rich resource for further exploration of human enhancer logic.
]]></description>
<dc:creator>Kosicki, M.</dc:creator>
<dc:creator>Zhang, B.</dc:creator>
<dc:creator>Pampari, A.</dc:creator>
<dc:creator>Akiyama, J. A.</dc:creator>
<dc:creator>Playzer-Frick, I.</dc:creator>
<dc:creator>Novak, C. S.</dc:creator>
<dc:creator>Tran, S.</dc:creator>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Kato, M.</dc:creator>
<dc:creator>Hunter, R. D.</dc:creator>
<dc:creator>von Maydell, K.</dc:creator>
<dc:creator>Barton, S.</dc:creator>
<dc:creator>Beckman, E.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Dickel, D. E.</dc:creator>
<dc:creator>Visel, A.</dc:creator>
<dc:creator>Pennacchio, L. A.</dc:creator>
<dc:date>2024-09-08</dc:date>
<dc:identifier>doi:10.1101/2024.09.06.611737</dc:identifier>
<dc:title><![CDATA[Mutagenesis Sensitivity Mapping of HumanEnhancers In Vivo]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.04.611293?rss=1">
<title>
<![CDATA[
Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSER 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.04.611293?rss=1</link>
<description><![CDATA[
Recent technological developments in single-cell RNA-seq CRISPR screens enable high-throughput investigation of the genome. Through transduction of a gRNA library to a cell population followed by transcriptomic profiling by scRNA-seq, it is possible to characterize the effects of thousands of genomic perturbations on global gene expression. A major source of noise in scRNA-seq CRISPR screens are ambient gRNAs, which are contaminating gRNAs that likely originate from other cells. If not properly filtered, ambient gRNAs can result in an excess of false positive gRNA assignments. Here, we utilize CRISPR barnyard assays to characterize ambient gRNA noise in single-cell CRISPR screens. We use these datasets to develop and train CLEANSER, a mixture model that identifies and filters ambient gRNA noise. This model takes advantage of the bimodal distribution between native and ambient gRNAs and includes both gRNA and cell-specific normalization parameters, correcting for confounding technical factors that affect individual gRNAs and cells. The output of CLEANSER is the probability that a gRNA-cell assignment is in the native distribution over the ambient distribution. We find that ambient gRNA filtering methods impact differential gene expression analysis outcomes and that CLEANSER outperforms alternate approaches by increasing gRNA-cell assignment accuracy.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=189 SRC="FIGDIR/small/611293v1_ufig1.gif" ALT="Figure 1">
View larger version (66K):
org.highwire.dtl.DTLVardef@165c63dorg.highwire.dtl.DTLVardef@ba0e15org.highwire.dtl.DTLVardef@f2b12eorg.highwire.dtl.DTLVardef@14e6c86_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Liu, S.</dc:creator>
<dc:creator>Hamilton, M. C.</dc:creator>
<dc:creator>Cowart, T. N.</dc:creator>
<dc:creator>Barrera, A.</dc:creator>
<dc:creator>Bounds, L. R.</dc:creator>
<dc:creator>Nelson, A. C.</dc:creator>
<dc:creator>Doty, R. W.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Crawford, G. E.</dc:creator>
<dc:creator>Majoros, W. H.</dc:creator>
<dc:creator>Gersbach, C. A.</dc:creator>
<dc:date>2024-09-04</dc:date>
<dc:identifier>doi:10.1101/2024.09.04.611293</dc:identifier>
<dc:title><![CDATA[Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSER]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.30.610571?rss=1">
<title>
<![CDATA[
BayeSMART: Bayesian Clustering of Multi-sample Spatially Resolved Transcriptomics Data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.30.610571?rss=1</link>
<description><![CDATA[
The field of spatially resolved transcriptomics (SRT) has greatly advanced our understanding of cellular microenvironments by integrating spatial information with molecular data collected from multiple tissue sections or individuals. However, methods for multi-sample spatial clustering are lacking, and existing methods primarily rely on molecular information alone. This paper introduces BayeSMART, a Bayesian statistical method designed to identify spatial domains across multiple samples. BayeSMART leverages artificial intelligence (AI)-reconstructed single-cell level information from the paired histology images of multi-sample SRT datasets while simultaneously considering the spatial context of gene expression. The AI integration enables BayeSMART to effectively interpret the spatial domains. We conducted case studies using four datasets from various tissue types and SRT platforms and compared BayeSMART with alternative multi-sample spatial clustering approaches and a number of state-of-the-art methods for single-sample SRT analysis, demonstrating that it surpasses existing methods in terms of clustering accuracy, interpretability, and computational efficiency. BayeSMART offers new insights into the spatial organization of cells in multi-sample SRT data.
]]></description>
<dc:creator>Guo, Y.</dc:creator>
<dc:creator>Zhu, B.</dc:creator>
<dc:creator>Tang, C.</dc:creator>
<dc:creator>Rong, R.</dc:creator>
<dc:creator>Ma, Y.</dc:creator>
<dc:creator>Xiao, G.</dc:creator>
<dc:creator>Xu, L.</dc:creator>
<dc:creator>Li, Q.</dc:creator>
<dc:date>2024-09-01</dc:date>
<dc:identifier>doi:10.1101/2024.08.30.610571</dc:identifier>
<dc:title><![CDATA[BayeSMART: Bayesian Clustering of Multi-sample Spatially Resolved Transcriptomics Data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.19.604364?rss=1">
<title>
<![CDATA[
Long-read sequencing transcriptome quantification with lr-kallisto 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.19.604364?rss=1</link>
<description><![CDATA[
RNA abundance quantification has become routine and affordable thanks to high-throughput "short-read" technologies that provide accurate molecule counts at the gene level. Similarly accurate and affordable quantification of definitive fulllength, transcript isoforms has remained a stubborn challenge, despite its obvious biological significance across a wide range of problems. "Long-read" sequencing platforms now produce data-types that can, in principle, drive routine definitive isoform quantification. However some particulars of contemporary long-read datatypes, together with isoform complexity and genetic variation, present bioinformatic challenges. We show here, using ONT data, that fast and accurate quantification of long-read data is possible and that it is improved by exome capture. To perform quantifications we developed lr-kallisto, which adapts the kallisto bulk and single-cell RNA-seq quantification methods for long-read technologies.
]]></description>
<dc:creator>Loving, R. K.</dc:creator>
<dc:creator>Sullivan, D. K.</dc:creator>
<dc:creator>Reese, F.</dc:creator>
<dc:creator>Rebboah, E.</dc:creator>
<dc:creator>Sakr, J.</dc:creator>
<dc:creator>Rezaie, N.</dc:creator>
<dc:creator>Liang, H. Y.</dc:creator>
<dc:creator>Filimban, G.</dc:creator>
<dc:creator>Kawauchi, S.</dc:creator>
<dc:creator>Oakes, C.</dc:creator>
<dc:creator>Trout, D.</dc:creator>
<dc:creator>Williams, B. A.</dc:creator>
<dc:creator>MacGregor, G.</dc:creator>
<dc:creator>Wold, B.</dc:creator>
<dc:creator>Mortazavi, A.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2024-07-19</dc:date>
<dc:identifier>doi:10.1101/2024.07.19.604364</dc:identifier>
<dc:title><![CDATA[Long-read sequencing transcriptome quantification with lr-kallisto]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.13.603403?rss=1">
<title>
<![CDATA[
Estimating cis and trans contributions todifferences in gene regulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.13.603403?rss=1</link>
<description><![CDATA[
We describe a coordinate system and associated hypothesis testing framework for determining whether cis or trans regulation is responsible for differences in gene expression between two homozygous strains or species. We apply our framework to data from single replicate studies on yeast strains and human-chimpanzee hybrid cells, as well as to data from a mouse study with replicates, showing marked differences between our gene regulatory assignments and those previously reported. We also show how our multi-sample framework can determine the context dependency of cis and trans effects as well as explicitly model different hypotheses regarding the underlying mechanism of trans regulation.
]]></description>
<dc:creator>Hallgrimsdottir, I. B.</dc:creator>
<dc:creator>Carilli, M.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2024-07-16</dc:date>
<dc:identifier>doi:10.1101/2024.07.13.603403</dc:identifier>
<dc:title><![CDATA[Estimating cis and trans contributions todifferences in gene regulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.12.603288?rss=1">
<title>
<![CDATA[
Cohesin-mediated 3D contacts tune enhancer-promoter regulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.12.603288?rss=1</link>
<description><![CDATA[
Enhancers are key drivers of gene regulation thought to act via 3D physical interactions with the promoters of their target genes. However, genome-wide depletions of architectural proteins such as cohesin result in only limited changes in gene expression, despite a loss of contact domains and loops. Consequently, the role of cohesin and 3D contacts in enhancer function remains debated. Here, we developed CRISPRi of regulatory elements upon degron operation (CRUDO), a novel approach to measure how changes in contact frequency impact enhancer effects on target genes by perturbing enhancers with CRISPRi and measuring gene expression in the presence or absence of cohesin. We systematically perturbed all 1,039 candidate enhancers near five cohesin-dependent genes and identified 34 enhancer-gene regulatory interactions. Of 26 regulatory interactions with sufficient statistical power to evaluate cohesin dependence, 18 show cohesin-dependent effects. A decrease in enhancer-promoter contact frequency upon removal of cohesin is frequently accompanied by a decrease in the regulatory effect of the enhancer on gene expression, consistent with a contact-based model for enhancer function. However, changes in contact frequency and regulatory effects on gene expression vary as a function of distance, with distal enhancers (e.g., >50Kb) experiencing much larger changes than proximal ones (e.g., <50Kb). Because most enhancers are located close to their target genes, these observations can explain how only a small subset of genes -- those with strong distal enhancers -- are sensitive to cohesin. Together, our results illuminate how 3D contacts, influenced by both cohesin and genomic distance, tune enhancer effects on gene expression.
]]></description>
<dc:creator>Guckelberger, P.</dc:creator>
<dc:creator>Doughty, B. R.</dc:creator>
<dc:creator>Munson, G.</dc:creator>
<dc:creator>Rao, S. S. P.</dc:creator>
<dc:creator>Tan, Y.</dc:creator>
<dc:creator>Cai, X. S.</dc:creator>
<dc:creator>Fulco, C. P.</dc:creator>
<dc:creator>Nasser, J.</dc:creator>
<dc:creator>Mualim, K. S.</dc:creator>
<dc:creator>Bergman, D. T.</dc:creator>
<dc:creator>Ray, J.</dc:creator>
<dc:creator>Jagoda, E.</dc:creator>
<dc:creator>Munger, C. J.</dc:creator>
<dc:creator>Gschwind, A. R.</dc:creator>
<dc:creator>Sheth, M. U.</dc:creator>
<dc:creator>Tan, A. S.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:creator>Lander, E. S.</dc:creator>
<dc:creator>Meissner, A.</dc:creator>
<dc:creator>Lieberman Aiden, E.</dc:creator>
<dc:creator>Engreitz, J. M.</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:identifier>doi:10.1101/2024.07.12.603288</dc:identifier>
<dc:title><![CDATA[Cohesin-mediated 3D contacts tune enhancer-promoter regulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.08.602569?rss=1">
<title>
<![CDATA[
Smooth muscle expression of RNA editing enzyme ADAR1 controls vascular integrity and progression of atherosclerosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.08.602569?rss=1</link>
<description><![CDATA[
Mapping the genomic architecture of complex disease has been predicated on the understanding that genetic variants influence disease risk through modifying gene expression. However, recent discoveries have revealed that a significant burden of disease heritability in common autoinflammatory disorders and coronary artery disease (CAD) is mediated through genetic variation modifying post-transcriptional modification of RNA through adenosine-to-inosine (A-to-I) RNA editing. This common RNA modification is catalyzed by ADAR enzymes, where ADAR1 edits specific immunogenic double stranded RNA (dsRNA) to prevent activation of the double strand RNA (dsRNA) sensor MDA5 (IFIH1) and stimulation of an interferon stimulated gene (ISG) response. Multiple lines of human genetic data indicate impaired RNA editing and increased dsRNA sensing by MDA5 to be an important mechanism of CAD risk. Here, we provide a crucial link between observations in human genetics and mechanistic cell biology leading to progression of CAD. Through analysis of human atherosclerotic plaque and culture of human coronary artery vascular smooth muscle cells (SMCs) we implicate the SMC to have a distinct requirement for RNA editing, and that MDA5 activation regulates SMC phenotypic modulation. Through generation of a conditional SMC specific Adar1 deletion mouse model on a pro-atherosclerosis background with additional constitutive deletion of MDA5 (Ifih1), and with incorporation of single cell RNA sequencing cellular profiling, we further show that Adar1 controls SMC phenotypic state by regulating Mda5 activation, is required to maintain vascular integrity, and controls progression of atherosclerosis and vascular calcification. Finally, we further corroborate our findings in a large human carotid endarterectomy dataset (Athero-Express) where we show that ISG activation is strongly associated with decreased plaque stability, increased SMC phenotypic modulation, and increased plaque calcification. Through this work, we describe a fundamental mechanism of CAD, where cell type and context specific RNA editing and sensing of dsRNA mediates disease progression, bridging our understanding of human genetics and disease causality.

One Sentence SummarySmooth muscle expression of RNA editing enzyme ADAR1 regulates activation of double strand RNA sensor MDA5 in novel mechanism of atherosclerosis.
]]></description>
<dc:creator>Weldy, C. S.</dc:creator>
<dc:creator>Li, Q.</dc:creator>
<dc:creator>Monteiro, J. P.</dc:creator>
<dc:creator>Guo, H.</dc:creator>
<dc:creator>Galls, D.</dc:creator>
<dc:creator>Gu, W.</dc:creator>
<dc:creator>Cheng, P. P.</dc:creator>
<dc:creator>Ramste, M.</dc:creator>
<dc:creator>Li, D. Y.</dc:creator>
<dc:creator>Palmisano, B. T.</dc:creator>
<dc:creator>Sharma, D.</dc:creator>
<dc:creator>Worssam, M. D.</dc:creator>
<dc:creator>Zhao, Q.</dc:creator>
<dc:creator>Bhate, A.</dc:creator>
<dc:creator>Kundu, R.</dc:creator>
<dc:creator>Nguyen, T.</dc:creator>
<dc:creator>Li, J. B.</dc:creator>
<dc:creator>Quertermous, T.</dc:creator>
<dc:date>2024-07-11</dc:date>
<dc:identifier>doi:10.1101/2024.07.08.602569</dc:identifier>
<dc:title><![CDATA[Smooth muscle expression of RNA editing enzyme ADAR1 controls vascular integrity and progression of atherosclerosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.04.602131?rss=1">
<title>
<![CDATA[
Stochastic Modeling of Biophysical Responses to Perturbation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.04.602131?rss=1</link>
<description><![CDATA[
Recent advances in high-throughput, multi-condition experiments allow for genome-wide investigation of how perturbations affect transcription and translation in the cell across multiple biological entities or modalities, from chromatin and mRNA information to protein production and spatial morphology. This presents an unprecedented opportunity to unravel how the processes of DNA and RNA regulation direct cell fate determination and disease response. Most methods designed for analyzing large-scale perturbation data focus on the observational outcomes, e.g., expression; however, many potential transcriptional mechanisms, such as transcriptional bursting or splicing dynamics, can underlie these complex and noisy observations. In this analysis, we demonstrate how a stochastic biophysical modeling approach to interpreting high-throughout perturbation data enables deeper investigation of the  how behind such molecular measurements. Our approach takes advantage of modalities already present in data produced with current technologies, such as nascent and mature mRNA measurements, to illuminate transcriptional dynamics induced by perturbation, predict kinetic behaviors in new perturbation settings, and uncover novel populations of cells with distinct kinetic responses to perturbation.
]]></description>
<dc:creator>Chari, T.</dc:creator>
<dc:creator>Gorin, G.</dc:creator>
<dc:creator>Pachter, L.</dc:creator>
<dc:date>2024-07-06</dc:date>
<dc:identifier>doi:10.1101/2024.07.04.602131</dc:identifier>
<dc:title><![CDATA[Stochastic Modeling of Biophysical Responses to Perturbation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.04.602130?rss=1">
<title>
<![CDATA[
Gene regulatory network structure informs the distribution of perturbation effects 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.04.602130?rss=1</link>
<description><![CDATA[
Gene regulatory networks (GRNs) govern many core developmental and biological processes underlying human complex traits. Even with broad-scale efforts to characterize the effects of molecular perturbations and interpret gene coexpression, it remains challenging to infer the architecture of gene regulation in a precise and efficient manner. Key properties of GRNs, like hierarchical structure, modular organization, and sparsity, provide both challenges and opportunities for this objective. Here, we seek to better understand properties of GRNs using a new approach to simulate their structure and model their function. We produce realistic network structures with a novel generating algorithm based on insights from small-world network theory, and we model gene expression regulation using stochastic differential equations formulated to accommodate modeling molecular perturbations. With these tools, we systematically describe the effects of gene knockouts within and across GRNs, finding a subset of networks that recapitulate features of a recent genome-scale perturbation study. With deeper analysis of these exemplar networks, we consider future avenues to map the architecture of gene expression regulation using data from cells in perturbed and unperturbed states, finding that while perturbation data are critical to discover specific regulatory interactions, data from unperturbed cells may be sufficient to reveal regulatory programs.
]]></description>
<dc:creator>Aguirre, M.</dc:creator>
<dc:creator>Spence, J. P.</dc:creator>
<dc:creator>Sella, G.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2024-07-05</dc:date>
<dc:identifier>doi:10.1101/2024.07.04.602130</dc:identifier>
<dc:title><![CDATA[Gene regulatory network structure informs the distribution of perturbation effects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.17.599448?rss=1">
<title>
<![CDATA[
A model for accurate quantification of CRISPR effects in pooled FACS screens 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.17.599448?rss=1</link>
<description><![CDATA[
CRISPR screens are powerful tools to identify key genes that underlie biological processes. One important type of screen uses fluorescence activated cell sorting (FACS) to sort perturbed cells into bins based on the expression level of marker genes, followed by guide RNA (gRNA) sequencing. Analysis of these data presents several statistical challenges due to multiple factors including the discrete nature of the bins and typically small numbers of replicate experiments. To address these challenges, we developed a robust and powerful Bayesian random effects model and software package called Waterbear. Furthermore, we used Waterbear to explore how various experimental design parameters affect statistical power to establish principled guidelines for future screens. Finally, we experimentally validated our experimental design model findings that, when using Waterbear for analysis, high power is maintained even at low cell coverage and a high multiplicity of infection. We anticipate that Waterbear will be of broad utility for analyzing FACS-based CRISPR screens.
]]></description>
<dc:creator>Pimentel, H.</dc:creator>
<dc:creator>Freimer, J.</dc:creator>
<dc:creator>Arce, M. M.</dc:creator>
<dc:creator>Garrido, C. M.</dc:creator>
<dc:creator>Marson, A.</dc:creator>
<dc:creator>Pritchard, J. K.</dc:creator>
<dc:date>2024-06-18</dc:date>
<dc:identifier>doi:10.1101/2024.06.17.599448</dc:identifier>
<dc:title><![CDATA[A model for accurate quantification of CRISPR effects in pooled FACS screens]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
